KOL | Erika RM von MutiusComprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, ... |
kolの履歴書 Erika RM von Mutius
| Year | |
|---|---|
| 2022 | Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, Munich, Germany; Institute of Asthma and Allergy Prevention (IAP), Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Institute for Asthma and Allergy Prevention, Helmholtz Centre Munich, 85764 Neuherberg, Germany |
| 2021 | Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany |
| 2020 | German Center for Lung Research, CPC-M From the Institute of Asthma and Allergy Prevention, Helmholtz Centre Munich, Munich, and the Asthma and Airway Disease Research Center, University of Arizona, Tucson. |
| 2019 | Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Institute for Asthma and Allergy Prevention, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany Dr von Hauner Children's Hospital, Ludwig Maximilian University German Center for Lung Research (DZL) |
| 2018 | Member of the German Centre for Lung Research, Munich, Germany Direktorin, Institut für Asthma und Allergieprävention Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstraße 1, 85764 Neuherberg |
| 2017 | Children Hospital and Children Polyclinic in the Dr. von Haunersches Children Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, 80337 Munich, Germany Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL) |
Erika RM von Mutius：統計に影響を与えます
レポートを実行します
| Concept | World rank |
|---|---|
| atopy farm | #1 |
| aor interquartile range | #1 |
| gsdma expression | #1 |
| children road traffic | #1 |
| data fetal growth | #1 |
| phenotypes atopic sensitization | #1 |
| farm milk | #1 |
| throat microbiota | #1 |
| allergic sensitization latex | #1 |
| preventive measures counselling | #1 |
| prenatal farm | #1 |
| atopy interactions | #1 |
| neonatal mice ahr | #1 |
| asthma protective | #1 |
| followup solar iii | #1 |
| unpasteurized cows milk | #1 |
| feeding cattle cowsheds | #1 |
| stepwise procedure risk | #1 |
| farm allergic rhinitis | #1 |
| allergies childhood phase | #1 |
| amish hutterite children | #1 |
| association atopic sensitization | #1 |
| farms farm homes | #1 |
| insight asthma | #1 |
| environmental exposures asthma | #1 |
| 12 months doctor | #1 |
| regression approach order | #1 |
| 95 hormonal contraceptives | #1 |
| otitis fever | #1 |
| order covariates | #1 |
| domestic asthma child | #1 |
| followup solar cohort | #1 |
| protective asthma | #1 |
| lps recognition development | #1 |
| children farm children | #1 |
| atopic dermatitis increase | #1 |
| netcomi functionality | #1 |
| 2nd followup challenges | #1 |
| methods solar cohort | #1 |
| bronchial hyperreactivity childhood | #1 |
| farm environments asthma | #1 |
| diversity microbial exposure | #1 |
| nickel allergy asthma | #1 |
| gene expression ilt4 | #1 |
| tnc asthma | #1 |
| farming nasal samples | #1 |
| consumption allergic | #1 |
| age dust microbiota | #1 |
| generations birth cohort | #1 |
| farm studies | #1 |
| rs11079788 | #1 |
| wholeto | #1 |
| yoghurt asthma risk | #1 |
| helminth parasites exposure | #1 |
| agents reduced risk | #1 |
| symptoms gender ratio | #1 |
| farm homes homes | #1 |
| egg aor | #1 |
| antipyretics reduced risk | #1 |
| unremitting wheeze | #1 |
| 95 asthma | #1 |
| epidemiological evidence consumption | #1 |
| transcription factors hlx1 | #1 |
| diagnosed fever 95 | #1 |
| life inversely | #1 |
| milkassociated cla | #1 |
| sige spt | #1 |
| interquartile range asthma | #1 |
| mold problems kitchen | #1 |
| risk tcell phenotypes | #1 |
| 420lys | #1 |
| sod3 sod3 snps | #1 |
| farmrelated exposures | #1 |
| allergies atopic dermatitis | #1 |
| microbial exposure sum | #1 |
| pierced ears asthma | #1 |
| stable dust extract | #1 |
| work overload school | #1 |
| incidence indoor allergens | #1 |
| year environmental exposures | #1 |
| 12 months crowding | #1 |
| bhr asthma child | #1 |
| skin tests spt | #1 |
| farm lung function | #1 |
| study questionnaire responses | #1 |
| pattern atopic sensitization | #1 |
| model hyperreactivity | #1 |
| allergen exposure life | #1 |
| data netcomi | #1 |
| lumbricoides crude measure | #1 |
| higher hscrp values | #1 |
| ddhay fever children | #1 |
| prevent allergic diseases | #1 |
| maturation gut microbiome | #1 |
| innate immunity receptors | #1 |
| mrna expression year | #1 |
| predictive models incidence | #1 |
| occurrence generations | #1 |
| lca pasture | #1 |
| bacterial exposures associations | #1 |
| late onset menarche | #1 |
| gabriel study | #1 |
| tbx21 hlx1 | #1 |
| life maternal atopy | #1 |
| allergic rhinitis menarche | #1 |
| tregs cd4cd25hi | #1 |
| atopic dermatitis jobs | #1 |
| environmental exposure age | #1 |
| solids relation | #1 |
| microbiome data package | #1 |
| rora snps | #1 |
| mold immune responsiveness | #1 |
| cla allergoprotective capacity | #1 |
| rhinitis predictor | #1 |
| solids development | #1 |
| lukas2 umc | #1 |
| anti‐asthmatic drugs | #1 |
| countries isaac phase | #1 |
| factors th1 | #1 |
| 5 years aor | #1 |
| farm rural children | #1 |
| ema protective farm | #1 |
| dampness childhood | #1 |
| increased expression ormdl3 | #1 |
| allergy exposures | #1 |
| munich dresden | #1 |
| cowsheds farm animals | #1 |
| farmers children | #1 |
| late introduction egg | #1 |
| asthma symptoms community | #1 |
| common inhalants | #1 |
| 3785 adolescents | #1 |
| allergies topic surveys | #1 |
| isaac phase data | #1 |
| soot benzene | #1 |
| endotoxin levels stables | #1 |
| antipyretics increased risk | #1 |
| tregs age | #1 |
| isolated cd4cd25hi tregs | #1 |
| 812 children | #1 |
| asthma toll | #1 |
| 7 yrs determinants | #1 |
| wheezing atopic sensitization | #1 |
| allergy cohort methods | #1 |
| predominant obstruction | #1 |
| transient wheeze age | #1 |
| health urbanrural differences | #1 |
| 95 grass pollen | #1 |
| fever atopic | #1 |
| infant inflammation crp | #1 |
| food diversity year | #1 |
| allergoprotective capacity | #1 |
| europe protection | #1 |
| microbial exposure patterns | #1 |
| crobiome data | #1 |
| atopic eczema 95 | #1 |
| followup solar | #1 |
| farm dwellings homes | #1 |
| rural children w12 | #1 |
| atopic embryonic allergic | #1 |
| 105 years richness | #1 |
| fpr2 clec4e | #1 |
| pet contact infancy | #1 |
| analyses provocation time | #1 |
| turkish children asthma | #1 |
| sige association | #1 |
| atopic sensitisation fever | #1 |
| allergies viral infections | #1 |
| traditional farms | #1 |
| selfreported nickel allergy | #1 |
| acrossolar | #1 |
| unprocessed cow | #1 |
| childhood asthma age | #1 |
| tobit regression ranks | #1 |
| positive sensitization egg | #1 |
| wheeze asthma questions | #1 |
| “hygiene hypothesis | #1 |
| prevalence environmental factors | #1 |
| rora asthma susceptibility | #1 |
| farming protective farm | #1 |
| west germany overweight | #1 |
| hyperreactive children | #1 |
| pasture cohort | #1 |
| 585883 | #1 |
| children amish farms | #1 |
| ige levels exposure | #1 |
| leipzig munich | #1 |
| preschool wheezing aor | #1 |
| authors grass arabinogalactans | #1 |
| wheezing fever | #1 |
| parental questionnaires | #1 |
| solar study | #1 |
| solar 2nd followup | #1 |
| exposure muramic | #1 |
| solar cohort | #1 |
| infant adolescent aging | #1 |
| male parents receptors | #1 |
| eczema regions | #1 |
| w12 ddhay fever | #1 |
| new microscope | #1 |
| asthmatics innate leukocytes | #1 |
| asthma indoor exposure | #1 |
| lpastimulation | #1 |
| infant contact animals | #1 |
| cleanliness dust parameters | #1 |
| development asthma | #1 |
| classical definitions lca | #1 |
| children alliance asthma | #1 |
| adolescence bronchial hyperreactivity | #1 |
| increased prevalence cough | #1 |
| feeding overweight | #1 |
| farm wheeze phenotypes | #1 |
| crp early age | #1 |
| development allergic illnesses | #1 |
| samples farm dwellings | #1 |
| coding region il4ra | #1 |
| allergic asthmatics asthmatics | #1 |
| farm milk asthma | #1 |
| newonset allergic rhinitis | #1 |
| fever farm | #1 |
| prediction quality snps | #1 |
| atopic diseases association | #1 |
| hlx1 snps cbmcs | #1 |
| asthmatics hc | #1 |
| risk mite sensitization | #1 |
| symptoms school age | #1 |
| treatment 9 bronchodilators | #1 |
| expiratory volume lca | #1 |
| school age early | #1 |
| tubes rnastabilizing solution | #1 |
| children unification | #1 |
| cd4creil13 | #1 |
| germany breast feeding | #1 |
| bronchial obstruction hyperreactivity | #1 |
| h4 acetylation offspring | #1 |
| farm milk meat | #1 |
| protective childhood | #1 |
| immune activation populations | #1 |
| prenatal animal | #1 |
| network differences groups | #1 |
| 17q21 polymorphisms ormdl3 | #1 |
| allergic rhinitis predictor | #1 |
| 17q21 polymorphisms | #1 |
| puberty infant | #1 |
| perinatal influences | #1 |
| animal sheds barns | #1 |
| tbx21 | #1 |
| annual concentrations benzene | #1 |
| 1120 children | #1 |
| infancy jia | #1 |
| indoor bacterial microbiota | #1 |
| asthma questionnaire responses | #1 |
| increased risk rhinoconjunctivitis | #1 |
| childhood allergy children | #1 |
| endotoxin level production | #1 |
| farm children hrqol | #1 |
| heattreated milk samples | #1 |
| hc aa | #1 |
| lps foxp3 demethylation | #1 |
| atopic sensitization birth | #1 |
| 035 iu specificity | #1 |
| 457 iu | #1 |
| non‐farm children | #1 |
| children 7 yrs | #1 |
| netcomi network construction | #1 |
| paediatric origins | #1 |
| allergy symptoms childhood | #1 |
| kitchen visible mold | #1 |
| allergyprotective potential | #1 |
| hyperreactivity expiratory volume | #1 |
| farm dairy products | #1 |
| interaction npsr1 polymorphisms | #1 |
| kitchen moisture damage | #1 |
| adolescent agriculture dust | #1 |
| questionnaires childhood | #1 |
| bronchial response wheeze | #1 |
| pasture lukas2 | #1 |
| richness farming | #1 |
| allergies cohort | #1 |
| endotoxin levels samples | #1 |
| influential factors health | #1 |
| cutoff 3 mm | #1 |
| microbial exposure asthma | #1 |
| harmful workplace exposure | #1 |
| gpra gene | #1 |
| protection childhood asthma | #1 |
| children beta 2agonists | #1 |
| messenger surveys | #1 |
| th2 th1 gsdma | #1 |
| asthma rhinoconjunctivitis eczema | #1 |
| rural allergy endotoxin | #1 |
| wheeze environmental determinants | #1 |
| hrqol protective | #1 |
| alpine farm environments | #1 |
| repeated infections life | #1 |
| multicenter cohort prevalence | #1 |
| asthmatic children result | #1 |
| stimulation 45yearold children | #1 |
| yogurt year | #1 |
| infant genetic polymorphism | #1 |
| aa clec4e | #1 |
| epidemiologic phenotypes | #1 |
| transient wheeze asthma | #1 |
| exposures pieces | #1 |
| influential factors phenotype | #1 |
| unprocessed cows milk | #1 |
| asthma arabinogalactan | #1 |
| regular farm animal | #1 |
| allergies endotoxin | #1 |
| infant design | #1 |
| dgge asthma | #1 |
| patients neutrophil inflammation | #1 |
| associations indoor mould | #1 |
| childhood dampness | #1 |
| mite exposure risk | #1 |
| menarche hormonal contraceptives | #1 |
| allergic diseases protective | #1 |
| adolescents jobs | #1 |
| cowsheds peak | #1 |
| farming exposure childhood | #1 |
| agreement spts | #1 |
| farm milk exposure | #1 |
| protection allergic diseases | #1 |
| studies microbial exposures | #1 |
| jobs potential confounders | #1 |
| concomitant bhr 95 | #1 |
| pollen concentration feeding | #1 |
| comparison microbiome data | #1 |
| features anthroposophic lifestyle | #1 |
| allergy‐protective effects | #1 |
| food sensitization egg | #1 |
| tnc risk gene | #1 |
| igein | #1 |
| genetic association tnc | #1 |
| igg1 galactosylation predictor | #1 |
| hlx1 polymorphisms influence | #1 |
| risk gene asthma | #1 |
| asthma risk lca | #1 |
| lower prevalence asthma | #1 |
| bronchial hyperreactivity adolescence | #1 |
| barns farm dwellings | #1 |
| edta tubes countries | #1 |
| farmers nonfarmers children | #1 |
| il13cd4 cells ilcs | #1 |
| exposure mattress dust | #1 |
| crude measure exposure | #1 |
| agreement association | #1 |
| gene expression ormdl3 | #1 |
| polymorphisms tbx21 | #1 |
| gel variations gels | #1 |
| farm animals cats | #1 |
| psychosocial characteristics asthma | #1 |
| aa nonallergic asthma | #1 |
| asthma dresden | #1 |
| immunity innate infant | #1 |
| work ilc2s | #1 |
| infants karelia | #1 |
| prehireonset odds ratio | #1 |
| allergic illnesses | #1 |
| new onset wheeze | #1 |
| sensitisation early | #1 |
| allergic germany | #1 |
| no2 traffic counts | #1 |
| farm lifestyles | #1 |
| anthroposophic families validity | #1 |
| npsr1 interaction | #1 |
| childhood bronchial hyperreactivity | #1 |
| atopy rural subjects | #1 |
| wheezerelated latent classes | #1 |
| lower atopic sensitization | #1 |
| lukas2 birth cohorts | #1 |
| countries pasture study | #1 |
| asthmatics asthma phenotypes | #1 |
| pets associations | #1 |
| allergies generations | #1 |
| chapter 16 epidemiology | #1 |
| environments pasture | #1 |
| wheezing w12 | #1 |
| cleanliness matter | #1 |
| wheeze bronchial | #1 |
| tolllike receptor farmers | #1 |
| cde source | #1 |
| genetic interaction npsr1 | #1 |
| dzl | #1 |
| 115 iu | #1 |
| protection yogurt | #1 |
| diversity consumed types | #1 |
| treatment childhood asthma | #1 |
| asthma turkish children | #1 |
| pets crowding | #1 |
| germany prevalence differences | #1 |
| german peers | #1 |
| phytohemagglutinin ormdl3 | #1 |
| maternal farm | #1 |
| atopic sensitization aor | #1 |
| alliance asthma | #1 |
| farm exposure asthma | #1 |
| 6 types cheese | #1 |
| dresden east germany | #1 |
| wheeze farmers children | #1 |
| ddhay fever 95 | #1 |
| rora neuropeptide receptor | #1 |
| 3 mm spt | #1 |
| hrqol farm children | #1 |
| interaction npsr1 protein | #1 |
| ddhay fever | #1 |
| lumbricoides farmers children | #1 |
| farming environments | #1 |
| gabriel advanced study | #1 |
| aa immunity receptors | #1 |
| pollen dairy farms | #1 |
| jobs asthma risk | #1 |
| associations dna fingerprinting | #1 |
| aetiology early years | #1 |
| west germany munich | #1 |
| atopic smokers baseline | #1 |
| cord blood offspring | #1 |
| farm exposure exposure | #1 |
| atopy allergen specificity | #1 |
| mite sensitization aor | #1 |
| immune stimulation life | #1 |
| observing children | #1 |
| npsr1 messenger receptors | #1 |
| dust parameters development | #1 |
| solar iii | #1 |
| allergic rhinitis jia | #1 |
| sum indicators | #1 |
| 95 atopic eczema | #1 |
| th2related genes | #1 |
| farm living | #1 |
| cε germline transcript | #1 |
| foxp3 demethylation tregs | #1 |
| 18 95 incidence | #1 |
| spts agreement | #1 |
| allergies year | #1 |
| mattress dust association | #1 |
| allergy protective | #1 |
| gsdma expression secretion | #1 |
| exposure farming environment | #1 |
| employment new onset | #1 |
| study prehireonset | #1 |
| preschool dermatitis questionnaires | #1 |
| cowsheds childrens bedrooms | #1 |
| microbial exposure endotoxin | #1 |
| mold subclinical inflammation | #1 |
| secretion life | #1 |
| actinomycetes cowsheds | #1 |
| farm children bavaria | #1 |
| domestic child child | #1 |
| recurrence atopic dermatitis | #1 |
| aa hcs | #1 |
| npsr1 tnc | #1 |
| ppg lpa ppg | #1 |
| groups rural areas | #1 |
| predictor immune activation | #1 |
| dairying environment pollen | #1 |
| allergic rhinitis puberty | #1 |
| polymorphisms lps recognition | #1 |
| contact farm | #1 |
| fever milk consumption | #1 |
| study rural environment | #1 |
| environments asthma | #1 |
| regular farm | #1 |
| children severe atopy | #1 |
| wheeze classes | #1 |
| asthma rora | #1 |
| 95 allergen | #1 |
| paper online questionnaires | #1 |
| hypopharynx moraxella | #1 |
| east germany allergic | #1 |
| farm farm children | #1 |
| city air pollution | #1 |
| 30 amish | #1 |
| association farm | #1 |
| rs7164773 | #1 |
| associations hscrp values | #1 |
| farms wheeze | #1 |
| barns samples | #1 |
| arabinogalactan cde | #1 |
| rhinoconjunctivitis participation | #1 |
| identification immune phenotypes | #1 |
| microbes epigenetic mechanisms | #1 |
| maternal farming activities | #1 |
| living area risk | #1 |
| personal cleanliness risk | #1 |
| phenotypes lca | #1 |
| menarche allergic | #1 |
| hrqol rural farm | #1 |
| package functionality | #1 |
| wheezing male respiratory | #1 |
| 13 microbial influences | #1 |
| atopic sensitization | #1 |
| benzene current wheeze | #1 |
| children preschool conjunctivitis | #1 |
| south bavarian | #1 |
| maternal farming | #1 |
| class pasture | #1 |
| association farm milk | #1 |
| factor school behavior | #1 |
| dampness bronchial hyperreactivity | #1 |
| insight environmental factors | #1 |
| 5–13‐year | #1 |
| t1432c | #1 |
| preschool children rhinitis | #1 |
| allergic rhinitis type | #1 |
| maternal atopy tregs | #1 |
| fever blood samples | #1 |
| asthma symptoms adulthood | #1 |
| pierced ears association | #1 |
| transmaternal asthma protection | #1 |
| subsample predominant obstruction | #1 |
| excessive sige production | #1 |
| juvenile crohn disease | #1 |
| grass arabinogalactan mice | #1 |
| prediction farm children | #1 |
| antibiotics allergies | #1 |
| current wheeze benzene | #1 |
| atopic disease bias | #1 |
| groups netcomi | #1 |
| protective mechanisms asthma | #1 |
| parents allergies | #1 |
| age increased diversity | #1 |
| domestic cats child | #1 |
| indicators total quantity | #1 |
| early phenotypes age | #1 |
| offspring atopic mothers | #1 |
| anthropometric data overweight | #1 |
| childhood protective | #1 |
| dermatitis symptoms | #1 |
| spink5 kazal type | #1 |
| rnastabilizing solution | #1 |
| childhood asthma allergies | #1 |
| germany dresden | #1 |
| farming environment development | #1 |
| yogurt cows milk | #1 |
| auc spt | #1 |
| analyses isaac phase | #1 |
| 18 months protective | #1 |
| allergen exposure associations | #1 |
| usage preventive measures | #1 |
| fever atopic dermatitis | #1 |
| ilt4 cb | #1 |
| childhood gondii seropositivity | #1 |
| ranks performance | #1 |
| persistence adolescence | #1 |
| worldwide asthma epidemic | #1 |
| ilcs inception | #1 |
| asthma wisc | #1 |
| bacterial exposures | #1 |
| oropharyngeal microbiota children | #1 |
| 57 911yearold children | #1 |
| allergic diseases hrqol | #1 |
| incident wheezing women | #1 |
| development atopic sensitisation | #1 |
| asthma puberty | #1 |
| computing microbial associations | #1 |
| farm fungi humans | #1 |
| hygiene hypothesis endotoxin | #1 |
| censored immunological | #1 |
| strongest predictor atopy | #1 |
| shop milk | #1 |
| coupled receptor polymorphisms | #1 |
| bifidobacterium breastfed infants | #1 |
| atopic dermatitis onset | #1 |
| farming environment role | #1 |
| farm asthma | #1 |
| farmers anthroposophic families | #1 |
| asthma bacteria | #1 |
| early age risk | #1 |
| amish hutterite | #1 |
| npsr1 rora | #1 |
| cd4cd25hi isolated cells | #1 |
| homes farm dwellings | #1 |
| respiratory symptoms childhood | #1 |
| allergen exposure age | #1 |
| newborn leukocytes surveys | #1 |
| asthma concomitant asthma | #1 |
| initial cohort pattern | #1 |
| children amish children | #1 |
| consumption farm milk | #1 |
| farm animal exposure | #1 |
| asthma richness | #1 |
| wheezing 3rd year | #1 |
| positive sensitization | #1 |
| stepwise procedure gene | #1 |
| increased diversity food | #1 |
| prognosis early wheeze | #1 |
| girls allergic rhinitis | #1 |
| feeding patterns risk | #1 |
| inhaled steroids dresden | #1 |
| association spink5 420lys | #1 |
| determinants airway responsiveness | #1 |
| identified polymorphisms asthma | #1 |
| asthma allergies | #1 |
| lower atopy asthma | #1 |
| spts specific ige | #1 |
| model bronchial hyperreactivity | #1 |
| interaction rora | #1 |
| asthma symptoms adolescence | #1 |
| dairy products protective | #1 |
| participants solar | #1 |
| 624 children | #1 |
| east germany leipzig | #1 |
| asthma diversity | #1 |
| asthma aor | #1 |
| hypersensitivity infections | #1 |
| allergoprotective | #1 |
| allergic rhinitis childhood | #1 |
| serum ige levels | #1 |
| lpa ppg stimulation | #1 |
| introduction yogurt | #1 |
| network construction netcomi | #1 |
| gasdermin gsdma | #1 |
| germany allergic | #1 |
| living environment children | #1 |
| asthma tregs | #1 |
| children acrossolar cohort | #1 |
| farm environments farms | #1 |
| igg1 galactosylation levels | #1 |
| review hygiene hypothesis | #1 |
| lca feeding patterns | #1 |
| anthroposophic lifestyle features | #1 |
| bronchial hyperreactivity age | #1 |
| immunity newborn mothers | #1 |
| potential confounders jobs | #1 |
| peak airborne moulds | #1 |
| clec4e aa | #1 |
| overweight marked differences | #1 |
| allergy prevention studies | #1 |
| aa ifih1 expression | #1 |
| newborn interleukin17 leukocytes | #1 |
| protection hygiene hypothesis | #1 |
| asthma interactions | #1 |
| crowding dry cough | #1 |
| consumption asthma | #1 |
| cumulative incidence finland | #1 |
| blood ormdl3 | #1 |
| aor farm exposures | #1 |
| cohorte pasture | #1 |
| farm reduced prevalence | #1 |
| 035 iu sige | #1 |
| cattle childrens bedrooms | #1 |
| animal farms substances | #1 |
| stepwise protocol phase | #1 |
| cbmcs ormdl3 | #1 |
| endotoxin exposure association | #1 |
| derp1lpa | #1 |
| 5–13‐year school children | #1 |
| asthma bacterial diversity | #1 |
| cough soot | #1 |
| bacterial groups prevalence | #1 |
| study parsifal | #1 |
| external microbial | #1 |
| seasonal allergens | #1 |
| occupational disinfectants asthma | #1 |
| protective exposures | #1 |
| damage systemic inflammation | #1 |
| 1314 newborn infants | #1 |
| farming environment protective | #1 |
| personal cleanliness | #1 |
| work overload followup | #1 |
| pasture cohort lca | #1 |
| accuracy regression approach | #1 |
| exposure gstm1 deficiency | #1 |
| obstruktive atemwegserkrankungen | #1 |
| tempo method | #1 |
| ilt4 cord blood | #1 |
| associations airwayrelated symptoms | #1 |
| mold problems children | #1 |
| subtypes atopic dermatitis | #1 |
| asthma concomitant bhr | #1 |
| treg marker genes | #1 |
| fever spt cutoff | #1 |
| ahr acinetobacter lwoffii | #1 |
| dermatitis depending | #1 |
| participation rates phase | #1 |
| asthma german | #1 |
| girls mechanism | #1 |
| clinical examinations challenges | #1 |
| endotoxin allergy | #1 |
| childhood asthma fever | #1 |
| unifying computational tool | #1 |
| asthma microbiome analysis | #1 |
| environmental factors sensitization | #1 |
| spink5 420lys | #1 |
| associations maternal sensitization | #1 |
| milk asthma | #1 |
| igg4 ige expression | #1 |
| development allergies | #1 |
| farm nonfarm children | #1 |
| igg4 coexpression | #1 |
| otus bacterial diversity | #1 |
| diseases farm | #1 |
| phenotypes atopic | #1 |
| wheeze active smoking | #1 |
| fpr2 aa | #1 |
| richness asthma | #1 |
| ormdl3 gsdma expression | #1 |
| bamse npsr1 | #1 |
| maschildren | #1 |
| protective atopic sensitization | #1 |
| male saline solution | #1 |
| igg nglycosylation populations | #1 |
| 6 years subtypes | #1 |
| late introduction solids | #1 |
| association farm contact | #1 |
| farm specific exposures | #1 |
| persistence bronchial hyperreactivity | #1 |
| protective farm asthma | #1 |
| association haplotype studies | #1 |
| farm exposure asthmatics | #1 |
| farm childhood asthma | #1 |
| tregs asthmatics | #1 |
| bacterial signals atopy | #1 |
| allergies early phenotypes | #1 |
| 15ans | #1 |
| children farmers | #1 |
| rora susceptibility gene | #1 |
| 911 yrs | #1 |
| asthmatic farm children | #1 |
| girls late onset | #1 |
| vehicle traffic asthma | #1 |
| 5 years predictor | #1 |
| aa increased atp2a3 | #1 |
| exposure farm | #1 |
| normal censored | #1 |
| predictor igg1 galactosylation | #1 |
| parsifal‐study | #1 |
| str bhr | #1 |
| recurrent unremitting wheeze | #1 |
| risk hutterite children | #1 |
| stepwise protocol bhr | #1 |
| tregs life | #1 |
| atopic sensitization development | #1 |
| regulatory triggering receptor | #1 |
| repeated episodes fever | #1 |
| source arabinogalactan | #1 |
| wheeze farm living | #1 |
| crohns disease atopy | #1 |
| 1 ppg stimulation | #1 |
| grass arabinogalactan | #1 |
| wheeze farming exposure | #1 |
| actinomycetes peak | #1 |
| protective farm environment | #1 |
| adolescent agriculture | #1 |
| pcr sscp method | #1 |
| diversity protective effects | #1 |
| rs11071559 | #1 |
| 95 late introduction | #1 |
| demethylation foxp3 demethylation | #1 |
| expression 17q21 | #1 |
| wheeze sensitisation | #1 |
| child environmental pollutants | #1 |
| provocation time bhr | #1 |
| loft farm milk | #1 |
| associations pet contact | #1 |
| mrna expression tregs | #1 |
| 17q21 locus method | #1 |
| farming children | #1 |
| childhood design | #1 |
| netcomi network | #1 |
| allergies personal cleanliness | #1 |
| specific exposures cows | #1 |
| immune receptors birth | #1 |
| tcells foxp3 | #1 |
| protection asthma | #1 |
| cla content plasma | #1 |
| 1120 german schoolchildren | #1 |
| fever atopic sensitization | #1 |
| farm fever | #1 |
| microorganisms farms | #1 |
| environmental microbial | #1 |
| traditional upbringing | #1 |
| common infections infants | #1 |
| phenotype health variables | #1 |
| bhr fall | #1 |
| atopy microbial influences | #1 |
| age bacterial endotoxin | #1 |
| asthma bronchial response | #1 |
| asthma west germany | #1 |
| 95 nonatopic asthma | #1 |
| 168fold | #1 |
| farming allergies | #1 |
| children automobiles child | #1 |
| muramic acid concentration | #1 |
| antiasthma drugs children | #1 |
| food items year | #1 |
| increased risks rhinoconjunctivitis | #1 |
| development childhood asthma | #1 |
| moderate‐to‐adequate | #1 |
| psychosocial characteristics children | #1 |
| histamine challenges age | #1 |
| ige seasonal allergens | #1 |
| overweight munich | #1 |
| children diabimmune study | #1 |
| infections hygiene hypothesis | #1 |
| gsdma phytohemagglutinin | #1 |
| kazal type spink5 | #1 |
| rhinoconjunctivitis sex | #1 |
| association incident rhinoconjunctivitis | #1 |
| birth tbx21 | #1 |
| asthma risk pasture | #1 |
| children atopic sensitization | #1 |
| protective cheese consumption | #1 |
| development preschool wheezing | #1 |
| persistence earlylife exposures | #1 |
| farm protects | #1 |
| increased food diversity | #1 |
| farmingrelated exposures | #1 |
| current asthma age | #1 |
| 95 puberty | #1 |
| protective allergic diseases | #1 |
| lpastimulation cord blood | #1 |
| health services exposure | #1 |
| exposure protective | #1 |
| lukas2 lca | #1 |
| evidence allergy prevention | #1 |
| protective farming | #1 |
| farming asthma | #1 |
| protective 6 years | #1 |
| asthma consumption | #1 |
| preschool children predictor | #1 |
| bronchial hyperreactivity wheezing | #1 |
| pasture study tubes | #1 |
| bactoscan | #1 |
| menarche hormonal | #1 |
| allergies respiratory infections | #1 |
| environmental differences finland | #1 |
| bmi allergic dermatitis | #1 |
| bhr str | #1 |
| gene expression ilt3 | #1 |
| selection bias responders | #1 |
| moisture mold exposure | #1 |
| overweight dresden | #1 |
| atopic dermatitis farm | #1 |
| doctor allergic rhinitis | #1 |
| physiciandiagnosed asthma groups | #1 |
| school university life | #1 |
| tregs maternal atopy | #1 |
| farm cowsheds | #1 |
| agriculture asthma | #1 |
| males pierced ears | #1 |
| immune responses birth | #1 |
| hyperreaktivität | #1 |
| allergic diseases questionnaires | #1 |
| 1133 children | #1 |
| cd4cd25hi tcells | #1 |
| children predominant hyperreactivity | #1 |
| health influential factors | #1 |
| heating children | #1 |
| logistic models npsr1 | #1 |
| age asthma child | #1 |
| questionnaire responses asthma | #1 |
| life chronic asthma | #1 |
| associations transient sensitization | #1 |
| early development wheeze | #1 |
| male poland quality | #1 |
| gabriel advanced surveys | #1 |
| muramic acid wheezing | #1 |
| grass pollen 95 | #1 |
| association occupational disinfectants | #1 |
| protective effects exposure | #1 |
| allergyrisk factors | #1 |
| phase international | #1 |
| wheezing children wheezing | #1 |
| life protective | #1 |
| visible mold homes | #1 |
| provocation time | #1 |
| school children germany | #1 |
| exposure farm children | #1 |
| snps wheeze | #1 |
| persistence allergic rhinitis | #1 |
| asthma turkish | #1 |
| network construction comparison | #1 |
| farming environments asthma | #1 |
| 9 bronchodilators | #1 |
| farm children microorganisms | #1 |
| unbalanced meat consumption | #1 |
| cowshed dust cde | #1 |
| parasitic infections predictor | #1 |
| helminths protective | #1 |
| single microbial markers | #1 |
| hlx1 polymorphisms | #1 |
| maternal atopy secretion | #1 |
| protective factors strategies | #1 |
| peptidoglycan ppg birth | #1 |
| asthma genetic effects | #1 |
| allergies | #1 |
| respiratory sounds immunity | #1 |
| allergic allergic dermatitis | #1 |
| validity food questionnaire | #1 |
| 45yearold children protection | #1 |
| breastfeeding length | #1 |
| children leipzig | #1 |
| kitchen living area | #1 |
| occurrence allergy | #1 |
| asthma german children | #1 |
| protective diversity | #1 |
| th2related genes cytokines | #1 |
| prehireonset | #1 |
| farm exposure igg4 | #1 |
| nct02496468 | #1 |
| tenascin neuropeptide receptor | #1 |
| rs2738751 | #1 |
| farm animals asthma | #1 |
| boys fever | #1 |
| amish environment | #1 |
| early life insight | #1 |
| immune responsiveness life | #1 |
| 95 agmr | #1 |
| seasonal rural | #1 |
| followup work discontent | #1 |
| lca male phenotype | #1 |
| failure☆ | #1 |
| ilcs neonatal mice | #1 |
| polysaccharides cde | #1 |
| higher specificity asthma | #1 |
| actinomycetes alpine farms | #1 |
| protective effects asthma | #1 |
| patients treg cells | #1 |
| neonatal immune mechanisms | #1 |
| linens child dust | #1 |
| allergic diseases cutoff | #1 |
| relation late introduction | #1 |
| sensitised children wheeze | #1 |
| wheezing invertedu shape | #1 |
| environmental exposures protection | #1 |
| asthma austria allergic | #1 |
| ascaris lumbricoides exposure | #1 |
| 20 fall volume | #1 |
| no2 allergic sensitisation | #1 |
| methods 2nd followup | #1 |
| role th2 immunity | #1 |
| airborne moulds actinomycetes | #1 |
| jia domestic arthritis | #1 |
| score total quantity | #1 |
| marked differences prevalence | #1 |
| airborne fungi actinomycetes | #1 |
| unhygienic contact | #1 |
| asthma food sensitization | #1 |
| tnc npsr1 | #1 |
| pets farm animals | #1 |
| dresden munich | #1 |
| analysis step package | #1 |
| tregs foxp3 demethylation | #1 |
| ml1 cohort studies | #1 |
| 95 asthmatic children | #1 |
| cowsheds cattle | #1 |
| association ilt4 | #1 |
| asthma asthma bacteria | #1 |
| asthmaprotective farm | #1 |
| atopic dermatitis adolescence | #1 |
| current contact asthma | #1 |
| lpastimulation carriers | #1 |
| alpine farms | #1 |
| prenatal animal contact | #1 |
| food allergy yogurt | #1 |
| increased atp2a3 fpr2 | #1 |
| infancy case status | #1 |
| work overload work | #1 |
| advanced surveys | #1 |
| incident wheezing | #1 |
| gpra polymorphisms | #1 |
| spt atopic dermatitis | #1 |
| gpra polymorphisms asthma | #1 |
| incident wheezing asthma | #1 |
| adolescent aging asthma | #1 |
| unprocessed farm milk | #1 |
| dgge health outcomes | #1 |
| environmental allergens variety | #1 |
| moisture damage kitchen | #1 |
| allergies cohort studies | #1 |
| asthma atopic disease | #1 |
| allergies existing cohort | #1 |
| topic puberty rhinitis | #1 |
| atopic sensitization early | #1 |
| tbx21 hlx1 snps | #1 |
| supplementation milk cla | #1 |
| 048 95 95 | #1 |
| reduced risk allergy | #1 |
| carriers hlx1 | #1 |
| children early phenotypes | #1 |
| followup farm living | #1 |
| managing wheezing | #1 |
| children indoor mould | #1 |
| asthma farm children | #1 |
| complementary food year | #1 |
| ormdl3 gasdermin | #1 |
| latent classes populations | #1 |
| netcomi | #1 |
| transient wheezing age | #1 |
| living farm | #1 |
| phase stratified sample | #1 |
| humans hypopharynx moraxella | #1 |
| 9 10yold children | #1 |
| swinesheds | #1 |
| lca clinical phenotypes | #1 |
| epidemiologic phenotype | #1 |
| changing gender ratio | #1 |
| children isaac asthma | #1 |
| life fungi humans | #1 |
| 1 year occurrence | #1 |
| 95 atopic sensitization | #1 |
| epigenetic regulation mechanism | #1 |
| protective effects diversity | #1 |
| animal sheds 28 | #1 |
| indoor microbiota development | #1 |
| aetiology atopic disease | #1 |
| 26 farms bavaria | #1 |
| animal contact infancy | #1 |
| pasture study spt | #1 |
| atopic embryonic | #1 |
| allergies protective pet | #1 |
| 28 dust samples | #1 |
| leur relation | #1 |
| menarche allergic rhinitis | #1 |
| otus farming | #1 |
| quantitative confirmation associations | #1 |
| south bavarian population | #1 |
| functionality network differences | #1 |
| farm living symptoms | #1 |
| il4ra association | #1 |
| microorganisms animal sheds | #1 |
| current asthma soot | #1 |
| abundances 6 otus | #1 |
| farm animals childhood | #1 |
| yogurt diversity | #1 |
| maternal farm exposure | #1 |
| regulatory responses protection | #1 |
| phase isaac programme | #1 |
| sige cutoff | #1 |
| asthma 105 years | #1 |
| incident wheezing association | #1 |
| sige sensitizations symptoms | #1 |
| farm dwellings children | #1 |
| copd sod3 | #1 |
| children rural allergy | #1 |
| 95 endotoxin exposure | #1 |
| life antibiotic exposure | #1 |
| acrossolar study | #1 |
| ilcs administration | #1 |
| estonia environmental differences | #1 |
| prevalence atopic sensitisation | #1 |
| munich leipzig | #1 |
| egg positive sensitization | #1 |
| foxp3 cd4cd25hi | #1 |
| allergies addition | #1 |
| “atopic march | #1 |
| coexpression igg1 | #1 |
| farm indoor | #1 |
| farm milk consumption | #1 |
| single taxa groups | #1 |
| 17q21 risk | #1 |
| west germany allergic | #1 |
| childrens bedrooms cowsheds | #1 |
| asthma risk class | #1 |
| predominant hyperreactivity subsample | #1 |
| mice atopic sensitization | #1 |
| covariates potential confounding | #1 |
| study participants levels | #2 |
| increase parent | #2 |
| relation dust endotoxin | #2 |
| alk samples | #2 |
| wheeze bronchial responsiveness | #2 |
| farming families allergies | #2 |
| atopic eczema phenotypes | #2 |
| age asthma cohort | #2 |
| atopic smokers | #2 |
| exposure environmental microorganisms | #2 |
| sensitization patterns inhalant | #2 |
| role maternal exposures | #2 |
| higher greenness quartile | #2 |
| peptidoglycan ppg | #2 |
| current interpretation | #2 |
| environmental microorganisms children | #2 |
| association opposite direction | #2 |
| life increased risk | #2 |
| increased risk employment | #2 |
| data maternal weight | #2 |
| wheeze 12 | #2 |
| atopic developing countries | #2 |
| asthma crp | #2 |
| environmental exposures mother | #2 |
| bronchial hyperresponsiveness allergic | #2 |
| pa interrelations | #2 |
| severity spirometric measures | #2 |
| fieldworkers house dust | #2 |
| quartile work discontent | #2 |
| causation environmental associations | #2 |
| geneenvironment interactions asthma | #2 |
| time breastfed children | #2 |
| fieldworkers absolute levels | #2 |
| immunoglobulin nod1 | #2 |
| neu5gc exposure | #2 |
| childhood lca | #2 |
| work discontent | #2 |
| current paracetamol 95 | #2 |
| cases objective measurements | #2 |
| opposite direction children | #2 |
| associations lessaffluent countries | #2 |
| demethylation foxp3 | #2 |
| lipid lpa | #2 |
| cd14 1721 association | #2 |
| consumption farm | #2 |
| atopic sensitization 14 | #2 |
| wheeze bronchial hyperresponsiveness | #2 |
| school level 95 | #2 |
| affluent countries | #2 |
| studies farms | #2 |
| lower atopy | #2 |
| university baseline | #2 |
| affluent countries eczema | #2 |
| foxp3 demethylation | #2 |
| frequency nocturnal asthma | #2 |
| animal exposure levels | #2 |
| influence cord | #2 |
| children farm | #2 |
| beta1 endotoxin | #2 |
| c4ma3 biomarker | #2 |
| messenger receptors tenascin | #2 |
| antiige therapy response | #2 |
| nonfarm homes children | #2 |
| imposed social isolation | #2 |
| farmers children children | #2 |
| protein rhinitis allergic | #2 |
| exposures farm | #2 |
| farming families | #2 |
| nocturnal asthma severity | #2 |
| standardized procedure centres | #2 |
| protect development | #2 |
| card4 21596 children | #2 |
| early life prevalence | #2 |
| fev1 fdr fdr | #2 |
| pha th17 lineage | #2 |
| farms reference | #2 |
| artemisia olive pollen | #2 |
| tregs cord blood | #2 |
| immunoglobulin life | #2 |
| allergic diseases allergies | #2 |
| developing allergies | #2 |
| alternaria animals animals | #2 |
| milk cd14 | #2 |
| consumption unpasteurized milk | #2 |
| parent asthma | #2 |
| bronchial hyperresponsiveness exposure | #2 |
| nonfarming families | #2 |
| farm children | #2 |
| lipid ppg | #2 |
| munich participants | #2 |
| rna russia | #2 |
| processed cow | #2 |
| bhr individual level | #2 |
| th17 lineage markers | #2 |
| expression innate | #2 |
| asthma phenotypes negative | #2 |
| ages current paracetamol | #2 |
| indoor bacterial | #2 |
| pha farming mothers | #2 |
| associations atopy | #2 |
| environmental microorganisms | #2 |
| atopic diseases subjects | #2 |
| socks dust | #2 |
| excessive edna production | #2 |
| atopic dermatitis wheeze | #2 |
| cd14 maternal exposures | #2 |
| coaacetate | #2 |
| cd14 genotypes asthma | #2 |
| grass pollen dander | #2 |
| allele specific ige | #2 |
| cd14 1721 | #2 |
| multivariate analyses haying | #2 |
| farmlike indoor microbiota | #2 |
| cd14 1721 children | #2 |
| nonfarm children | #2 |
| interval156 | #2 |
| increase worldwide | #2 |
| aa hc | #2 |
| cd4 cells offspring | #2 |
| il4 il13 pathway | #2 |
| t2inflammation | #2 |
| association atopic children | #2 |
| doctors diagnosis aor | #2 |
| rhinitis adolescents | #2 |
| halle west germany | #2 |
| doctors diagnosed asthma | #2 |
| alliance ages | #2 |
| asthma parsifal | #2 |
| adult farmers role | #2 |
| fev1 fdr | #2 |
| premature respiratory | #2 |
| childhood phase | #2 |
| igg4 ige levels | #2 |
| farmers child cross | #2 |
| eczema lessaffluent countries | #2 |
| subsample children | #2 |
| 17q21 | #2 |
| interactions asthma | #2 |
| ga²len harmonization | #2 |
| maternal immunity gondii | #2 |
| study design participation | #2 |
| children bronchial obstruction | #2 |
| fdr clinical response | #2 |
| difference endotoxin levels | #2 |
| measles vaccination infection | #2 |
| bhr tirana | #2 |
| eczema farm exposures | #2 |
| life current symptoms | #2 |
| bhr west germany | #2 |
| influences development | #2 |
| dander artemisia | #2 |
| children nonfarm homes | #2 |
| protection allergy | #2 |
| eczema symptom prevalence | #2 |
| probability incidence | #2 |
| dust endotoxin allele | #2 |
| card4 protein rhinitis | #2 |
| endotoxin allergen exposure | #2 |
| 645 children | #2 |
| bronchial hyperresponsiveness children | #2 |
| symptom control bmi | #2 |
| study participants fieldworkers | #2 |
| followup university | #2 |
| exposure lifestyle factors | #2 |
| age allergic rhinitis | #2 |
| tirana mumbai | #2 |
| serum levels c4ma3 | #2 |
| exposure life | #2 |
| farming environment mother | #2 |
| allergies genetic variation | #2 |
| cats eczema | #2 |
| statistical analysis performance | #2 |
| early immune maturation | #2 |
| snps inflammatory diseases | #2 |
| isaac atopic eczema | #2 |
| sensitized patients order | #2 |
| life rural children | #2 |
| values edna concentrations | #2 |
| positive maternal record | #2 |
| sputum extracellular | #2 |
| allergen levels socks | #2 |
| polymorphisms card4 | #2 |
| symptom control pa | #2 |
| higher foxp3 | #2 |
| asthma meeting | #2 |
| card4 association | #2 |
| snps il4 gene | #2 |
| eczema conjunctivitis eczema | #2 |
| improvements fdr score | #2 |
| adult arm alliance | #2 |
| environmental microbial exposure | #2 |
| card4 21596 | #2 |
| associations hscrp levels | #2 |
| asthma observed | #2 |
| neu5gc role | #2 |
| adaptor protein rhinitis | #2 |
| farming exposure | #2 |
| south bavaria | #2 |
| agmr 95 | #2 |
| fieldworkers dust collection | #2 |
| eczema affluent | #2 |
| eczema allergic dermatitis | #2 |
| severe exacerbations feno | #2 |
| maternal contact protective | #2 |
| viable listeria spp | #2 |
| asthma protection | #2 |
| children affluent countries | #2 |
| phase prevalence rates | #2 |
| human microbiota asthma | #2 |
| childhood obesoty | #2 |
| negative volatile organic | #2 |
| prenatal farm exposure | #2 |
| microbial exposure risk | #2 |
| il13 gene linkage | #2 |
| farming anthroposophic | #2 |
| phase isaac | #2 |
| 95 047 95 | #2 |
| ages strongest associations | #2 |
| allele card4 21596 | #2 |
| new onset wheezing | #2 |
| microbial exposure study | #2 |
| lessaffluent countries | #2 |
| asthma hygiene hypothesis | #2 |
| nocturnal symptoms spirometry | #2 |
| exposure farmers children | #2 |
| 047 95 gg | #2 |
| farming environment allergies | #2 |
| current symptoms asthmaassociated | #2 |
| dresden higher greenness | #2 |
| low sensitization rates | #2 |
| living farms | #2 |
| collected dust indoor | #2 |
| microbial agents association | #2 |
| positive spt sige | #2 |
| consumption unprocessed | #2 |
| healthcare precision medicine | #2 |
| exposure farming | #2 |
| highdna | #2 |
| bm190th | #2 |
| pregnancy specific ige | #2 |
| 95 school level | #2 |
| allergic asthma degradation | #2 |
| alk samples fieldworkers | #2 |
| nocturnal asthma life | #2 |
| farming nonfarming families | #2 |
| order sensitized patients | #2 |
| paracetamol fever | #2 |
| 19th century allergic | #2 |
| dust samples levels | #2 |
| histamine challenges | #2 |
| tbx21 gene | #2 |
| fev1 score associations | #2 |
| farmers asthma symptoms | #2 |
| immunoglobulin analyses children | #2 |
| arg130gln polymorphism linkage | #2 |
| cd4cd25hi foxp3 | #2 |
| pha maternal farming | #2 |
| role helminths | #2 |
| specificity lca | #2 |
| polymorphisms il13 gene | #2 |
| allergies cd14 expression | #2 |
| affluent countries associations | #2 |
| newonset asthma symptoms | #2 |
| strachan | #2 |
| sod3 transcript | #2 |
| gmcsf ifnγ levels | #2 |
| lessaffluent countries adolescents | #2 |
| animal sheds pregnancy | #2 |
| antit2 biological therapy | #2 |
| atopic sensitization upregulation | #2 |
| c4ma3 asthma | #2 |
| relapse newonset | #2 |
| tregs demethylation | #2 |
| current exposure cats | #2 |
| socks alk samples | #2 |
| immune responses function | #2 |
| leipzig halle | #2 |
| allele cd14 1721 | #2 |
| th2 cytokines ilc2s | #2 |
| allergic disorders children | #2 |
| hc ca2 | #2 |
| association allergic diseases | #2 |
| traditional farm | #2 |
| fever west germany | #2 |
| antiidiotypic aspergillosis | #2 |
| amish farms | #2 |
| allergic rhinitis adolescence | #2 |
| improvements fdr | #2 |
| allergies farming status | #2 |
| asthma symptoms fever | #2 |
| childhood symptoms relapse | #2 |
| dendritic cells dust | #2 |
| asthma adolescence | #2 |
| alk samples levels | #2 |
| antibiotic asthma risk | #2 |
| ppg pha | #2 |
| parsifal study phenotypes | #2 |
| dairying eczema | #2 |
| 95 protective factors | #2 |
| siblings atopic children | #2 |
| ifnγ levels snps | #2 |
| children dresden | #2 |
| agriculture allergens | #2 |
| bronchitis east germany | #2 |
| asthma child dermatitis | #2 |
| hutterite farm children | #2 |
| germany asthma | #2 |
| 14 260 | #2 |
| farm animals symptoms | #2 |
| frequency nocturnal symptoms | #2 |
| allergic tolllike receptor | #2 |
| isaac prevalence rates | #2 |
| children bronchial hyperresponsiveness | #2 |
| pattern missing values | #2 |
| th17 markers | #2 |
| prediction asthma | #2 |
| atopy early life | #2 |
| participants dresden | #2 |
| followup ndvi | #2 |
| genetic variation card4 | #2 |
| inflammatory diseases allergy | #2 |
| nonfarming mothers lipid | #2 |
| asthma symptoms children | #2 |
| eczema farmers children | #2 |
| asthmaassociated aor | #2 |
| farming mothers ppg | #2 |
| rora asthma | #2 |
| individual level bhr | #2 |
| amish hutterite homes | #2 |
| patients childhood symptoms | #2 |
| atopic dermatitis childhood | #2 |
| asthma cohort | #2 |
| asthmaassociated | #2 |
| levels alk samples | #2 |
| atopic eczema causation | #2 |
| asthma symptoms eczema | #2 |
| il4 gene | #2 |
| breathomics asthma | #2 |
| asthma control pa | #2 |
| ors affluent countries | #2 |
| domestic child dust | #2 |
| olive pollen dander | #2 |
| affluent countries centers | #2 |
| gels bands | #2 |
| life pvalues | #2 |
| lifelong farm exposure | #2 |
| bacteriological properties | #2 |
| microbial influences | #2 |
| farm milk pregnancy | #2 |
| highrisk predictors | #2 |
| bronchial challenge children | #2 |
| development atopic diseases | #2 |
| test inhalent | #2 |
| onset male recurrence | #2 |
| asthma farming environment | #3 |
| growing farm | #3 |
| 280met | #3 |
| cowshed dust | #3 |
| asthma cattle | #3 |
| increased treg cells | #3 |
| life allergic diseases | #3 |
| f78 | #3 |
| farming farm | #3 |
| young adult europe | #3 |
| hygiene hypothesis development | #3 |
| endotoxin levels asthma | #3 |
| col29a1 expression eczema | #3 |
| rare tlr2 mutations | #3 |
| children african ancestry | #3 |
| eczema international study | #3 |
| regular contact | #3 |
| eczema isaac phase | #3 |
| german children munich | #3 |
| stat6 gene regulation | #3 |
| exposure helminths | #3 |
| rural areas europe | #3 |
| cytokine cluster bhr | #3 |
| arabinogalactan isolated | #3 |
| bacterial diversity asthma | #3 |
| locus dennd1b | #3 |
| risk nonatopic asthma | #3 |
| rhinitis increased risk | #3 |
| 95ci nonatopic asthma | #3 |
| allergy protection | #3 |
| onset asthma child | #3 |
| children farming | #3 |
| microorganisms dust | #3 |
| parent prevalence | #3 |
| asthma genetic severity | #3 |
| farm dust endotoxin | #3 |
| 1q31 locus | #3 |
| allergic diseases children | #3 |
| associations pcdh1 | #3 |
| cx3cr1 polymorphisms atopy | #3 |
| c39134a | #3 |
| puberty risk factors | #3 |
| asthma amino acid | #3 |
| age 7–10 years | #3 |
| dogs exposure | #3 |
| protection contre | #3 |
| forward initiative | #3 |
| mmp9 variants mmp9 | #3 |
| rhinoconjunctivitis atopic eczema | #3 |
| atopic mothers | #3 |
| markers fetal growth | #3 |
| severity moisture damage | #3 |
| role asthma prevalence | #3 |
| cohort alliance | #3 |
| maternal tlr | #3 |
| hlx1 gene variants | #3 |
| network construction | #3 |
| prevalence asthma | #3 |
| gni measurements | #3 |
| crth2 influences development | #3 |
| amino acid cx3cr1 | #3 |
| munich polymorphism | #3 |
| farm animals farm | #3 |
| female fetus immunity | #3 |
| work work overload | #3 |
| role neu5gc | #3 |
| sige asthma | #3 |
| asthma subphenotypes | #3 |
| col29a1 variants eczema | #3 |
| asthma pcdh1 | #3 |
| countries endotoxin levels | #3 |
| paf sensitisation | #3 |
| asthma genetic association | #3 |
| populations illness surveys | #3 |
| il5 c746t | #3 |
| perennial allergens paf | #3 |
| polymorphisms hlx1 gene | #3 |
| protocadherin‐1 | #3 |
| endotoxin milk | #3 |
| effects single snps | #3 |
| ferme | #3 |
| childhood asthma community | #3 |
| il5 il5 c746 | #3 |
| atopic dermatitis aor | #3 |
| allergy a20 induction | #3 |
| putative functional role | #3 |
| albania antibody specificity | #3 |
| overweight germany | #3 |
| susceptibility col29a1 expression | #3 |
| sod3 variants | #3 |
| pcdh1 polymorphisms associations | #3 |
| 1431c | #3 |
| adam33 polymorphisms asthma | #3 |
| role atopic sensitization | #3 |
| asthma tolllike receptors | #3 |
| il5 c746 allergic | #3 |
| hlx1 gene development | #3 |
| genetic variation crth2 | #3 |
| eosinophil pathway genes | #3 |
| il15 associations | #3 |
| protein rhinitis | #3 |
| t3085 | #3 |
| 1q31 locus dennd1b | #3 |
| 1000 enfants | #3 |
| dcs a20 induction | #3 |
| crosssectional population | #3 |
| farm contact | #3 |
| cx3cr1 polymorphisms polymorphism | #3 |
| lwoffii f78 | #3 |
| occurrence rhinitis | #3 |
| allergic asthmatics aa | #3 |
| wheeze allergy | #3 |
| auc asthma | #3 |
| asthma atopic sensitization | #3 |
| atopic diseases mutations | #3 |
| protective farm | #3 |
| experimental asthma progeny | #3 |
| asthma endotoxin levels | #3 |
| prenatal protection asthma | #3 |
| allergic phenotypes correction | #3 |
| atopic female germany | #3 |
| bdnf polymorphisms asthma | #3 |
| cd14 association | #3 |
| children bronchial hyperreactivity | #3 |
| atopic asthma effects | #3 |
| g1258a | #3 |
| duration prevalence | #3 |
| —study | #3 |
| bhr pcdh1 polymorphisms | #3 |
| anthroposophic children | #3 |
| tlr2 amino acid | #3 |
| asthma snp rs2786098 | #3 |
| rhinoconjunctivitis paf | #3 |
| responses innate | #3 |
| isaac polymorphisms | #3 |
| rhinoconjunctivitis conjunctivitis | #3 |
| allergic inflammation polymorphisms | #3 |
| bhr haplotypes humans | #3 |
| tlr2 polymorphisms | #3 |
| asthma 1431c | #3 |
| allergyprotective | #3 |
| il15 gene variants | #3 |
| jobrelated chronic stress | #3 |
| atopic sensitisation | #3 |
| nonatopic asthma 95ci | #3 |
| farms asthma | #3 |
| paf allergic | #3 |
| substances protection | #3 |
| today1 | #3 |
| endotoxin dust samples | #3 |
| domestic asthma | #3 |
| eosinophils matrix metalloproteinase | #3 |
| children negative spts | #3 |
| rural dwellings | #3 |
| prenatal protection | #3 |
| eosinophil pathway | #3 |
| sod3 extracellular matrix | #3 |
| farm dwellings | #3 |
| questionnaires physical examination | #3 |
| vivo expression irf1 | #3 |
| culture techniques study | #3 |
| 45yearold children | #3 |
| col29a1 polymorphisms | #3 |
| gni rho | #3 |
| eczema col29a1 | #3 |
| farming status | #3 |
| tlr2 receptor function | #3 |
| allergic phenotype polymorphism | #3 |
| ile117thr | #3 |
| asthma major | #3 |
| disequilibrium rhinitis allergic | #3 |
| dennd1b asthma | #3 |
| ppg expression | #3 |
| t12888c | #3 |
| col29a1 eczema | #3 |
| nf kappa polymorphism | #3 |
| prenatal asthma protection | #3 |
| treatment asthma phenotypes | #3 |
| col29a1 polymorphisms eczema | #3 |
| atopy dresden | #3 |
| life development | #3 |
| phase international study | #3 |
| lukas2 birth | #3 |
| allergic disequilibrium rhinitis | #3 |
| stat1 gene variations | #3 |
| individual level centers | #3 |
| throat microbiota asthma | #3 |
| monocytes lps stimulation | #3 |
| bias asthma bias | #3 |
| progeny asthma | #3 |
| c2892 | #3 |
| fever aor | #3 |
| 3099 children | #3 |
| asthma identified | #3 |
| current asthma rhinoconjunctivitis | #3 |
| domestic arthritis | #3 |
| prevalence allergies | #3 |
| breastfeeding overweight | #3 |
| wheezing neutrophils | #3 |
| col29a1 genetic variants | #3 |
| blatella | #3 |
| adam33 snps | #3 |
| characteristics respiratory | #3 |
| united kingdom albania | #3 |
| blood allergen | #3 |
| conjunctivitis paf | #3 |
| moraxella colonization | #3 |
| biomaterial collection | #3 |
| hlx1 gene | #3 |
| european ancestry asthma | #3 |
| samples 1q31 locus | #3 |
| mmp9 variants risk | #3 |
| sensitisation affluent countries | #3 |
| animal sheds | #3 |
| seasonal allergens atopy | #3 |
| dennd1b chromosome | #3 |
| environmental dusts | #3 |
| 53152 | #3 |
| bavaria obesity | #3 |
| individual level questionnaires | #3 |
| polymorphisms gm csf | #3 |
| doctors diagnosis | #3 |
| affluent countries atopy | #3 |
| organic waste storage | #3 |
| protection development | #3 |
| germany west german | #3 |
| cowshed dust extract | #3 |
| pcr sscp analysis | #3 |
| role adam33 polymorphisms | #3 |
| dresden odds ratio | #3 |
| population german | #3 |
| asthma protection progeny | #3 |
| hygiene hypothesis | #3 |
| eczema farmers | #3 |
| persistent flexural eczema | #3 |
| il15 il15 associations | #3 |
| col29a1 polymorphisms susceptibility | #3 |
| asthma bordetella | #3 |
| european science foundation | #3 |
| irf1 interferon expression | #3 |
| 9 mmp9 mmp9 | #3 |
| microbiota farm | #3 |
| children isaac phase | #3 |
| il15 gene asthma | #3 |
| 1431c specific ige | #3 |
| c1407t | #3 |
| mmp9 influence development | #3 |
| crude measure | #3 |
| c746t | #3 |
| paracetamol risk | #3 |
| paf seasonal allergens | #3 |
| food correction | #3 |
| pcdh1 asthma | #3 |
| stat6 haplotype | #3 |
| eczema strong association | #3 |
| food year | #3 |
| microbial compounds | #4 |
| bacillus licheniformis spores | #4 |
| early life basis | #4 |
| adolescents duration | #4 |
| current symptoms asthma | #4 |
| benzene no2 | #4 |
| tolllike receptors receptor | #4 |
| predictor wheezing | #4 |
| eczema questionnaires adolescent | #4 |
| ilc2s human asthma | #4 |
| cheese consumption | #4 |
| stable dust | #4 |
| allergy international study | #4 |
| pro27ser | #4 |
| incident sensitization | #4 |
| t2high asthma | #4 |
| birthcohort study | #4 |
| asthma symptoms association | #4 |
| wheeze bhr | #4 |
| genotypes cd14 | #4 |
| anthroposophic families | #4 |
| tlr2 mutations | #4 |
| early identification atopy | #4 |
| genetic nod1 | #4 |
| eczema flg mutations | #4 |
| indoor pollen | #4 |
| east germany bhr | #4 |
| endotoxin relation | #4 |
| leisure time activity | #4 |
| development atopic | #4 |
| asthma 3 | #4 |
| occurrence atopic dermatitis | #4 |
| asthma medication exposure | #4 |
| permanovas | #4 |
| adult lung disease | #4 |
| asthma current symptoms | #4 |
| children farms | #4 |
| stables farm milk | #4 |
| sas genetics | #4 |
| dust personal | #4 |
| common sensitizations | #4 |
| rs2786098 | #4 |
| study centers phase | #4 |
| initial data analysis | #4 |
| questionnaires adolescent eczema | #4 |
| flexural eczema | #4 |
| immunity receptors | #4 |
| cromolyns | #4 |
| fever eczema | #4 |
| ige levels associations | #4 |
| spt sige | #4 |
| a20 induction | #4 |
| aetiology asthma | #4 |
| prevalence random | #4 |
| neonatal window | #4 |
| allergic dermatitis allergic | #4 |
| asthma induction | #4 |
| atopic dermatitis birth | #4 |
| human genetic nod1 | #4 |
| children mattresses | #4 |
| farm environment development | #4 |
| licheniformis spores | #4 |
| fever 17 | #4 |
| asthma phenotype children | #4 |
| lower risk allergy | #4 |
| feeding prevalence | #4 |
| phase 2 allergies | #4 |
| cough bronchitis | #4 |
| parent odds ratio | #4 |
| environmental factors development | #4 |
| promoter region arg130gln | #4 |
| allergic ecuador eczema | #4 |
| lrti asthma | #4 |
| secretory receptors allergic | #4 |
| microbes asthma | #4 |
| glu420lys | #4 |
| risk factor symptoms | #4 |
| minimum battery | #4 |
| participants fieldworkers | #4 |
| genetic rhinitis allergic | #4 |
| cd4cd25hi tregs | #4 |
| asthma symptoms adults | #4 |
| wheeze ige levels | #4 |
| exposure cats | #4 |
| col29a1 gene | #4 |
| c746 | #4 |
| groups taxa | #4 |
| risk atopic dermatitis | #4 |
| birth atopic dermatitis | #4 |
| gene expression receptors | #4 |
| allergic diseases humans | #4 |
| particle boluses | #4 |
| asthma hygiene | #4 |
| environmental dust samples | #4 |
| genes il4r | #4 |
| dietary habits children | #4 |
| crp blood leukocytes | #4 |
| 99th dahlem conference | #4 |
| nonfarming | #4 |
| sounds rhinitis | #4 |
| lukas2 | #4 |
| life childhood | #4 |
| development atopic sensitization | #4 |
| fetal growth asthma | #4 |
| cats pregnancy | #4 |
| heating prevalence | #4 |
| questionnaires populations | #4 |
| current asthma bhr | #4 |
| cx3cr1 polymorphisms | #4 |
| h20like homeobox | #4 |
| childhood protect | #4 |
| increase eczema prevalence | #4 |
| asthma snps | #4 |
| high‐sensitivity c‐reactive protein | #4 |
| predictors visits | #4 |
| fever year | #4 |
| allergies children | #4 |
| childhood asthma | #4 |
| allergic il5 | #4 |
| il4r tlr4 | #4 |
| children maternal overweight | #4 |
| n2267 | #4 |
| late phenotype | #4 |
| wheezing onset | #4 |
| lifetime prevalence asthma | #4 |
| candidate genes wheeze | #4 |
| exposure microbial | #4 |
| rare tlr2 | #4 |
| cowsheds | #4 |
| infections early | #4 |
| children munich | #4 |
| german children bavaria | #4 |
| fatty acids allergic | #4 |
| 95 gene expression | #4 |
| 5 13 years | #4 |
| cord blood lipid | #4 |
| parental allergic rhinitis | #4 |
| asthma atopic diseases | #4 |
| factors wheeze | #4 |
| questionnaires eczema | #4 |
| asthma auc | #4 |
| prenatal asthma | #4 |
| antibiotics antipyretics | #4 |
| gabriel advanced | #4 |
| col29a1 expression | #4 |
| doctors diagnosis asthma | #4 |
| mother role | #4 |
| occupational allergy risks | #4 |
| agreement spt | #4 |
| alliance cohort | #4 |
| inhalant patients | #4 |
| n1046 | #5 |
| allergystudy | #5 |
| influence ige | #5 |
| subtypes risk | #5 |
| atopy airway hyperresponsiveness | #5 |
| young adults methods | #5 |
| atopy flexural eczema | #5 |
| childhood isaac phase | #5 |
| il13cd4 cells | #5 |
| receptors innate immunity | #5 |
| c2892t | #5 |
| cd14 gene expression | #5 |
| asthma girls | #5 |
| delayed manifestation | #5 |
| adulthood asthma | #5 |
| children current wheeze | #5 |
| puberty menarche | #5 |
| wisconsin infant | #5 |
| allergic diseases exposure | #5 |
| genetic asthma | #5 |
| current symptoms rhinoconjunctivitis | #5 |
| il13cd4 | #5 |
| communitybased random sample | #5 |
| phänotypen | #5 |
| genetic variants tbx21 | #5 |
| severe atopy | #5 |
| tbx21 polymorphisms development | #5 |
| 95 populationattributable risk | #5 |
| moisture mold problems | #5 |
| 2nd followup | #5 |
| popular terms | #5 |
| 14452 | #5 |
| mechanism environmental factors | #5 |
| milk exposure | #5 |
| allergic rhinitis wheeze | #5 |
| tbx21 promoter activity | #5 |
| life questionnaires switzerland | #5 |
| eczema relation | #5 |
| nonfarmers children | #5 |
| ormdl3 gsdma | #5 |
| environmental dust | #5 |
| inverse association overweight | #5 |
| agriculture animals | #5 |
| parental reports asthma | #5 |
| nod1 variation | #5 |
| atopic sensitization asthma | #5 |
| tnc nps | #5 |
| disinfectants asthma | #5 |
| ige regulation | #5 |
| dresden | #5 |
| lung health disease | #5 |
| verlaufsformen | #5 |
| children validity | #5 |
| risk atopic | #5 |
| airway responsiveness age | #5 |
| 2q14 | #5 |
| cats risk factor | #5 |
| milk odds | #5 |
| ors positive association | #5 |
| trigger factors asthma | #5 |
| ornonaffluent | #5 |
| thr280met | #5 |
| cowshed | #5 |
| rural subjects | #5 |
| rhinitis increase | #5 |
| sensitization atopic | #5 |
| linkage development | #5 |
| moulds actinomycetes | #5 |
| combination hlx1 polymorphisms | #5 |
| asthma endotoxins | #5 |
| allergen 95 | #5 |
| hlx1 polymorphisms development | #5 |
| 95 reverse causation | #5 |
| pattern sensitization | #5 |
| tbx21 gene variants | #5 |
| farming mothers | #5 |
| cow milk samples | #5 |
| neu5gc mice | #5 |
| flexural eczema strength | #5 |
| taxa groups | #5 |
| cd4cd25hi | #5 |
| 26 farms | #5 |
| west german children | #5 |
| endotoxin protection | #5 |
| visits predictors | #5 |
| consumption 4 years | #5 |
| duration jobs | #5 |
| participation behaviour | #5 |
| hlx1 variants | #5 |
| tbx21 combination | #5 |
| combination hlx1 variants | #5 |
| atopic dermatitis age | #5 |
| dogs symptoms | #5 |
| jf1 msf | #5 |
| timing exposures | #5 |
| female germany allergic | #5 |
| mmp9 influence | #5 |
| asthma child dust | #5 |
| asthma medication 95 | #5 |
| atopic eczema allergic | #5 |
| exposure rhinitis | #5 |
| milk consumption age | #5 |
| associations wheeze | #5 |
| incident wheeze | #5 |
| ors atopy | #5 |
| pregnancy year | #5 |
| hyperreactivity child | #5 |
| helsinki alert | #5 |
| rs3771300 | #5 |
| processing intensity | #5 |
| tests bronchitis | #5 |
| rhinoconjunctivitis eczema | #6 |
| systemic inflammation age | #6 |
| fever wheezing | #6 |
| il33 17q12q21 | #6 |
| overweight data | #6 |
| asthma allergic sensitisation | #6 |
| 16q12 region | #6 |
| allergic epistasis | #6 |
| isaac programme | #6 |
| deubiquitinating enzyme tao | #6 |
| allergoprotective properties | #6 |
| childhood asthma genes | #6 |
| allergens needed | #6 |
| central europe interactions | #6 |
| children positive spt | #6 |
| nonaffluent | #6 |
| susceptibility gene asthma | #6 |
| data 7 years | #6 |
| rora npsr1 | #6 |
| prevent allergic | #6 |
| onset disease germany | #6 |
| 5 regions tao | #6 |
| bolus dispersion | #6 |
| food allergy 95 | #6 |
| asthma genotypes | #6 |
| new locus time | #6 |
| primary preventive strategies | #6 |
| eating environmental | #6 |
| children farming environment | #6 |
| fever atopy | #6 |
| genetic variants time | #6 |
| strategies disease | #6 |
| european dairy farms | #6 |
| 7 years association | #6 |
| nd132656 | #6 |
| tlr1 tlr10 | #6 |
| childhood asthma phenotypes | #6 |
| children east germany | #6 |
| progression asthma | #6 |
| dust collection | #6 |
| central europe asthma | #6 |
| asthma context | #6 |
| sounds surveys | #6 |
| abschnitten | #6 |
| devenues | #6 |
| inversely asthma | #6 |
| allergic immunologic receptors | #6 |
| 939 children | #6 |
| asthma transition | #6 |
| rhinoconjunctivitis atopic | #6 |
| comprehensive questionnaires | #6 |
| interactions farm exposures | #6 |
| childhood aa | #6 |
| study rarer snps | #6 |
| asthma authors | #6 |
| oropharyngeal microbiota | #6 |
| german nationality | #6 |
| yearly interviews | #6 |
| allergic diseases | #6 |
| allergy tests children | #6 |
| distinct underlying mechanisms | #6 |
| microorganisms samples | #6 |
| allergic markers | #6 |
| parsifal | #6 |
| 17q12q21 earlier onset | #6 |
| lowgrade inflammation hscrp | #6 |
| longitudinal populations | #6 |
| tripeptidylpeptidases subunit p40 | #6 |
| polymorphisms stat6 gene | #6 |
| pair deubiquitinating enzyme | #6 |
| responders frequency | #6 |
| lifestyle factors symptoms | #6 |
| pair male nod2 | #6 |
| countries albania | #6 |
| sensitisation exposure | #6 |
| no2 current asthma | #6 |
| sscp method | #6 |
| tests asthma | #6 |
| protection allergies | #6 |
| 14 genes tripeptidylpeptidases | #6 |
| cold air challenge | #6 |
| complete screening | #6 |
| hypertonic skin tests | #6 |
| pierced ears | #6 |
| current contact | #6 |
| natural atopic dermatitis | #6 |
| dipeptidyl peptidases tripeptidylpeptidases | #6 |
| farm nonfarm | #6 |
| 11094 | #6 |
| dogs environmental exposure | #6 |
| steiner schools | #6 |
| asthma austria | #6 |
| atemwegserkrankungen | #6 |
| genetic variants 17q12q21 | #6 |
| lung barrier | #6 |
| bavarian preschool children | #6 |
| juvenile inflammatory | #7 |
| murine offspring | #7 |
| hypertonic sensitivity | #7 |
| farm exposure | #7 |
| symptoms adulthood | #7 |
| perennial allergen | #7 |
| environmental exposure endotoxin | #7 |
| fetal development allergic | #7 |
| polymorphisms il4 gene | #7 |
| children international study | #7 |
| farm homes | #7 |
| pregnancy atopic dermatitis | #7 |
| invading microorganism | #7 |
| allergic atopic embryonic | #7 |
| levels farm | #7 |
| asthma school age | #7 |
| questionnaires allergic | #7 |
| children breast | #7 |
| immunologic receptors allergic | #7 |
| paracetamol year | #7 |
| pasture birth | #7 |
| cells dust | #7 |
| highrisk occupations | #7 |
| european science | #7 |
| birth function | #7 |
| interleukin4 sequence analysis | #7 |
| asthma environmental factors | #7 |
| centers increase | #7 |
| pasture study | #7 |
| association cord blood | #7 |
| steiner school | #7 |
| infantis populations | #7 |
| reference exposure | #7 |
| atopic europe | #7 |
| children prognosis | #7 |
| questionnaires phase | #7 |
| environmental factors children | #7 |
| pbmcs asthmatics | #7 |
| log2fold | #7 |
| secretory receptors | #7 |
| childhoodonset disease | #7 |
| large centres | #7 |
| aerosol bolus dispersion | #7 |
| rhinitis early childhood | #7 |
| birth cohorts report | #7 |
| atopic dermatitis association | #7 |
| bhr current asthma | #7 |
| childrens bedrooms | #7 |
| breastfeeding prevalence | #7 |
| 15245 | #7 |
| diversity introduction | #7 |
| indoor moisture | #7 |
| hypersensitivity male | #7 |
| seasonal sensitivity allergic | #7 |
| lower risk asthma | #7 |
| foxp3 blood | #7 |
| fever atopic asthma | #7 |
| strategies asthma | #7 |
| amish children | #7 |
| endotoxin allergen | #7 |
| asthma fever | #7 |
| school age asthma | #7 |
| allergy antibiotics | #7 |
| chemokine cx3cl1 cx3cr1 | #7 |
| isaac eczema | #7 |
| stat1 gene | #7 |
| lung sod3 | #7 |
| hutterite children | #7 |
| infectious diseases phenotype | #7 |
| farm life | #7 |
| nonfarm homes | #7 |
| fieldworkers | #7 |
| exposure farms | #7 |
| 5 harmonization | #7 |
| biomarker immune activation | #7 |
| wheeze 12 months | #7 |
| child dust | #7 |
| steiner school children | #7 |
| preanalytix | #7 |
| functional phenotypes | #7 |
| genetic predisposition role | #7 |
| influence neonatal | #7 |
| 95 endotoxin | #7 |
| grass rphl | #7 |
| adult farmers | #7 |
| viral infections development | #7 |
| level variety | #7 |
| wheeze atopy | #7 |
| exposure neu5gc | #7 |
| inverse association consumption | #7 |
| inhalant age | #7 |
| lymphoid cells asthma | #7 |
| children regular contact | #7 |
| factor analysis factor | #8 |
| 3113 children | #8 |
| th2 cells ilc2s | #8 |
| lipid peptidoglycan | #8 |
| children anthroposophic | #8 |
| antibiotics year | #8 |
| il15 snps | #8 |
| exposure dogs | #8 |
| 17q12q21 | #8 |
| study rural | #8 |
| sensitization mite | #8 |
| children anthroposophic families | #8 |
| proteins dendritic cells | #8 |
| inhalant europe | #8 |
| igg1 galactosylation | #8 |
| c4ma3 | #8 |
| asthma bias | #8 |
| immunity gene expression | #8 |
| surveyed children | #8 |
| ppg stimulation | #8 |
| crohns disease polymorphisms | #8 |
| diversity year | #8 |
| cows milk age | #8 |
| amino acid asthma | #8 |
| gabriela | #8 |
| finlande | #8 |
| agmr | #8 |
| chromosome childhoodonset disease | #8 |
| asthmaprotective | #8 |
| atopic sensitization prevalence | #8 |
| austrian schoolchildren | #8 |
| hrqol questions | #8 |
| gabriela study | #8 |
| asthma physiciandiagnosed asthma | #8 |
| asthma atopic sensitisation | #8 |
| influence cytokine | #8 |
| asthma analyses | #8 |
| p7×10−14 | #8 |
| p11×10−8 | #8 |
| asthma child conjunctivitis | #8 |
| international variations | #8 |
| childhood asthma atopy | #8 |
| association wheeze | #8 |
| eczema asthma child | #8 |
| fever atopic sensitisation | #8 |
| age 911 years | #8 |
| dogs risk factor | #8 |
| invertedu shape | #8 |
| allergy epidemiology | #8 |
| genetic risk asthma | #8 |
| asthma birth weight | #8 |
| association food diversity | #8 |
| university work | #8 |
| mice children | #8 |
| allergy study | #8 |
| 824 children | #8 |
| early age exposure | #8 |
| sensitization patterns | #8 |
| indoor microbiota | #8 |
| repeats sequence homology | #8 |
| allergies childhood | #8 |
| amish child | #8 |
| highthroughput sequencing data | #8 |
| diet year | #8 |
| asthma maternal smoking | #8 |
| airwayrelated symptoms | #8 |
| current asthma data | #8 |
| hlx1 | #8 |
| p3×10−9 | #8 |
| asthma 08 | #8 |
| il13 variants | #8 |
| chromosome 2q14 | #8 |
| children reference | #8 |
| 95 food allergy | #8 |
| p4×10−9 | #8 |
| rs8076131 | #8 |
| childhoodonset disease elevation | #8 |
| age positive spts | #8 |
| bronchial histamine challenge | #8 |
| animals supplementation | #9 |
| asthma symptoms baseline | #9 |
| atopic sensitization children | #9 |
| asthma risk | #9 |
| young german | #9 |
| 5 european | #9 |
| ausprägungen | #9 |
| asthma child child | #9 |
| positive spts | #9 |
| rad50 gene chromosome | #9 |
| farming environment | #9 |
| conjunctivitis cross | #9 |
| role human asthma | #9 |
| rural farm | #9 |
| autriche | #9 |
| life prenatal exposure | #9 |
| association wheezing | #9 |
| symptoms 12 months | #9 |
| subspecies bifidobacterium | #9 |
| study asthma | #9 |
| npsr1 snps | #9 |
| 1314yrolds | #9 |
| regulatory th17 cells | #9 |
| asthma respiratory conditions | #9 |
| ige levels gwas | #9 |
| unprocessed milk | #9 |
| random subsample | #9 |
| teenagers asthma | #9 |
| polymorphisms development | #9 |
| asthma child | #9 |
| partial nonresponders | #9 |
| regular exposure | #9 |
| allergic preschool conjunctivitis | #9 |
| eczema weight | #9 |
| asthma antibiotics | #9 |
| microbial substances | #9 |
| relation asthma | #9 |
| asthma allergy symptoms | #9 |
| clinical response score | #9 |
| kazal type | #9 |
| longitudinal follow‐up | #9 |
| chromosome ige levels | #9 |
| 1314 children | #9 |
| germany munich | #9 |
| igg4 ige | #9 |
| allergic seasonal risk | #9 |
| asthma early life | #9 |
| allergic phenotypes | #9 |
| col29a1 variants | #9 |
| life ahr | #9 |
| microbial exposure | #9 |
| prevalence atopic | #9 |
| life female germany | #9 |
| ribosomal 16s risk | #9 |
| 105 years age | #9 |
| ecuador eczema | #9 |
| cord blood cytokines | #9 |
| allergic inflammation patients | #9 |
| association stat6 variation | #9 |
| factors sensitization | #9 |
| tbx21 promoter | #9 |
| low levels hscrp | #9 |
| levels allergens | #9 |
| dennd1b | #9 |
| bronchial hyper‐responsiveness | #9 |
| relation environment | #9 |
| gwas approaches | #9 |
| drug development strategies | #9 |
| cytokines environmental | #9 |
| fcer1a susceptibility locus | #9 |
| skinprick | #9 |
| 1 npsr1 | #9 |
| n7498 | #9 |
| exposure farming environments | #9 |
| asthma infant | #9 |
| hormonal factors role | #10 |
| early life immunity | #10 |
| phase protocol | #10 |
| bias exposure | #10 |
| production cord blood | #10 |
| asthma nocturnal | #10 |
| ige levels asthma | #10 |
| rural school children | #10 |
| airway hyperresponsiveness children | #10 |
| young german adults | #10 |
| genetic probability receptors | #10 |
| new onset rhinitis | #10 |
| farm exposures asthma | #10 |
| predictors health utilization | #10 |
| indoor heating | #10 |
| life allergen | #10 |
| new zealand bhr | #10 |
| latex children | #10 |
| reservoir method | #10 |
| endotoxin muramic acid | #10 |
| mattress dust | #10 |
| bhr prevalence | #10 |
| atopic dermatitis 95 | #10 |
| bdnf gene variants | #10 |
| house dust endotoxin | #10 |
| n1138 | #10 |
| urban rural area | #10 |
| missing values paper | #10 |
| adult cases controls | #10 |
| context eczema | #10 |
| farm children children | #10 |
| substances development | #10 |
| gabriel advanced studies | #10 |
| leipzig east germany | #10 |
| receptors immunity | #10 |
| 1992–2001 | #10 |
| asthma chromosome | #10 |
| infection allergic | #10 |
| countries centres | #10 |
| mechanisms oral tolerance | #10 |
| consumption raw | #10 |
| interrelations risk factors | #10 |
| association atopic | #10 |
| blood samples tubes | #10 |
| association new onset | #10 |
| ilt3 ilt4 | #10 |
| international study asthma | #10 |
| study occupational | #10 |
| ratio asthma | #10 |
| humans hypersensitivity | #10 |
| 45 saline | #10 |
| centers prevalence rates | #10 |
| mothers contact | #10 |
| prevalence differences | #10 |
| children rural | #11 |
| asthma lower | #11 |
| symptoms allergic rhinoconjunctivitis | #11 |
| atopic dust | #11 |
| atopy | #11 |
| overweight body mass | #11 |
| parsifal study | #11 |
| school beginners | #11 |
| transient wheezing | #11 |
| blood foxp3 | #11 |
| early life development | #11 |
| npsr1 polymorphisms | #11 |
| newborn male polymorphism | #11 |
| tuberculosis notification rates | #11 |
| ige measurements | #11 |
| farm buildings | #11 |
| occupational disinfectants | #11 |
| asthma risk participants | #11 |
| asthma bacterial | #11 |
| german schoolchildren | #11 |
| pregnancy early life | #11 |
| wheeze year | #11 |
| samples persons | #11 |
| health outcomes countries | #11 |
| allergic disease children | #11 |
| allergy risks | #11 |
| association respiratory health | #11 |
| allergic asthma conjunctivitis | #11 |
| genotyped polymorphisms | #11 |
| lebensbedingungen | #11 |
| factors agriculture | #11 |
| wheeze aor | #11 |
| farm exposures | #11 |
| microbiome lung | #11 |
| subsequent development asthma | #11 |
| active smoking association | #11 |
| cytokines allergic inflammation | #11 |
| tbx21 polymorphisms | #11 |
| persistent uncontrolled asthma | #11 |
| children school entry | #11 |
| fetal ige | #11 |
| reduced risk asthma | #11 |
| protective development | #11 |
| symptoms atopic | #12 |
| cattle child | #12 |
| german multicentre | #12 |
| rural environments | #12 |
| damage mold | #12 |
| children low levels | #12 |
| farm | #12 |
| standard deviation skewness | #12 |
| overweight breast | #12 |
| healthy children asthma | #12 |
| stepwise protocol | #12 |
| mattress dust samples | #12 |
| children exposed children | #12 |
| exposure asthma symptoms | #12 |
| management childhood asthma | #12 |
| asthmatic cohort | #12 |
| asthma epidemic | #12 |
| 95 nox | #12 |
| association moisture | #12 |
| east germany munich | #12 |
| sensitization birth | #12 |
| fever exposure | #12 |
| validated questions | #12 |
| skin prick testing | #12 |
| current paracetamol | #12 |
| dermatitis phenotypes | #12 |
| young adults school | #12 |
| female humans hypersensitivity | #12 |
| participants allergic rhinitis | #12 |
| polymorphisms bdnf gene | #12 |
| ige grass | #12 |
| child environmental | #12 |
| children background | #12 |
| early priming | #12 |
| asthma parent | #12 |
| bhr wheeze | #12 |
| hypersensitivity immunity | #12 |
| birth cohorts asthma | #12 |
| incident asthma 95 | #12 |
| transient wheeze | #12 |
| 7 years data | #12 |
| polymorphism asthma | #12 |
| infection analyses | #12 |
| munich west germany | #12 |
| increase prevalence | #12 |
| pet contact | #12 |
| doctor asthma | #12 |
| male respiratory | #12 |
| asthma disease humans | #12 |
| age 105 years | #12 |
| asthma candidate gene | #12 |
| multicentre allergy | #12 |
| backgroundasthma | #12 |
| dresden germany | #13 |
| atopic eczema symptoms | #13 |
| allergic sensitisation children | #13 |
| sx1 | #13 |
| asthma rhinoconjunctivitis | #13 |
| children polymorphisms | #13 |
| switzerland children | #13 |
| farming exposures | #13 |
| asthma outcomes patients | #13 |
| developing microbiota | #13 |
| rural schoolchildren | #13 |
| hygiene hypersensitivity | #13 |
| wheezing ages | #13 |
| nod1 gene | #13 |
| groups phenotype | #13 |
| local immunity | #13 |
| rhinitis allergens | #13 |
| eastern western germany | #13 |
| asthma bronchial | #13 |
| npsr1 | #13 |
| asthma community | #13 |
| n349 | #13 |
| northern indiana | #13 |
| antibiotic exposure pregnancy | #13 |
| farm dust | #13 |
| spt specific ige | #13 |
| farm animal contact | #13 |
| cord adult blood | #13 |
| occupational exposure disinfectants | #13 |
| asthma mental health | #13 |
| subjects jobs | #13 |
| childhood allergy | #13 |
| asthma snp | #13 |
| polymorphisms influence | #13 |
| children inhaled steroids | #13 |
| children raised | #13 |
| childhood isaac | #13 |
| ibd sle | #13 |
| expression ormdl3 | #13 |
| th1cells | #13 |
| asthma nocturnal symptoms | #13 |
| fx5 | #14 |
| asthma bronchial hyperresponsiveness | #14 |
| maternal sensitization | #14 |
| il15 gene | #14 |
| increased risk age | #14 |
| german children | #14 |
| allergic sensitization age | #14 |
| asthma1 | #14 |
| role lung microbiome | #14 |
| mrna expression vivo | #14 |
| symptoms rhinoconjunctivitis | #14 |
| changing gender | #14 |
| delayed introduction solids | #14 |
| polymorphisms ormdl3 | #14 |
| 7 polymorphisms | #14 |
| innate infant | #14 |
| breast feeding children | #14 |
| cross environmental exposure | #14 |
| asthma step | #14 |
| exacerbations fev1 | #14 |
| untypical | #14 |
| upper respiratory symptoms | #14 |
| diabimmune study | #14 |
| 3099 | #14 |
| late introduction | #14 |
| positive spts age | #14 |
| respiratory atopic | #14 |
| incidence rhinitis | #14 |
| preventive development | #14 |
| th2 commitment | #14 |
| rhinitis conjunctivitis | #14 |
| diseases atopic | #14 |
| atopic environmental | #14 |
| nonaffluent countries | #14 |
| farm rural | #14 |
| air challenge | #14 |
| introduction complementary food | #14 |
| 10‐year‐old children | #14 |
| burden prevalence | #14 |
| standardised questionnaires | #14 |
| farming lifestyle | #14 |
| detailed questionnaires | #14 |
| bronchial responsiveness children | #15 |
| children early | #15 |
| factors bronchial | #15 |
| sensitization indoor allergens | #15 |
| 17q21 locus | #15 |
| bronchial hyperreactivity | #15 |
| unpasteurized | #15 |
| mold problems | #15 |
| allele2 | #15 |
| puberty rhinitis | #15 |
| asthma allergy | #15 |
| allele evidence | #15 |
| contact farm animals | #15 |
| association asthma symptoms | #15 |
| ω3 polyunsaturated | #15 |
| children allele | #15 |
| diabimmune | #15 |
| pregnancy protective | #15 |
| respective tlrs | #15 |
| rhinitis puberty | #15 |
| immunity asthma | #15 |
| skin prick tests | #15 |
| dogs children | #15 |
| nocturnal symptoms | #15 |
| ahr male mice | #15 |
| allergy risk | #15 |
| epidemiological studies exposure | #15 |
| street residence | #15 |
| nonatopic asthma children | #16 |
| protocadherin1 | #16 |
| n1133 | #16 |
| 80 chromosomes | #16 |
| endotoxin house | #16 |
| microbial environment | #16 |
| bacteria respiratory tract | #16 |
| sas institute | #16 |
| wheeze trajectories | #16 |
| lung microbiome health | #16 |
| childhood asthma asthma | #16 |
| polymorphisms atopy | #16 |
| microbial exposures | #16 |
| asthma asthma risk | #16 |
| increased food | #16 |
| chronic asthma children | #16 |
| burden childhood asthma | #16 |
| multi‐centre study | #16 |
| allergic diseases childhood | #16 |
| diseases allergy | #16 |
| 9 11 | #16 |
| seasonal surveys questionnaires | #16 |
| hutterite | #16 |
| exposure atopic | #16 |
| newborn phenotype | #16 |
| association atopy | #16 |
| asthma farm | #16 |
| clinical response measures | #16 |
| 7 year | #16 |
| epidemiologic dermatitis | #17 |
| function school | #17 |
| asthma environment | #17 |
| allergic asthma aa | #17 |
| eczema exposure | #17 |
| factors atopic | #17 |
| dust extract | #17 |
| asthma associations | #17 |
| munich | #17 |
| levels microbial | #17 |
| bavarian | #17 |
| asthma 95 | #17 |
| pregnancy gene expression | #17 |
| animals domestic | #17 |
| humans preschool haemophilus | #17 |
| ga2len skin | #17 |
| aerosol bolus | #17 |
| munich germany | #17 |
| child allergic | #17 |
| single microbial | #17 |
| persistent sensitization | #17 |
| variants increase | #17 |
| respiratory health children | #17 |
| asthma immune responses | #17 |
| atopy childhood | #17 |
| asthma biomarkers humans | #17 |
| rhinoconjunctivitis | #17 |
| neuropeptide receptor npsr1 | #17 |
| age 7 years | #17 |
| increase childhood | #18 |
| col29a1 | #18 |
| eczema 95 | #18 |
| atopy rhinitis | #18 |
| anthroposophic lifestyle | #18 |
| protective microbiota | #18 |
| maternal contact | #18 |
| children german | #18 |
| cbmcs | #18 |
| measles infection | #18 |
| asthma exposure | #18 |
| trajectories asthma | #18 |
| underlying responses | #18 |
| type employment | #18 |
| preschool dna ribosomal | #18 |
| phenotypes children | #18 |
| edna concentrations | #18 |
| asthma phenotyping | #18 |
| cb production | #18 |
| female humans asthma | #18 |
| asthma 6 years | #18 |
| german populations | #18 |
| meat children | #18 |
| polymorphism genetic receptors | #18 |
| maternallyacquired mice mice | #18 |
| wheeze | #18 |
| pregnancy 6 years | #18 |
| immune adaptation | #18 |
| mef75 | #18 |
| ormdl3 gene | #18 |
| 7 yrs | #18 |
| childrens mattresses | #18 |
| current wheezers | #18 |
| 3 years life | #19 |
| microbial association networks | #19 |
| atopic dermatitis studies | #19 |
| crp levels age | #19 |
| children current | #19 |
| higher levels endotoxin | #19 |
| disease atopic | #19 |
| life asthma risk | #19 |
| german center | #19 |
| innate mice models | #19 |
| farming activities | #19 |
| birth 13 years | #19 |
| rural children | #19 |
| receptors innate immune | #19 |
| child crosssectional studies | #19 |
| arg130gln | #19 |
| susceptibility human | #19 |
| sounds risk | #19 |
| asthma | #19 |
| tcell phenotypes | #19 |
| asthma bronchiale | #19 |
| cary | #19 |
| poor symptom control | #19 |
| life diversity | #19 |
| seasonal risk | #19 |
| regulatory tolllike receptor | #19 |
| asthma report | #19 |
| atopy phenotypes | #19 |
| viable bacterial counts | #19 |
| ilt4 | #19 |
| expression treg | #19 |
| life exposures | #19 |
| developing asthma | #19 |
| asthma allergy development | #19 |
| hscrp age | #19 |
| linkage disequilibrium polymorphisms | #19 |
| symptoms asthma | #19 |
| receptors innate | #19 |
| newonset symptoms | #19 |
| adults childhood | #20 |
| mice sod3 | #20 |
| symptoms wheeze | #20 |
| dermatitis early | #20 |
| breast feeding risk | #20 |
| haplotype studies | #20 |
| gene expression measurements | #20 |
| pvalues patients | #20 |
| unboiled | #20 |
| asthma nonatopic asthma | #20 |
| unhygienic | #20 |
| specific ige food | #20 |
| gender ratio | #20 |
| infant colonization | #20 |
| disease germany | #20 |
| life farm | #20 |
| stables | #20 |
| npsr1 nps | #20 |
| persistent uncontrolled | #20 |
| westernized countries | #20 |
| dust female humans | #20 |
| atopy snps | #20 |
| animal exposure | #20 |
| allergic disease prevalence | #20 |
| asthma trajectories | #20 |
| 6 haplotype | #20 |
| farm environments | #20 |
| children living | #20 |
| school university | #20 |
| isaac | #20 |
| inbred balb spores | #20 |
| prevalence rates symptoms | #21 |
| tripeptidylpeptidases | #21 |
| children inhaled | #21 |
| studies eczema | #21 |
| plasma erythrocyte membranes | #21 |
| germany humans germany | #21 |
| children east | #21 |
| network differences | #21 |
| tlr2 receptor | #21 |
| c589t | #21 |
| turkish children | #21 |
| farm environment | #21 |
| atopic asthma children | #21 |
| asthma review | #21 |
| bhr 95 | #21 |
| n1062 | #21 |
| patients degradation | #21 |
| gstm1 deficiency | #21 |
| markers early | #21 |
| environmental microbiome | #21 |
| rora | #21 |
| ige igg4 | #21 |
| hypersensitivity infant | #21 |
| childhood background | #21 |
| current asthma wheeze | #21 |
| pregnancy production | #21 |
| unremitting | #21 |
| eczema atopy | #21 |
| environment lifestyle | #21 |
| development allergic diseases | #21 |
| bifidobacterium colonization | #21 |
| pseudocroup | #21 |
| exposure germany | #22 |
| lower prevalences | #22 |
| neonatal immune responses | #22 |
| seasonal risk factors | #22 |
| 95 prenatal exposure | #22 |
| gabriel | #22 |
| lps risk | #22 |
| isaac childhood | #22 |
| npsr1 gene | #22 |
| chromosome asthma | #22 |
| β1→3glucans | #22 |
| feeding obesity | #22 |
| r753q | #22 |
| crth2 th2 cells | #22 |
| alleles asthma | #22 |
| asthmatic phenotypes | #22 |
| endotoxin house dust | #22 |
| 17q21 asthma | #22 |
| samples dust | #22 |
| childhood atopy | #22 |
| effective airway | #22 |
| immune maturation | #22 |
| respiratory diseases children | #22 |
| muramic acid | #22 |
| allergic rhinitis 95 | #22 |
| highschool | #22 |
| food diversity | #22 |
| objective sought | #22 |
| living germany | #22 |
| asthma agents | #23 |
| breast feeding asthma | #23 |
| traffic counts | #23 |
| child cross | #23 |
| asthma 12 months | #23 |
| childhood allergies | #23 |
| gross national | #23 |
| single taxa | #23 |
| rapid alternative | #23 |
| isaac phase | #23 |
| new onset | #23 |
| southern bavaria | #23 |
| nonfarm | #23 |
| farm childhood | #23 |
| symptoms atopic eczema | #23 |
| microbiota respiratory | #23 |
| association atopic asthma | #23 |
| fecal microbiota children | #23 |
| 7 prevalence | #23 |
| hillerød | #23 |
| children adulthood | #23 |
| asthma cats | #23 |
| bronchial challenge tests | #23 |
| nonlinear relations | #23 |
| current symptoms | #24 |
| asthma early | #24 |
| 2fold risk | #24 |
| asthma bhr | #24 |
| exposure road traffic | #24 |
| 4 phenotypes | #24 |
| children indoor | #24 |
| countrys | #24 |
| tobit regression | #24 |
| gene expression immunity | #24 |
| asthma 5 years | #24 |
| dust endotoxin | #24 |
| contact livestock | #24 |
| asthma cross | #24 |
| asthma age | #24 |
| allergic dermatitis | #24 |
| phenotypes childhood | #24 |
| asthma aa | #24 |
| wheeze symptoms | #24 |
| differences asthma prevalence | #24 |
| west german | #24 |
| bronchitis child | #24 |
| doctor diagnosed | #24 |
| eczema susceptibility | #24 |
| asthma prevention | #24 |
| allergic respiratory symptoms | #24 |
| haying | #24 |
| 5030 | #25 |
| methods association | #25 |
| car traffic | #25 |
| antibiotic year | #25 |
| 2 12 months | #25 |
| cytokines children | #25 |
| environmental determinants | #25 |
| expression ige | #25 |
| il13 pathway | #25 |
| igg1 ige | #25 |
| prevention asthma | #25 |
| sensitization early | #25 |
| exposure paracetamol | #25 |
| risk atopic diseases | #25 |
| farm animals | #25 |
| wheezing childhood | #26 |
| allergen sensitisation | #26 |
| 5 european countries | #26 |
| increased treg | #26 |
| trendwise | #26 |
| blood samples children | #26 |
| levels mite | #26 |
| sputum eosinophils feno | #26 |
| early atopic | #26 |
| farms humans | #26 |
| 3rd year | #26 |
| asthma syndrome | #26 |
| early phenotypes | #26 |
| card4 | #26 |
| environmental asthma | #26 |
| clinical phenotypes children | #26 |
| risk allergic sensitization | #26 |
| written questionnaire | #26 |
| risk factors probability | #26 |
| child conjunctivitis | #26 |
| microbiota asthma | #26 |
| fev1 bhr | #26 |
| association childhood asthma | #27 |
| 035 iu | #27 |
| asthma childhood | #27 |
| children asthma symptoms | #27 |
| specific ige levels | #27 |
| single snps | #27 |
| wheeze childhood | #27 |
| npsr1 asthma | #27 |
| prevalence atopic eczema | #27 |
| asthma child cross | #27 |
| factors year | #27 |
| childhood origins | #27 |
| visible mould | #27 |
| asthma environmental | #27 |
| ilt3 | #27 |
| asthmatic participants | #27 |
| 9 11 years | #27 |
| children parental asthma | #27 |
| respiratory infections year | #27 |
| prevalence fever | #27 |
| consumption raw milk | #27 |
| prevention allergic diseases | #27 |
| muramic | #27 |
| allergens europe | #27 |
| pregnancy increase | #28 |
| weekly diaries | #28 |
| 10 years data | #28 |
| levels sensitization | #28 |
| childhood asthma risk | #28 |
| east germany | #28 |
| ige therapy | #28 |
| higher hrqol | #28 |
| host factors infection | #28 |
| recurrence persistence | #28 |
| atopic phenotypes | #28 |
| early identification children | #28 |
| gene asthma | #28 |
| il13 polymorphisms | #28 |
| analysis lca | #28 |
| feno fev1 | #28 |
| dust children | #28 |
| immune phenotypes | #28 |
| primary prevention asthma | #29 |
| pblc | #29 |
| enhanced expression genes | #29 |
| bioair | #29 |
| pediatric asthma patients | #29 |
| mite sensitization | #29 |
| dust indoor | #29 |
| farming | #29 |
| preschool environmental | #29 |
| polymorphisms il13 | #29 |
| questionnaires urban | #29 |
| early years life | #29 |
| women males | #29 |
| polymorphisms identified | #29 |
| anthroposophy | #29 |
| vivo age | #29 |
| centers prevalence | #29 |
| rad50 gene | #29 |
| adult agriculture | #29 |
| acinetobacter lwoffii | #29 |
| asthma childhood asthma | #30 |
| dismutase 3 | #30 |
| incidence recurrence | #30 |
| affluent | #30 |
| biodiversity child | #30 |
| effective ways | #30 |
| il10 snps | #30 |
| viral infections asthma | #30 |
| boys asthma | #30 |
| traditional farming | #31 |
| enhancer marks | #31 |
| il10 polymorphisms | #31 |
| questionnaires asthma | #31 |
| atopy children | #31 |
| persons european ancestry | #31 |
| childhood infectious | #31 |
| moisture damage | #31 |
| ribosomal preschool dna | #31 |
| atopic food | #31 |
| card4 nod1 | #31 |
| centres countries | #31 |
| asthma atopic | #31 |
| probability persistence | #31 |
| children diagnosed asthma | #31 |
| bronchial obstruction | #31 |
| african ancestry asthma | #32 |
| asthma odds ratio | #32 |
| r2447x | #32 |
| huge burden | #32 |
| transferase deficiency | #32 |
| prick tests | #32 |
| atopic diseases | #32 |
| preschool day | #32 |
| germany leipzig | #32 |
| cohorts asthma | #32 |
| epidemiology asthma | #32 |
| microbial environments | #32 |
| obese children age | #32 |
| association paracetamol | #32 |
| studies dermatitis | #32 |
| disease childhood | #32 |
| living environments | #32 |
| gata3 gene | #32 |
| rural regions | #32 |
| allergic diseases age | #32 |
| linked polymorphisms | #32 |
| symptoms childhood | #32 |
| microbial components | #32 |
| infants countries | #32 |
| susceptibility asthma | #32 |
| doctordiagnosed | #32 |
| européens | #32 |
| asthma associations loci | #33 |
| immune cell enhancer | #33 |
| bhr fev1 | #33 |
| specificity skin tests | #33 |
| multiancestry association | #33 |
| genetic epigenesis allergic | #33 |
| allergic genetic epigenesis | #33 |
| eczema prevalence | #33 |
| imputation data | #33 |
| multiancestry association study | #33 |
| health utilization children | #34 |
| development atopy | #34 |
| participants childhood | #34 |
| fascinating | #34 |
| year life | #34 |
| asthma atopic eczema | #34 |
| pattern frequency | #34 |
| indoor mould | #34 |
| dust microbiota | #34 |
| asthma risk children | #34 |
| bacterial farms | #34 |
| mite allergen exposure | #34 |
| clec4e | #34 |
| infant contact | #34 |
| bradykinin receptor gene | #34 |
| pregnancy maternal health | #34 |
| studies dust | #34 |
| curve asthma | #34 |
| new onset symptoms | #34 |
| participants questionnaire | #34 |
| tests surveys | #34 |
| endotoxins environmental | #34 |
| western lifestyle | #35 |
| endotoxin levels | #35 |
| preschool fatty acids | #35 |
| prick testing | #35 |
| anthroposophic | #35 |
| feno lung function | #35 |
| children cross | #35 |
| asthma conjunctivitis | #35 |
| western germany | #35 |
| germany haplotypes | #35 |
| raw cows milk | #35 |
| analysis steps | #35 |
| nonatopic mothers | #35 |
| tagging polymorphisms | #35 |
| urbanrural differences | #35 |
| asthma asthma phenotypes | #35 |
| 95 atopic dermatitis | #35 |
| risk asthma | #35 |
| wingedhelix | #35 |
| farms female | #35 |
| diseases rhinitis | #35 |
| asthma dendritic cells | #36 |
| maternal exposures | #36 |
| skin test reactivity | #36 |
| 1 stimulation | #36 |
| tolerance biomarkers | #36 |
| prevalence childhood asthma | #36 |
| 16s rrna data | #36 |
| chapter 1 epidemiology | #36 |
| exposure genetic | #36 |
| maternal vitamin intake | #36 |
| leipzig | #36 |
| case status | #37 |
| lifestyle environment | #37 |
| incidence persistence | #37 |
| allemagne | #37 |
| 8263 | #37 |
| ril33 | #37 |
| nasal samples | #37 |
| native milk | #37 |
| asthma candidate | #37 |
| earlylife exposures | #37 |
| life increased | #38 |
| foxp3 levels | #38 |
| dust asthma | #38 |
| association ndvi | #38 |
| reverse causation | #38 |
| atopy prevalence | #38 |
| asthma cough | #38 |
| innate immunity genes | #38 |
| itchy | #38 |
| maximum expiratory flow | #38 |
| recurrence risk factors | #38 |
| ormdl3 expression | #38 |
| nps npsr1 | #38 |
| asthma allergens | #38 |
| endotoxin asthma | #38 |
| development allergic | #38 |
| mouse model asthma | #38 |
| allergy birth | #38 |
| wisc | #38 |
| amish | #38 |
| eczema environmental | #38 |
| diversity environmental | #39 |
| haploview | #39 |
| seasonal perennial | #39 |
| adulthood risk factors | #39 |
| levels house | #39 |
| igg nglycosylation | #39 |
| c589 | #39 |
| wheezing phenotypes | #39 |
| allergic symptoms children | #39 |
| traffic asthma | #39 |
| polymorphisms asthma | #39 |
| genetic rhinitis | #39 |
| ige switching | #39 |
| maternal health pregnancy | #39 |
| protect children | #39 |
| degradation patients | #39 |
| animal farms | #40 |
| preschool conjunctivitis | #40 |
| transcription 6 | #40 |
| eczema | #40 |
| symptoms allergic | #40 |
| crosssectional studies | #40 |
| biodiversity health | #40 |
| antibiotics development | #40 |
| children bronchial | #40 |
| isolated polysaccharides | #40 |
| mite exposure | #40 |
| 4606 | #40 |
| discotheques | #41 |
| allergens age | #41 |
| treg cells patients | #41 |
| risk factors health | #41 |
| small airway dysfunction | #41 |
| stress young | #41 |
| asthma wheeze | #41 |
| farm residence | #41 |
| allergic child | #41 |
| effects asthma | #41 |
| german cities | #41 |
| eczema phenotypes | #41 |
| polymorphism single nucleotide | #42 |
| dust female | #42 |
| microbiome data | #42 |
| international patterns | #42 |
| food questionnaire | #42 |
| onset year | #42 |
| pcdh1 | #42 |
| bronchiale | #42 |
| 95 antibiotics | #42 |
| treg th17 cells | #43 |
| dermatitis food | #43 |
| subspecies infantis | #43 |
| time asthma | #43 |
| asthma onset | #43 |
| sensitized subjects | #43 |
| worldwide variations | #43 |
| increased regulatory | #43 |
| asthma food | #43 |
| developing countries children | #44 |
| national institute allergy | #44 |
| microbiome asthma | #44 |
| prevalence symptoms | #44 |
| atopic diseases asthma | #44 |
| early childhood infections | #44 |
| followup physical activity | #44 |
| gsdma | #44 |
| asthma food allergy | #44 |
| sequential switching | #44 |
| wide variations | #44 |
| work overload | #44 |
| increased risk symptoms | #44 |
| cells cord | #44 |
| facklamia | #44 |
| atp2a3 | #44 |
| 97th | #44 |
| diseases childhood | #44 |
| asthma cystic fibrosis | #44 |
| dust endotoxins | #45 |
| phenotype respiratory | #45 |
| exposure early life | #45 |
| antiasthma drugs | #45 |
| questionnaire responses | #45 |
| 7445 | #45 |
| traffic exposure | #45 |
| sensitization inhalant | #45 |
| animals pregnancy | #45 |
| fever 95 | #45 |
| birth 12 months | #45 |
| bamse | #45 |
| biodiversity hypothesis | #45 |
| severe atopic eczema | #45 |
| prevalence diseases | #46 |
| evidence gene | #46 |
| asthma gwas | #46 |
| control physical | #46 |
| adolescence differences | #46 |
| farm animal | #46 |
| asthma cluster | #46 |
| improvement reduction | #46 |
| spt reactivity | #46 |
| prevalence bhr | #46 |
| atopic diseases children | #46 |
| humans hygiene | #46 |
| prevalence current wheeze | #46 |
| receptor tolllike receptors | #46 |
| franche | #47 |
| prevalence rhinoconjunctivitis | #47 |
| wheeze phenotypes | #47 |
| children atopic disease | #47 |
| international study | #47 |
| analysis step | #47 |
| 95 eczema | #47 |
| efraim | #47 |
| germany east | #47 |
| factors asthma | #47 |
| tirana | #47 |
| halle | #48 |
| polymorphisms il4 | #48 |
| asthma risk loci | #48 |
| breath volatile | #48 |
| prevalences asthma | #48 |
| fungal flora | #48 |
| frequent wheeze | #48 |
| cluster children | #48 |
| asthma biological | #48 |
| airways diseases | #48 |
| perennial allergens | #48 |
| parental interviews | #48 |
| doctordiagnosed asthma | #48 |
| wheeze age | #48 |
| lung function spirometry | #48 |
| asthma adjusted | #48 |
| fcer1a | #49 |
| children paracetamol | #49 |
| risk factors incidence | #49 |
| children female humans | #49 |
| chromosome susceptibility | #49 |
| milk farm | #49 |
| n228 | #49 |
| background atopic | #50 |
| bacterial markers | #50 |
| physiciandiagnosed | #50 |
| unpasteurized milk | #50 |
| diversity food | #50 |
| longum subsp infantis | #50 |
| exposures asthma | #50 |
| pcrsscp | #50 |
| beta13glucans | #50 |
| maintenant | #51 |
| microbial burden | #51 |
| common chronic disease | #51 |
| association atopic dermatitis | #51 |
| lwoffii | #51 |
| children cities | #51 |
| association allergic | #51 |
| identified polymorphisms | #51 |
| asthma maternal | #51 |
| country prevalence | #51 |
| conjugated mice mice | #51 |
| allergy symptoms | #51 |
| asthma dust | #51 |
| populationattributable risk | #51 |
| igg1 igg4 | #51 |
| age wheezing | #52 |
| indoor endotoxin | #52 |
| wheeze cough | #52 |
| epidemiologischen | #52 |
| geneenvironment interactions | #52 |
| gpra | #52 |
| infant study | #52 |
| milk consumption | #52 |
| doctor diagnosis | #52 |
| eczema childhood | #52 |
| bmi asthma | #52 |
| specific protective | #52 |
| ige sige | #52 |
| sensitization children | #52 |
| 9357 | #52 |
| itchy rash | #52 |
| prevalence wheeze | #52 |
| 2q32 | #53 |
| il13 gene | #53 |
| outdoor pollution | #53 |
| atopic eczema children | #53 |
| adam33 asthma | #53 |
| early life exposure | #53 |
| ige children | #53 |
| life exposure | #53 |
| children current asthma | #53 |
| nonmicrobial | #54 |
| estonian children | #54 |
| asthma odds | #54 |
| female germany life | #54 |
| cross sectional studies | #54 |
| animals asthma | #54 |
| male prevalence | #54 |
| prevalence wheezing | #54 |
| bacterial microbiota | #55 |
| cough wheeze | #55 |
| prevalence association | #55 |
| year asthma | #55 |
| stepwise procedure | #55 |
| samples farm | #55 |
| random samples | #56 |
| maternal ige | #56 |
| alex study | #56 |
| immunoglobulin interleukin13 | #56 |
| tuberculosis notification | #56 |
| atopy development | #56 |
| adult asthma patients | #56 |
| strong protective | #56 |
| cd14 tolllike receptor | #56 |
| asthma atopy | #56 |
| visible mold | #56 |
| eczema flg | #57 |
| mononuclear lipid | #57 |
| adam33 polymorphisms | #57 |
| member 1 polymorphism | #57 |
| pollutant exposure | #57 |
| 3785 | #57 |
| mef50 | #57 |
| prevention allergic | #57 |
| diseases methods | #57 |
| life atopic dermatitis | #57 |
| atopy wheeze | #57 |
| asthma allergic rhinoconjunctivitis | #57 |
| derp1 | #57 |
| reported parents | #58 |
| total serum | #58 |
| hypersensitivity immunoglobulin | #58 |
| specificity asthma | #58 |
| diseases children | #58 |
| eczema female | #58 |
| stat6 gene | #58 |
| early asthma | #58 |
| german participants | #59 |
| 6 years age | #59 |
| asthma morbidity children | #59 |
| farm families | #59 |
| finland estonia | #59 |
| 1q31 | #59 |
| milk cla | #59 |
| th17 lineage | #59 |
| iedap | #60 |
| beta 2agonists | #60 |
| allergic surveys | #60 |
| birth school age | #60 |
| rna yield | #60 |
| development childhood | #60 |
| preschool wheezing | #60 |
| predictors incidence | #60 |
| implicated genes | #61 |
| species colonization | #61 |
| exposure asthma | #61 |
| breastfed children | #61 |
| seasonal skin tests | #61 |
| atopy eczema | #61 |
| childhoodonset asthma | #62 |
| life immune | #62 |
| development airway hyperresponsiveness | #62 |
| asthma birth | #62 |
| respiratory sounds | #62 |
| immunoglobulin infant | #62 |
| estonia finland | #62 |
| large german | #62 |
| persistence asthma | #62 |
| endotoxin level | #63 |
| exposure assessed | #63 |
| dermatitis risk | #63 |
| children role | #63 |
| indoor allergen exposure | #63 |
| asthma breast | #63 |
| atopic | #63 |
| total quantity | #63 |
| children regions | #63 |
| cystic fibrosis abpa | #63 |
| hyperreactivity bronchial | #63 |
| no2 benzene | #64 |
| children centers | #64 |
| dust parameters | #64 |
| helminth ascariasis ascaris | #64 |
| differential networks | #64 |
| newborn lymphocyte | #64 |
| allergenspecific ige | #64 |
| animal contact | #65 |
| risk wheezing | #65 |
| healthy controls children | #65 |
| childhood allergic diseases | #65 |
| allergic rhinitis age | #66 |
| immunological data | #66 |
| prevalence current asthma | #66 |
| living area | #66 |
| dust extracts | #66 |
| ga²len | #66 |
| atopic symptoms | #66 |
| preschool haemophilus humans | #66 |
| umc | #66 |
| sensitization allergic | #66 |
| maternal atopy | #67 |
| biomarkers predictors | #67 |
| ige expression | #67 |
| 2 questionnaires | #67 |
| pa obesity | #67 |
| respiratory allergies | #67 |
| mère | #68 |
| early wheeze | #68 |
| antibiotic sales | #68 |
| weight boys | #68 |
| ige allergens | #69 |
| suisse | #70 |
| allergic disorders | #70 |
| sod3 | #70 |
| atopic disease children | #70 |
| asthma complex | #70 |
| hypersensitivity immunization | #70 |
| gene gene interaction | #70 |
| prenatal vitamin | #71 |
| occurrence progression | #71 |
| tlr2 tlr1 | #71 |
| barns | #71 |
| small airway function | #71 |
| allergic sensitization children | #71 |
| atopic rhinitis | #71 |
| breathomics | #71 |
| unprocessed | #71 |
| association occupational exposure | #72 |
| children wheeze | #72 |
| persistent asthma children | #72 |
| infantis | #72 |
| factor asthma | #72 |
| molecular fingerprinting | #72 |
| 158 95 | #72 |
| sounds respiratory | #73 |
| gni | #73 |
| ormdl3 | #73 |
| european ancestry association | #73 |
| onset allergic | #73 |
| severe eczema | #74 |
| health services children | #74 |
| exposure europe | #74 |
| west humans | #74 |
| food allergy asthma | #74 |
| risk wheeze | #74 |
| rfel | #75 |
| chromosome 17q21 | #75 |
| total serum ige | #75 |
| children hrqol | #75 |
| standardized procedure | #75 |
| maternal immunity | #75 |
| asthma genome | #75 |
| asthmatic mothers | #75 |
| allergy childhood | #76 |
| microbial molecules | #76 |
| food inhalant | #76 |
| rural differences | #76 |
| symptoms eczema | #76 |
| wheezing | #76 |
| eczema children | #76 |
| asthma case | #76 |
| asthma healthy | #77 |
| sexspecific association | #77 |
| hyperresponsiveness bhr | #77 |
| diversity microbial | #77 |
| 9 mmp9 | #77 |
| childhood | #78 |
| years odds | #78 |
| 6399 | #78 |
| blood cytokines | #78 |
| edta tubes | #78 |
| findings prevalence | #78 |
| turkish origin | #78 |
| sensitisation children | #78 |
| rhinitis atopic | #78 |
| wheezing illnesses | #78 |
| mothers asthma | #78 |
| interactions snps | #79 |
| genes innate immunity | #79 |
| 95 protection | #79 |
| seasonal asthma | #79 |
| milk yoghurt | #79 |
| neuropeptide receptor | #79 |
| cats child | #80 |
| ige skin | #80 |
| dander | #80 |
| prevalence respiratory | #81 |
| development atopic dermatitis | #81 |
| lower prevalence | #81 |
| forkhead box protein | #81 |
| microbial agents | #81 |
| childhood wheeze | #81 |
| symptoms 12 | #81 |
| age prevalence | #82 |
| bacterial viral infections | #82 |
| ribosomal pcr | #82 |
| introduction solids | #82 |
| children european | #82 |
| laryngitis | #82 |
| concentrations so2 | #82 |
| age 45 | #82 |
| 13 14 | #82 |
| gut commensals | #83 |
| hypersensitivity risk | #83 |
| reporter genetic predisposition | #83 |
| current wheezing | #83 |
| microbial stimulation | #83 |
| cleanliness | #83 |
| study population patients | #83 |
| study pcr | #83 |
| children siblings | #83 |
| total fat content | #83 |
| oligoarticular juvenile | #84 |
| tests child | #84 |
| 4732 | #84 |
| new asthma | #84 |
| specific exposures | #84 |
| control pa | #84 |
| bronchial responsiveness | #85 |
| single nucleotide rna | #85 |
| européenne | #85 |
| n134 | #85 |
| atopy risk | #85 |
| α1 antitrypsin | #85 |
| truck traffic | #86 |
| arabinogalactan | #86 |
| children feeding | #86 |
| infant inflammation | #86 |
| ige levels | #86 |
| wheeze prevalence | #86 |
| bifidobacterium species | #86 |
| hyper responsiveness | #86 |
| comté | #86 |
| exposure associations | #87 |
| age asthma | #87 |
| genes asthma | #87 |
| influential factors | #87 |
| visits asthma | #87 |
| analysis respiratory | #87 |
| 95 fever | #87 |
| exposure tobacco smoke | #88 |
| asthma polymorphisms | #88 |
| pollution allergens | #88 |
| rhinitis risk | #88 |
| tolllike receptors tlrs | #88 |
| allergy tests | #88 |
| asthma children | #89 |
| bronchial hyper | #89 |
| asthma phenotypes | #89 |
| rphl | #89 |
| aged 6 | #89 |
| children area | #90 |
| current exposure | #90 |
| critical time window | #90 |
| allergic seasonal surveys | #90 |
| asthma school | #91 |
| joint workshop | #91 |
| newborn limit | #91 |
| newborn leukocytes | #91 |
| filaggrin mutations | #91 |
| development eczema | #91 |
| sensitisation | #92 |
| mononuclear polymorphism | #92 |
| rs2305480 | #93 |
| experimental asthma | #93 |
| east west germany | #93 |
| preschool haemophilus | #93 |
| south germany | #93 |
| low levels exposure | #93 |
| previous studies association | #93 |
| allergic rhinitis symptoms | #93 |
| geführt | #93 |
| zpbp2 | #94 |
| tregulatory cells | #94 |
| pertussis infection | #94 |
| expression toll | #95 |
| international variation | #95 |
| nickel allergy | #95 |
| asthma common | #95 |
| eczema symptoms | #95 |
| asthma loci | #95 |
| university life | #95 |
| fed children | #95 |
| 16q12 | #95 |
| greater consumption | #95 |
| anaphylaxie | #96 |
| cumulative prevalence | #96 |
| expression th1 | #96 |
| lps recognition | #96 |
| trigger factors | #96 |
| dust environmental | #96 |
| airway dysfunction | #96 |
| dysbalance | #96 |
| allergic sensitisation | #96 |
| onset wheeze | #96 |
| nonfarmers | #96 |
| indoor factors | #97 |
| 95 overweight | #97 |
| schoolchildren aged | #97 |
| city air | #97 |
| regulatory treg | #97 |
| inhalant allergens | #97 |
| age 3 years | #98 |
| tlr1 tlr2 | #98 |
| seasonal sensitivity | #98 |
| factors school | #98 |
| background asthma | #98 |
| children germany | #98 |
| childhood adulthood | #98 |
| comprehensive questionnaire | #99 |
| seasonal surveys | #99 |
| earlyonset asthma | #99 |
| years aor | #99 |
| current wheeze | #99 |
| eastern germany | #99 |
| children atopic | #99 |
| asthma inflammation | #99 |
| rural school | #99 |
| preschool crosssectional studies | #100 |
| isaac questionnaire | #100 |
| childhood atopic dermatitis | #100 |
| summarised | #101 |
| weight girls | #101 |
| mef25 | #101 |
| genetic factors susceptibility | #101 |
| raw cow | #101 |
| expression measurements | #101 |
| tenascin tnc | #102 |
| effects respiratory | #102 |
| risk factors persistence | #102 |
| retinoid acid | #102 |
| factors wheezing | #102 |
| ige concentrations | #102 |
| years early | #103 |
| hdm exposure | #103 |
| irf1 gene | #103 |
| 4264 | #103 |
| children increased risk | #103 |
| sensitization eczema | #103 |
| sensitization childhood | #104 |
| children relation | #104 |
| exposure milk | #104 |
| hutterites | #105 |
| pollen concentration | #105 |
| hyperreactivity | #105 |
| arabinogalactans | #105 |
| high‐sensitivity | #105 |
| questionnaires switzerland | #106 |
| physiciandiagnosed asthma | #106 |
| wheezing disorders | #106 |
| blood ige | #106 |
| prevalence atopy | #106 |
| animal dander | #106 |
| children contact | #106 |
| puberty age | #107 |
| underlying factor | #107 |
| detailed questionnaire | #107 |
| socs4 | #107 |
| overweight 95 | #108 |
| breast feeding | #108 |
| inverse associations | #108 |
| fever episodes | #108 |
| moulds | #109 |
| complex syndrome | #109 |
| air pollution children | #109 |
| allergic perennial rhinitis | #109 |
| healthy children children | #109 |
| asthma wheezing | #109 |
| publication air pollution | #109 |
| rs7216389 | #110 |
| folgenden | #110 |
| genotype germany | #110 |
| p≤003 | #110 |
| female germany | #110 |
| atopic eczema humans | #110 |
| parental questionnaire | #111 |
| il4ra | #111 |
| tbox transcription factor | #112 |
| olive pollen | #112 |
| 1314 | #112 |
| milk samples | #112 |
| female histones | #112 |
| environmental study | #112 |
| risk allergic | #113 |
| phenotypes asthma | #113 |
| flg variants | #113 |
| experimental allergic asthma | #113 |
| indoor asthma | #113 |
| allergic | #113 |
| asthma sensitization | #114 |
| tests bronchial | #114 |
| challenge data | #114 |
| mould exposure | #114 |
| allergic disease | #114 |
| parent reported | #114 |
| occupational allergy | #114 |
| igg4 responses | #115 |
| cough children | #115 |
| increased diversity | #115 |
| cord blood ige | #115 |
| foxp3 locus | #115 |
| notification rates | #115 |
| immune responsiveness | #116 |
| exclusive breast feeding | #116 |
| aged 9 | #116 |
| regulatory th17 | #116 |
| psychosocial characteristics | #117 |
| children underwent | #117 |
| glutathione transferase gst | #117 |
| skinprick tests | #118 |
| allergic sensitization | #118 |
| living rural | #118 |
| ratio prevalence | #118 |
| indoor microbial | #118 |
| west germany | #118 |
| reference children | #118 |
| germany humans | #118 |
| skin prick | #119 |
| delayed introduction | #119 |
| ancestry asthma | #119 |
| children wheezing | #119 |
| switching immunoglobulin | #119 |
| levels endotoxin | #120 |
| association chromosome | #120 |
| childhood risk factors | #120 |
| environment children | #120 |
| fibrolysis | #120 |
| lung function measurements | #121 |
| aliments | #121 |
| symptom control | #121 |
| vitamin supplementation pregnancy | #121 |
| factors rural | #121 |
| dampness | #121 |
| allergens asthma | #121 |
| common aeroallergens | #121 |
| preventive potential | #122 |
| life early | #122 |
| tlr10 | #122 |
| 300 people | #122 |
| hayfever | #123 |
| frequency pattern | #123 |
| urban traffic | #123 |
| passive smoke exposure | #124 |
| atopic manifestations | #124 |
| severe eosinophilic asthma | #124 |
| germany prevalence | #124 |
| active asthma | #124 |
| il18r1 | #125 |
| potted plants | #125 |
| immunologic tolllike receptor | #125 |
| common inhalant | #125 |
| eczema patients | #126 |
| await | #126 |
| exposure pets | #126 |
| sensitization development | #126 |
| asthma background | #126 |
| 3 infections | #126 |
| prevalence allergic diseases | #126 |
| paediatric studies | #126 |
| effects prevalence | #126 |
| prävalenz | #127 |
| test reactivity | #127 |
| 95 ors | #127 |
| parent questionnaire | #127 |
| exposure endotoxin | #127 |
| adaptive cells | #127 |
| environmental allergens | #127 |
| allergens child | #127 |
| caspase recruitment domain | #127 |
| bdnf polymorphisms | #128 |
| microbial markers | #129 |
| receptors male | #129 |
| bdnf gene | #129 |
| medall | #130 |
| test study | #131 |
| respiratory symptoms children | #131 |
| sensitization allergens | #131 |
| protein allergy | #131 |
| asthma objective | #131 |
| severe eosinophilic | #131 |
| factors allergens | #131 |
| common allergens | #131 |
| hypersensitivity respiratory | #131 |
| diseases asthma | #132 |
| expression receptors | #132 |
| asthma adolescent | #132 |
| effects development | #132 |
| immunoglobulin inflammation | #132 |
| male occupational | #132 |
| bavaria | #133 |
| age 7 | #133 |
| early age | #133 |
| understanding natural | #133 |
| pollen prevalence | #133 |
| allergy | #134 |
| 7 years age | #134 |
| dpp10 | #134 |
| prevalence rhinitis | #135 |
| body composition bmi | #135 |
| childhood risk | #135 |
| crth2 | #135 |
| 95 ages | #135 |
| 60 iu | #136 |
| eczema risk | #136 |
| bronchial response | #136 |
| allergic phenotype | #136 |
| asthma young | #136 |
| snps asthma | #137 |
| ga2len | #137 |
| actinomycetes | #137 |
| 6 7 | #137 |
| mechanisms asthma | #137 |
| exposure children | #137 |
| ms4a2 | #137 |
| mattress | #138 |
| reduced prevalence | #138 |
| pollutants allergens | #138 |
| régions | #138 |
| asthma atopic dermatitis | #138 |
| asthma development | #138 |
| snps interactions | #138 |
| sensitized children | #138 |
| allergen levels | #139 |
| listeria spp | #139 |
| milk animals | #139 |
| sebacate | #139 |
| 3 14 | #139 |
| pollution asthma | #139 |
| serum ige | #139 |
| largest reduction | #140 |
| exposure symptoms | #140 |
| tregs foxp3 | #140 |
| pasture | #140 |
| duration type | #140 |
| microbiota children | #140 |
| age 6 years | #141 |
| exposure indoor | #141 |
| asthma genes | #141 |
| indoor allergens | #142 |
| asthma bronchitis | #142 |
| susceptibility children | #142 |
| n183 | #142 |
| questionnaires illness surveys | #142 |
| factors difference | #142 |
| cla content | #142 |
| unifrac | #143 |
| pregnancy early | #143 |
| pet exposure | #144 |
| asthma defined | #144 |
| replication association | #144 |
| incident asthma | #144 |
| exposure year | #144 |
| inconclusive | #144 |
| snps chromosome | #144 |
| children allergy | #145 |
| dermatitis asthma | #145 |
| expositions | #145 |
| onset menarche | #145 |
| prevalence skin | #146 |
| interleukin13 interleukin4 | #146 |
| health outcomes children | #146 |
| lower airways | #146 |
| allergy testing | #146 |
| prematurely born children | #146 |
| airway mechanics | #146 |
| biomarkers child | #147 |
| original article | #147 |
| study centers | #147 |
| germany west | #148 |
| association early | #148 |
| feno patients | #148 |
| children 6 | #148 |
| indoor allergen | #149 |
| atopic outcomes | #149 |
| early immune | #149 |
| fall fev1 | #150 |
| pregnancy respiratory | #150 |
| perennial rhinitis allergic | #150 |
| prevalence childhood | #151 |
| wheeze children | #151 |
| confer protection | #151 |
| wheezing children | #151 |
| profound differences | #151 |
| 105 years | #151 |
| established asthma | #152 |
| children review | #152 |
| environmental exposure | #152 |
| exposure increased | #152 |
| bhr | #152 |
| immunomodulatory molecules | #152 |
| distribution asthma | #152 |
| consumption dairy products | #152 |
| wheeze asthma | #153 |
| tagging single | #153 |
| common respiratory | #153 |
| asthma dermatitis | #153 |
| function measurements | #153 |
| hens egg | #153 |
| hormonal factors | #154 |
| cd28null | #154 |
| onset association | #155 |
| bronchial challenge | #155 |
| neighboring countries | #155 |
| tests sex factors | #155 |
| atopic children | #156 |
| association asthma | #156 |
| severity frequency | #157 |
| neu5gc | #157 |
| development allergy | #157 |
| absolute levels | #157 |
| positive spt | #157 |
| gene 3 | #157 |
| bacterial lysates | #158 |
| asthma females | #158 |
| early environmental | #158 |
| paediatric asthma | #158 |
| lower diversity | #158 |
| children asthma | #159 |
| patients controlled asthma | #159 |
| prevention allergy | #159 |
| developing immune | #159 |
| allergic seasonal | #160 |
| spts | #160 |
| reported prevalence | #160 |
| children rhinitis | #160 |
| microbiome diversity | #160 |
| german adults | #160 |
| children homes | #160 |
| atopy asthma | #161 |
| newborn longitudinal | #161 |
| preventive measure | #161 |
| asthma presence | #161 |
| wheeze rhinitis | #161 |
| parental asthma | #162 |
| female humans allergic | #162 |
| children lower | #162 |
| immune pathways | #162 |
| perennial rhinitis | #163 |
| specific ige | #163 |
| environmental associations | #163 |
| exposure prevalence | #163 |
| sensitised | #164 |
| sscp | #164 |
| kindl | #164 |
| atopic eczema | #165 |
| asthma ige | #165 |
| atopic dermatitis | #165 |
| children sensitized | #165 |
| illness surveys questionnaires | #166 |
| feeding child | #166 |
| infant respiratory | #166 |
| epidemiologie | #166 |
| 5q31 | #166 |
| ige asthma | #166 |
| studies exposure | #167 |
| air pollutant concentrations | #167 |
| preadolescent children | #167 |
| disease life | #167 |
| preschool cross | #167 |
| adolescent allergens | #167 |
| current asthma | #168 |
| year children | #168 |
| years lung | #168 |
| regulatory treg cells | #169 |
| workplace young | #169 |
| stratification patients | #169 |
| airway size | #169 |
| 2688 | #169 |
| chronic inflammatory disease | #170 |
| aged 13 | #171 |
| inhalant | #171 |
| nucleotide rna | #171 |
| adolescent analysis | #171 |
| sensitization pollen | #171 |
| endotoxins female | #172 |
| sheds | #172 |
| skin prick test | #172 |
| ifnγ levels | #172 |
| studien | #172 |
| prevalence current | #172 |
| nucleotide pregnancy | #172 |
| risk score model | #173 |
| unifying concept | #173 |
| risk atopy | #174 |
| antipyretics | #174 |
| female humans questionnaires | #175 |
| small airway | #175 |
| mice asthma | #175 |
| patients nocturnal | #175 |
| school level | #176 |
| sensitization common | #176 |
| serine protease inhibitor | #176 |
| repeated infections | #176 |
| asthma attack | #176 |
| life respiratory function | #177 |
| sensitization pattern | #177 |
| wheezers | #177 |
| situ hybridization infant | #177 |
| childhood infections | #178 |
| aa patients | #178 |
| genetic severity | #178 |
| sensitization asthma | #178 |
| 9p24 | #178 |
| childhood adolescence | #179 |
| sputum neutrophils | #179 |
| traffic characteristics | #179 |
| standardized methodology | #179 |
| objective measurements | #179 |
| nocturnal asthma | #179 |
| studies environmental | #179 |
| w12 | #179 |
| socks | #180 |
| breastfed infant | #180 |
| asthma genetic | #180 |
| lung function testing | #181 |
| children environmental | #181 |
| bacterial count | #181 |
| environmental predictors | #181 |
| mattresses | #181 |
| dust levels | #182 |
| dermatitis children | #182 |
| vitamin asthma | #182 |
| immunemediated diseases | #182 |
| differences hrqol | #182 |
| environmental microbiology | #183 |
| vocational training | #183 |
| mögliche | #183 |
| german population | #183 |
| tlr signaling | #183 |
| children levels | #183 |
| exposure humans | #183 |
| school district | #185 |
| incidence allergic | #185 |
| life prevalence | #185 |
| work asthma | #186 |
| protein child | #187 |
| asthma body | #188 |
| tests children | #188 |
| selfselection | #188 |
| childhood early adulthood | #188 |
| qpcrs | #188 |
| environmental exposures | #188 |
| development allergic disease | #188 |
| tlr genes | #189 |
| jf1 | #189 |
| mother pregnancy | #190 |
| early wheezing | #190 |
| association antibiotic | #190 |
| muscle mass patients | #190 |
| type duration | #190 |
| wheezing age | #190 |
| bacterial groups | #190 |
| inversely | #190 |
| atopic dermatitis children | #191 |
| blood gene | #191 |
| dry cough | #191 |
| cd14 gene | #191 |
| longum subsp | #192 |
| adjusted irr | #192 |
| pyroglyphidae | #192 |
| milk serum | #193 |
| adam33 | #193 |
| model allergic | #193 |
| cε | #193 |
| eosinophilic asthma | #195 |
| prevalence severity | #195 |
| estonian | #195 |
| caspase recruitment | #196 |
| enthusiasm | #197 |
| review asthma | #197 |
| germany switzerland | #197 |
| earlylife | #198 |
| questionnaire data | #198 |
| rhinitis eczema | #199 |
| decreased prevalence | #199 |
| representative population | #199 |
| upper lower airways | #200 |
| complex interplay | #202 |
| bacteria role | #202 |
| allergy infectious diseases | #202 |
| patients europe | #203 |
| bronchial hyperresponsiveness bhr | #203 |
| paediatrician | #203 |
| difference prevalence | #204 |
| patients aa | #204 |
| phenotyped | #204 |
| amebocyte | #205 |
| new locus | #205 |
| 13 years age | #205 |
| dermatitis atopic | #205 |
| allergen specific | #206 |
| 3034 | #206 |
| asthma respiratory symptoms | #207 |
| factors atopy | #207 |
| asthma methods | #207 |
| male phenotype | #208 |
| diagnosed asthma | #208 |
| karelia | #208 |
| allergic asthmatics | #208 |
| studies germany | #208 |
| studies cytokines | #209 |
| higher diversity | #209 |
| sensitization age | #209 |
| glycolylneuraminic acid | #209 |
| innate adaptive immunity | #209 |
| col4a3 | #209 |
| newborn logistic | #209 |
| prevalence obesity | #209 |
| bhr asthma | #210 |
| bronchial provocation | #210 |
| symptoms children | #210 |
| core microbiome | #210 |
| epithelial barrier function | #210 |
| influence development | #211 |
| exposure sensitization | #211 |
| low prevalence | #211 |
| cats dogs | #211 |
| birth 6 | #212 |
| atopic dermatitis asthma | #212 |
| asthma allergic | #212 |
| asthma animals | #212 |
| tlr4 cd14 | #212 |
| methodssubjects | #212 |
| cohort methods | #213 |
| patients uncontrolled asthma | #213 |
| exposure allergens | #213 |
| 1872 | #213 |
| distinct clusters | #213 |
| asthma allergic diseases | #214 |
| reverse causality | #214 |
| expression cd14 | #214 |
| workplace exposure | #214 |
| rural environment | #214 |
| prevalence allergic | #214 |
| 00035 | #214 |
| life allergic | #215 |
| regulatory responses | #216 |
| mast cell chymase | #216 |
| obesity overweight | #216 |
| il2rb | #218 |
| atopic female | #218 |
| causation | #219 |
| microbial products | #219 |
| disinfectants | #219 |
| child dna | #219 |
| geneticist | #219 |
| pierced | #220 |
| steiner | #220 |
| allergy development | #220 |
| variants asthma | #220 |
| homogenised | #221 |
| schistosoma schistosomiasis | #221 |
| method participants | #221 |
| sensitization rates | #222 |
| 90 children | #222 |
| increased asthma | #222 |
| environmental epidemiology | #223 |
| symptoms baseline | #223 |
| groups asthma | #224 |
| sibship size | #225 |
| german study | #225 |
| conjunctivitis allergic | #226 |
| german | #226 |
| alpha1 antitrypsin | #226 |
| sensitization allergen | #226 |
| school age | #227 |
| provocative concentration | #227 |
| data asthma | #228 |
| specific stimulation | #228 |
| test spt | #228 |
| allergic diseases asthma | #228 |
| 95 obesity | #228 |
| lung health | #228 |
| tuberculosis prevalence | #229 |
| healthy worker | #229 |
| road traffic | #229 |
| understanding asthma | #229 |
| wheezing asthma | #229 |
| asthma allergic rhinitis | #230 |
| butyryl | #230 |
| cord blood cells | #230 |
| umwelt | #230 |
| asthma phenotype | #230 |
| allergy prevention | #231 |
| cord blood cb | #231 |
| discontent | #232 |
| living conditions | #232 |
| 20 fall | #232 |
| subgroup children | #232 |
| nonallergic asthma | #232 |
| health variables | #232 |
| innate leukocytes | #233 |
| prevalence overweight | #233 |
| lively | #233 |
| dermatophagoides pteronyssinus | #234 |
| complementary food | #234 |
| hyperreactive | #234 |
| n144 | #235 |
| fourth grade | #235 |
| specific allergen | #236 |
| exposure pregnancy | #236 |
| resequenced | #236 |
| levels asthma | #236 |
| puberty girls | #238 |
| finland france | #238 |
| strategies prevention | #239 |
| incidence asthma | #239 |
| neutrophilic asthma | #240 |
| preschool cytokines | #241 |
| regulatory th1 | #242 |
| th2 immunity | #243 |
| age exposure | #243 |
| immune development | #243 |
| receptor 1 | #245 |
| adjusted odds ratio | #245 |
| adaptor protein polymorphism | #245 |
| muropeptides | #246 |
| fungal dna ribosomal | #246 |
| fever asthma | #247 |
| prick test | #247 |
| role development | #247 |
| nasal microbiota | #247 |
| patients healthcare | #248 |
| children analysis | #248 |
| baseline incidence | #249 |
| factors allergic | #249 |
| class analysis | #249 |
| therapy severe | #250 |
| clinical science | #250 |
| tlr2 gene | #251 |
| biological therapy | #251 |
| communism | #252 |
| china factors | #253 |
| asthma symptoms | #253 |
| cold air | #253 |
| contact animals | #253 |
| hormonal influences | #254 |
| lowgrade inflammation | #255 |
| atopic disease | #255 |
| preschool dermatitis | #256 |
| low pa | #256 |
| h4 acetylation | #256 |
| 454pyrosequencing | #257 |
| human asthma | #257 |
| adolescent asthma | #257 |
| body mass children | #257 |
| niaid | #258 |
| association expression | #258 |
| airborne fungi | #259 |
| epidemiological studies | #259 |
| prediction quality | #259 |
| age 6 | #260 |
| 2051 | #260 |
| rhinitis allergic | #260 |
| exposure early | #260 |
| life asthma | #260 |
| life symptoms | #260 |
| westernization | #261 |
| eczema atopic | #261 |
| discriminate | #261 |
| early life | #261 |
| spink5 | #262 |
| utilization health services | #262 |
| interferon expression | #262 |
| protein 15 | #263 |
| physician diagnosed | #263 |
| development immune | #263 |
| milk pregnancy | #263 |
| alpha1antitrypsin | #263 |
| children associations | #264 |
| tightly linked | #265 |
| exposure traffic | #265 |
| indoor exposures | #265 |
| latex sensitization | #265 |
| increase asthma | #266 |
| nox concentrations | #266 |
| early work | #267 |
| age 13 years | #267 |
| settled dust | #267 |
| pollen sensitization | #268 |
| fever children | #269 |
| rhinitis | #269 |
| prick | #269 |
| symptom prevalence | #270 |
| allergen extracts | #270 |
| hypersensitivity immune | #270 |
| conditions asthma | #271 |
| relation body mass | #272 |
| child chromosomes | #272 |
| dipeptidyl peptidases | #273 |
| study centres | #273 |
| objective markers | #274 |
| asthma control patients | #274 |
| inflammatory properties | #275 |
| exposure female | #276 |
| host microbiome | #276 |
| extracellular polysaccharides | #277 |
| future asthma | #277 |
| dust samples | #277 |
| male microbiota | #277 |
| increased exposure | #278 |
| study birth | #279 |
| remedy | #280 |
| tests allergens | #280 |
| hire | #280 |
| questionnaires adolescent | #281 |
| 6 years | #282 |
| allergies asthma | #282 |
| child dermatitis | #282 |
| adolescent animals | #282 |
| impulse oscillometry | #284 |
| randomeffects | #284 |
| collection methods | #284 |
| population burden | #285 |
| 17 children | #285 |
| allergic symptoms | #286 |
| tests respiratory | #287 |
| cells ilc2s | #287 |
| differences asthma | #287 |
| gg 95 | #288 |
| geometric ratio | #288 |
| epidemiological surveys | #289 |
| hdms | #289 |
| pollution air | #289 |
| data normalization | #290 |
| role asthma | #290 |
| risk factors children | #290 |
| asthma increased | #291 |
| allergic manifestations | #291 |
| eczema food | #292 |
| asthma factors | #292 |
| recruitment domain | #293 |
| indoor exposure | #293 |
| longitudinal cohort study | #293 |
| answered | #293 |
| allergic perennial | #293 |
| environnement | #293 |
| cohort participants | #293 |
| exposure environmental | #293 |
| asthma data | #294 |
| cbmc | #294 |
| mucosal surfaces | #296 |
| smoke pollution | #297 |
| pollution respiratory | #297 |
| bifidobacterium | #298 |
| global synthesis | #298 |
| exposure allergic | #299 |
| obesity asthma | #299 |
| nonatopic | #299 |
| exposure benzene | #299 |
| unification | #299 |
| paxgene | #299 |
| infancy development | #300 |
| risk allergy | #303 |
| asthma drugs | #306 |
| reported association | #307 |
| lumbricoides | #307 |
| analysis phase | #307 |
| antigens dermatophagoides | #308 |
| severe exacerbations | #308 |
| ige sensitization | #309 |
| neonatal immune | #309 |
| messenger tlymphocytes | #309 |
| exposure childhood | #309 |
| 2623 | #309 |
| mucosal microbiota | #309 |
| controlled asthma | #311 |
| factors early | #311 |
| birth cohort studies | #312 |
| atopic march | #312 |
| midexpiratory | #312 |
| allergy age | #313 |
| asthma inflammatory | #313 |
| signal transducer activator | #314 |
| skin examination | #314 |
| bacillus spores | #315 |
| jusqu | #315 |
| genotyping data | #315 |
| variance animals antigens | #315 |
| 2 toll | #316 |
| independent study | #316 |
| older siblings | #317 |
| pregnancy expression | #318 |
| adjustment covariates | #318 |
| child comorbidity | #318 |
| compared children | #319 |
| fpr2 | #320 |
| il5 il13 | #320 |
| bmi united states | #320 |
| mfi20 | #321 |
| chronic airway inflammation | #321 |
| moisturizer | #323 |
| children birth | #324 |
| ige responses | #325 |
| maximal expiratory | #325 |
| airway hyperresponsiveness ahr | #326 |
| 2 yrs | #326 |
| stratified sample | #326 |
| flg mutations | #327 |
| ichthyosis vulgaris | #327 |
| active smoking | #328 |
| bedrooms | #328 |
| recurrent wheeze | #328 |
| selfadministered questionnaire | #328 |
| extracellular dna | #329 |
| glycolylneuraminic | #330 |
| male milk | #330 |
| accuracy analysis | #331 |
| floor dust | #331 |
| demethylation | #331 |
| dermatophagoides asthma | #331 |
| reference equations | #331 |
| pollutant levels | #331 |
| asthma biomarkers | #333 |
| streptococcaceae | #333 |
| onset asthma | #333 |
| development sensitization | #334 |
| reduced lung function | #334 |
| upper respiratory | #334 |
| children controls | #335 |
| boluses | #336 |
| asthma china | #336 |
| prevalence surveys | #337 |
| predictive risk factors | #337 |
| 1st year | #337 |
| risk current | #337 |
| childhood atopic | #338 |
| 3113 | #338 |
| risk eczema | #339 |
| respiratory outcomes | #339 |
| asthma parents | #340 |
| medical advice | #340 |
| adultonset asthma | #341 |
| exposure development | #341 |
| humans prevalence | #341 |
| filaggrin gene | #342 |
| persistent wheeze | #342 |
| kitchen | #342 |
| nonatopic asthma | #343 |
| age introduction | #343 |
| age 9 | #344 |
| breast fed | #345 |
| hypersensitivity | #346 |
| stat6 transcription | #346 |
| 90th | #348 |
| childhood onset | #349 |
| rates asthma | #350 |
| increasing prevalence | #350 |
| prevalence | #350 |
| exposed children | #350 |
| factors surveys | #351 |
| th1 th2 cells | #353 |
| activator transcription | #354 |
| repeated episodes | #356 |
| freeways | #358 |
| purposepatients | #359 |
| genetic interaction | #359 |
| subsequent asthma | #360 |
| regression approach | #360 |
| kazal | #360 |
| children cohort | #361 |
| asthma disease | #361 |
| strength association | #361 |
| eurotium | #361 |
| cord blood | #363 |
| expression asthma | #363 |
| age 3 | #363 |
| allergic outcomes | #364 |
| farming practices | #364 |
| food sensitization | #364 |
| austria germany | #365 |
| annual concentrations | #365 |
| chronic inflammatory disorders | #366 |
| children reported | #366 |
| lactadherin | #368 |
| atopic status | #369 |
| adolescent air | #370 |
| single snp | #370 |
| expression tlr2 | #370 |
| earlylife exposure | #370 |
| testing procedures | #371 |
| 1159 | #371 |
| austria switzerland | #371 |
| conclusionwe | #371 |
| obesity prevalence | #373 |
| time activity | #373 |
| east west | #373 |
| asthma current | #374 |
| 22 countries | #374 |
| paragraphs | #374 |
| asthmatic symptoms | #374 |
| performance accuracy | #374 |
| foxp3 tregs | #375 |
| smoking asthma | #375 |
| upper respiratory tract | #376 |
| asthma cases | #376 |
| statistical approaches | #377 |
| associations exposure | #377 |
| positional cloning | #377 |
| cows milk | #377 |
| parental reports | #379 |
| mite allergens | #379 |
| population studies | #379 |
| dietary strategies | #381 |
| pieces | #382 |
| inverse association | #383 |
| unifying | #384 |
| measles vaccination | #384 |
| preschool cohort studies | #384 |
| normal lung function | #385 |
| latex | #386 |
| chronic asthma | #386 |
| impaired lung function | #386 |
| bronchial | #386 |
| alliance | #388 |
| gene environment | #389 |
| allergie | #390 |
| potential association | #391 |
| immunological analysis | #391 |
| haplotype analyses | #391 |
| critical window | #391 |
| 11 year | #392 |
| cde | #393 |
| 14 year | #394 |
| early feeding | #394 |
| mmp9 gene | #394 |
| risk sensitization | #394 |
| linear regressions | #395 |
| polymorphism gene | #395 |
| increased risk asthma | #395 |
| immunological mechanisms | #396 |
| th2 th1 | #398 |
| salmeterol xinafoate | #399 |
| study polymorphisms | #399 |
| respiratory health | #399 |
| receptor cx3cr1 | #400 |
| antiviral responses | #401 |
| regions countries | #402 |
| receptor polymorphisms | #402 |
| 2033 | #402 |
| exposure animals | #403 |
| length time | #403 |
| analysis asthma | #403 |
| plea | #404 |
| allergens | #405 |
| timothy grass | #405 |
| study agreement | #405 |
| cells asthma | #406 |
| production ifngamma | #406 |
| allergen exposure | #406 |
| 071 | #407 |
| childhood allergic | #407 |
| mugwort | #407 |
| geneenvironment interaction | #409 |
| data cohort | #409 |
| mold exposure | #410 |
| living room | #411 |
| common occurrence | #411 |
| endotoxin exposure | #411 |
| blood cb | #413 |
| gene variations | #413 |
| blood rna | #413 |
| ige synthesis | #414 |
| germany | #415 |
| mite allergen | #416 |
| childhood exposure | #416 |
| facemasks | #416 |
| house dust | #417 |
| illness asthma | #418 |
| bronchial hyperresponsiveness | #418 |
| 7 years | #418 |
| extended haplotypes | #419 |
| alimentary | #420 |
| age 2 years | #420 |
| population sample | #420 |
| halfwidth | #421 |
| prenatal factors | #421 |
| confers protection | #424 |
| tnc | #424 |
| cytokine secretion | #426 |
| asthma eczema | #427 |
| parasitic infections | #427 |
| asthma treatment | #428 |
| duration breastfeeding | #429 |
| childhood eczema | #429 |
| childrens hospitals | #430 |
| tlr1 | #430 |
| allergic conditions | #431 |
| clinical examinations | #432 |
| risk overweight | #433 |
| 441 | #433 |
| specific sensitization | #434 |
| respiratory allergic | #434 |
| decrements | #438 |
| age odds ratio | #438 |
| tobit | #438 |
| allergy diagnosis | #438 |
| conundrum | #440 |
| asthma gene | #441 |
| annual prevalence | #441 |
| population asthma | #442 |
| fecal microbiota | #443 |
| male odds | #443 |
| inception | #443 |
| chronic inflammatory diseases | #443 |
| asthma effects | #444 |
| cell phenotypes | #444 |
| persisting | #444 |
| observed differences | #445 |
| increase bmi | #445 |
| asthma respiratory | #446 |
| specific serum | #446 |
| exposure respiratory | #448 |
| ethnic origin | #449 |
| allergic rhinoconjunctivitis | #449 |
| 033 | #450 |
| allergy food | #450 |
| adult asthmatics | #451 |
| n149 | #452 |
| associations asthma | #452 |
| including asthma | #455 |
| school entry | #456 |
| dermatophagoides farinae | #457 |
| pregnancy increased risk | #457 |
| germany health | #458 |
| mice role | #460 |
| provocation tests | #460 |
| allergic risk | #460 |
| external environment | #460 |
| airway hyper | #462 |
| westernized | #463 |
| asthma higher | #464 |
| rural health | #464 |
| asthma control test | #465 |
| environmental factors | #466 |
| cells innate | #467 |
| postal questionnaire | #467 |
| opposite effects | #467 |
| immunocap | #468 |
| severity asthma | #468 |
| alex | #468 |
| so2 concentrations | #469 |
| clinical asthma | #470 |
| early identification | #470 |
| nod1 signaling | #470 |
| exposure | #471 |
| emphasised | #471 |
| microbial counts | #471 |
| asthma rhinitis | #471 |
| fodder | #473 |
| birth cohorts | #473 |
| antibiotics children | #473 |
| yrs | #474 |
| 1133 | #474 |
| cross sectional survey | #476 |
| champ | #476 |
| exposure antibiotics | #477 |
| early exposure | #481 |
| risk severity | #482 |
| childhood environment | #483 |
| asthma association | #484 |
| total immunoglobulin | #484 |
| subphenotypes | #485 |
| atopic disorders | #486 |
| immunity genes | #486 |
| children | #486 |
| phenotypes | #487 |
| prospective birth cohort | #487 |
| exposure data | #489 |
| potential confounding | #489 |
| genes environment | #490 |
| studies rhinitis | #490 |
| multicenter cohort | #491 |
| snp association | #494 |
| polymorphisms association | #495 |
| uncontrolled asthma | #495 |
| age 10 | #496 |
| lifestyles | #496 |
| housing animal | #497 |
| southern germany | #497 |
| children jia | #497 |
| individual level | #498 |
| phenotype polymorphism | #498 |
| asthma severe | #498 |
| omega6 fatty acids | #500 |
| respiratory hypersensitivity | #500 |
| birth age | #501 |
| asthma susceptibility | #503 |
| lung function children | #503 |
| sensitizations | #504 |
| white children | #505 |
| tests specific | #505 |
| methods studies | #505 |
| diet diversity | #505 |
| allergy children | #508 |
| ranks | #508 |
| rna samples | #509 |
| childhood respiratory | #509 |
| prevalence rates | #509 |
| housing humans | #510 |
| stimulation lps | #511 |
| perennial | #511 |
| il15 | #513 |
| age 10 years | #514 |
| europe female | #514 |
| asthma prevalence | #515 |
| children exposed | #515 |
| receptor tlr | #516 |
| cities china | #516 |
| infections asthma | #516 |
| levels children | #516 |
| asthma bronchiolitis | #516 |
| cd4cd25high | #517 |
| dpps | #518 |
| atopic conditions | #519 |
| th2 immune | #519 |
| haplotype association | #520 |
| eczema asthma | #522 |
| neutrophils eosinophils | #522 |
| polymorphisms snps | #523 |
| age 1 year | #523 |
| p0041 | #523 |
| children maternal | #523 |
| risk factors asthma | #523 |
| time window | #524 |
| rural areas | #524 |
| maternal vitamin | #525 |
| adolescence age | #525 |
| trans fatty acids | #526 |
| baseline participants | #528 |
| obesity body mass | #528 |
| bmi increased risk | #528 |
| allergens animals | #529 |
| 117 95 | #529 |
| c‐reactive protein | #529 |
| blood humans | #529 |
| persistent asthma | #530 |
| edifice | #530 |
| environmental bacteria | #531 |
| obesity smoking | #531 |
| protect | #532 |
| samples children | #532 |
| oral tolerance | #533 |
| allergic airway inflammation | #534 |
| children methods | #535 |
| immune stimulation | #536 |
| topic rhinitis | #537 |
| il4r | #538 |
| blood eosinophil counts | #539 |
| industrialised | #540 |
| adolescence early adulthood | #541 |
| human microbiota | #541 |
| airway symptoms | #542 |
| lipopolysaccharide receptors | #543 |
| immunological markers | #543 |
| pregnancy asthma | #543 |
| rubella virus | #543 |
| cypress | #544 |
| pathomechanisms | #545 |
| regulatory cell | #546 |
| 17q12 | #547 |
| antitrypsin alpha | #547 |
| greenness | #548 |
| oligoarticular | #549 |
| floorcoverings | #549 |
| hypersensitivity humans | #550 |
| isotype switching | #553 |
| epidemic proportions | #553 |
| association children | #553 |
| lung microbiome | #554 |
| multidisciplinary study | #554 |
| mental health patients | #555 |
| children parental | #555 |
| overweight prevalence | #556 |
| asthma status | #556 |
| allergic rhinitis asthma | #558 |
| aqlq | #558 |
| 1129 | #559 |
| blood eosinophils | #560 |
| letzten | #560 |
| activity body | #561 |
| reduced exposure | #564 |
| inhaled steroids | #566 |
| 2 immunity | #566 |
| hormonal contraceptives | #566 |
| 077 | #567 |
| immune regulatory | #569 |
| exposure matrix | #570 |
| initial observations | #570 |
| tripeptidyl | #570 |
| asthma symptom | #571 |
| health urban | #571 |
| levels total | #575 |
| affluence | #575 |
| hcs patients | #575 |
| diseases prevalence | #575 |
| atopic asthma | #579 |
| creactive protein levels | #579 |
| oro | #580 |
| followups | #580 |
| age controls | #581 |
| association obesity | #581 |
| flanking regions | #582 |
| fdr | #582 |
| asthma population | #582 |
| uht | #584 |
| asthma severity | #584 |
| tlr6 | #584 |
| function asthma | #585 |
| bacterial microbiome | #588 |
| gsdmb | #589 |
| longum | #590 |
| n63 | #590 |
| skin test | #591 |
| 1 antitrypsin | #592 |
| endotoxin concentrations | #593 |
| holiday | #593 |
| il1rl1 | #596 |
| gasdermin | #596 |
| factors respiratory | #596 |
| model asthma | #597 |
| advising | #598 |
| pathogenesis asthma | #598 |
| total specific | #598 |
| zeigen | #598 |
| galactosylation | #600 |
| genetic environmental | #600 |
| active immunity | #601 |
| factors humans | #602 |
| 048 | #603 |
| pregnancy maternal | #603 |
| hladqa1 | #604 |
| statistical analyses | #604 |
| humans human | #604 |
| agents asthma | #606 |
| microbes | #606 |
| sensitization | #606 |
| microbiome studies | #607 |
| ige production | #608 |
| allergic rhinitis | #610 |
| 2 inflammation | #610 |
| infant feeding practices | #611 |
| work life | #612 |
| regulatory molecules | #612 |
| 11–13 | #612 |
| bolus | #612 |
| pollen allergens | #616 |
| albania | #619 |
| aged allergens | #619 |
| chronic stress | #619 |
| urban populations | #620 |
| life age | #621 |
| body plethysmography | #621 |
| arthropod proteins | #621 |
| deep phenotyping | #622 |
| radioallergosorbent | #623 |
| unstimulated | #623 |
| functional features | #625 |
| data prevalence | #627 |
| 779 | #627 |
| endotoxin | #627 |
| protective properties | #629 |
| crosssectional | #629 |
| smoking surveys | #632 |
| school children | #632 |
| models asthma | #633 |
| exacerbating | #635 |
| settled | #635 |
| feeding patterns | #635 |
| child asthma | #636 |
| standardized questionnaire | #637 |
| children atopic dermatitis | #637 |
| lifetime prevalence | #638 |
| european children | #639 |
| factors urban | #639 |
| igg glycosylation | #639 |
| clustering approach | #641 |
| grass pollen | #642 |
| innate immunity | #642 |
| humans microbiota | #643 |
| years increased | #645 |
| symptoms | #646 |
| innate lung | #647 |
| pollen concentrations | #648 |
| health rural | #650 |
| pets | #650 |
| kindern | #650 |
| participation rates | #650 |
| life children | #650 |
| glucocorticoid induced | #652 |
| helsinki | #653 |
| dermatitis allergic | #654 |
| comprehensive analysis | #654 |
| prospective studies association | #656 |
| 16 countries | #658 |
| common chronic | #659 |
| latent classes | #662 |
| age 1 | #662 |
| conclusion data | #663 |
| cd14 expression | #664 |
| abpa | #665 |
| di2ethylhexyl | #665 |
| hygiene | #665 |
| pvalues | #666 |
| hypertonic saline | #667 |
| chemokine cx3cl1 | #668 |
| adult lung | #669 |
| standardized questionnaires | #670 |
| birth cohort | #671 |
| central european | #672 |
| susceptibility locus | #672 |
| cellules | #673 |
| études | #674 |
| jobs | #676 |
| ilc2s | #677 |
| age 45 years | #679 |
| common infections | #680 |
| female forced | #681 |
| random sample | #681 |
| protective | #681 |
| dairy farm | #681 |
| egg allergy | #682 |
| cohorte | #683 |
| dietary habits | #685 |
| recurrent wheezing | #685 |
| childhood experiences | #686 |
| factors air | #688 |
| european community | #692 |
| major gene | #693 |
| doctor | #693 |
| turkish | #694 |
| factors skin | #695 |
| physical examination | #699 |
| rhinitis symptoms | #702 |
| sensitization food | #703 |
| hypersensitivity inflammation | #703 |
| microbial flora | #703 |
| risk obesity | #703 |
| tao | #707 |
| 459 | #708 |
| microbial interactions | #708 |
| dramatic increase | #708 |
| immune activation | #709 |
| perpetuation | #709 |
| immunologic tlymphocytes | #712 |
| population surveys | #712 |
| children time | #713 |
| pregnancy children | #718 |
| bacterial spores | #720 |
| mediated diseases | #721 |
| allergy asthma | #722 |
| ratio aor | #724 |
| sensitized patients | #727 |
| function children | #727 |
| alias | #734 |
| 95 males | #734 |
| il4 il13 | #738 |
| linkage chromosome | #741 |
| population adolescent | #741 |
| nonasthmatic | #742 |
| fractional exhaled | #742 |
| farms | #743 |
| treg cell | #745 |
| traffic air | #748 |
| type 5 | #748 |
| ifih1 | #749 |
| children low | #753 |
| earlier study | #754 |
| total lung | #755 |
| environment interactions | #758 |
| h20 | #758 |
| aeroallergens | #759 |
| moderate levels | #764 |
| indoor dust | #766 |
| air trapping | #768 |
| edn1 | #768 |
| pulmonary function tests | #769 |
| hscrp levels | #769 |
| allergists | #769 |
| hyperresponsiveness | #770 |
| pattern recognition receptors | #770 |
| blood leukocytes | #770 |
| asthma adults | #771 |
| strabismus surgery | #772 |
| nucleotide receptors | #773 |
| incidence longitudinal | #773 |
| term impact | #773 |
| volume humans | #777 |
| rhinitis children | #781 |
| studies asthma | #784 |
| new associations | #784 |
| factors incidence | #785 |
| children allergic | #785 |
| nonallergic | #788 |
| factors tobacco | #788 |
| shortness breath | #789 |
| asthma therapy | #791 |
| gis | #793 |
| male metaanalysis | #793 |
| children health | #794 |
| βdiversity | #795 |
| airway hyperresponsiveness | #795 |
| natural habitat | #796 |
| distinct trajectories | #796 |
| personalization | #798 |
| pc20 | #798 |
| card15 | #799 |
| protective effects | #799 |
| 45 years | #800 |
| pair 1 chromosomes | #801 |
| confer | #802 |
| allergen | #805 |
| age 4 years | #806 |
| infant food | #807 |
| dairy farms | #808 |
| exposure age | #810 |
| tenascin | #810 |
| bifidobacterium longum | #810 |
| subclinical inflammation | #811 |
| pteronyssinus | #811 |
| peak flow | #813 |
| bacillus licheniformis | #813 |
| boiled | #814 |
| initial data | #814 |
| onset age | #815 |
| foe | #816 |
| foxp3 | #817 |
| brevibacterium | #818 |
| positive skin | #819 |
| 0053 | #820 |
| food infant | #821 |
| skin tests | #822 |
| breastfeeding duration | #822 |
| spt | #827 |
| trier | #830 |
| studies respiratory | #830 |
| prevention strategies | #831 |
| asthma health | #832 |
| current analysis | #833 |
| rad50 | #833 |
| promoter polymorphisms | #834 |
| snps haplotypes | #835 |
| regularly | #835 |
| farinae | #835 |
| igg4 | #835 |
| adolescent age | #837 |
| cx3cr1 | #838 |
| exhaled breath | #838 |
| asthma bronchi | #839 |
| toll receptors | #839 |
| public health problem | #839 |
| parental smoking | #839 |
| subsequent development | #840 |
| cladosporium | #841 |
| chronification | #844 |
| fetal blood | #845 |
| modifies | #845 |
| innate | #849 |
| potted | #849 |
| bacterial endotoxin | #850 |
| maternal exposure | #850 |
| allergen sensitization | #852 |
| inspections | #854 |
| 17q | #855 |
| infant health | #856 |
| provocation | #856 |
| infant infant | #858 |
| age 5 | #861 |
| repeatedly | #861 |
| paracetamol | #862 |
| asthma lung | #864 |
| receptors tlrs | #864 |
| questionnaires young adult | #864 |
| volatile organic | #865 |
| airway eosinophilia | #866 |
| birth cohort study | #866 |
| ige | #866 |
| cumulative incidence | #874 |
| outdoor air pollution | #874 |
| latent class analysis | #875 |
| dermatitis | #878 |
| hmos | #878 |
| microbiome humans | #879 |
| 1940 | #880 |
| 057 | #880 |
| 12q | #884 |
| ifngamma tnfalpha | #886 |
| brink | #888 |
| 856 | #888 |
| oscillometry | #890 |
| european populations | #891 |
| bacterial counts | #892 |
| exposure study | #895 |
| subsample | #895 |
| asthma incidence | #896 |
| esl | #896 |
| impact asthma | #900 |
| immunoglobulin ige | #902 |
| inflammation airway | #902 |
| breastfed | #904 |
| respiration disorders | #905 |
| allergen induced | #907 |
| shortness | #908 |
| adult asthma | #908 |
| children overweight | #910 |
| microbiome composition | #910 |
| microbiota development | #912 |
| complex disease | #917 |
| cow milk | #917 |
| immunity innate | #919 |
| 710 | #920 |
| peripheral blood samples | #920 |
| methods cross | #920 |
| estonia | #923 |
| prospective birth | #927 |
| sectional population | #928 |
| sounds | #928 |
| ilcs | #929 |
| biomérieux | #929 |
| participants baseline | #932 |
| lactococcus lactis | #939 |
| 026 | #939 |
| 13 years | #940 |
| dermatophagoides | #940 |
| potential confounders | #940 |
| floors | #942 |
| life style | #944 |
| microbiome host | #949 |
| 055 | #950 |
| identification genes | #952 |
| environmental effects | #952 |
| 454 pyrosequencing | #953 |
| asthma exercise | #954 |
| solids | #954 |
| polymorphisms | #954 |
| 1120 | #954 |
| genotyped | #954 |
| human life | #955 |
| infections child | #957 |
| children countries | #959 |
| fever | #959 |
| domestic | #961 |
| rhinitis asthma | #961 |
| exposures | #961 |
| nasal secretions | #964 |
| disease asthma | #964 |
| immunoglobulin male | #965 |
| cytokines female | #965 |
| obesity children | #966 |
| innsbruck | #970 |
| readings | #971 |
| fev | #973 |
| immunization immunoglobulin | #973 |
| onset child child | #974 |
| teenagers | #975 |
| orphan receptor | #976 |
| gondii infection | #976 |
| bmi physical activity | #977 |
| nucleotide promoter | #978 |
| respiratory conditions | #979 |
| xinafoate | #981 |
| 682 | #981 |
| receptor gene | #981 |
| yearly | #982 |
| 1333 | #983 |
| small effects | #984 |
| child cohort | #986 |
| adolescents asthma | #987 |
| 12 months age | #990 |
| 068 | #991 |
| pasteurization | #991 |
| c3h hej | #991 |
| hercules | #992 |
| asthma humans | #992 |
| function development | #992 |
| sectional | #994 |
| design methods | #994 |
| immunoglobulin class | #995 |
| diagnosis asthma | #998 |
| respiratory symptoms | #1001 |
| bradykinin receptors | #1003 |
| yoghurt | #1005 |
| ppg | #1006 |
| rural population | #1006 |
| maternally | #1006 |
| linens | #1009 |
| preventive measures | #1010 |
| pt15 | #1012 |
| asthma outcomes | #1014 |
| timeframe | #1016 |
| 039 | #1017 |
| phytohemagglutinin | #1017 |
| association physical activity | #1018 |
| median levels | #1019 |
| strongest associations | #1020 |
| asthma medication | #1021 |
| western countries | #1022 |
| sought | #1024 |
| raw milk | #1027 |
| asthma adult | #1029 |
| outcome variables | #1030 |
| upper airways | #1031 |
| 096 | #1033 |
| genomewide association | #1033 |
| asthmatic children | #1035 |
| veillonella | #1037 |
| cell child | #1038 |
| breastmilk | #1039 |
| dairying | #1039 |
| nod1 | #1042 |
| disease children | #1046 |
| milieu | #1046 |
| missing values | #1047 |
| exposure conditions | #1048 |
| controls age | #1051 |
| severe allergic | #1057 |
| il5 | #1058 |
| infant gut | #1059 |
| hobbies | #1059 |
| metalloprotease | #1060 |
| pregnancy prospective | #1062 |
| class switching | #1064 |
| signaling adaptor | #1065 |
| predictor | #1066 |
| rural | #1066 |
| skin sensitization | #1068 |
| 8 12 | #1068 |
| gnp | #1069 |
| central europe | #1070 |
| moraxella | #1070 |
| margarine | #1070 |
| prevalence prospective | #1071 |
| expression humans | #1072 |
| interrelation | #1075 |
| cross sectional study | #1077 |
| large population | #1077 |
| west east | #1079 |
| box transcription | #1079 |
| trflp | #1080 |
| factors child | #1081 |
| risk development | #1081 |
| life respiratory | #1082 |
| study areas | #1083 |
| cells tregs | #1083 |
| allergic airway | #1083 |
| children prevalence | #1086 |
| sufferers | #1086 |
| maternal asthma | #1089 |
| gene expression data | #1090 |
| lca | #1090 |
| exposure delayed | #1091 |
| longduration | #1094 |
| disintegrin | #1095 |
| nationality | #1096 |
| proteins polymorphism | #1096 |
| 930 | #1097 |
| supplementary data | #1098 |
| overweight bmi | #1101 |
| forkhead | #1103 |
| enfants | #1103 |
| conjunctivitis | #1104 |
| studies evidence | #1104 |
| adolescence adulthood | #1105 |
| cd14 | #1106 |
| 248 | #1116 |
| weight risk | #1116 |
| characteristically | #1117 |
| risk gene | #1117 |
| associations observed | #1118 |
| meat consumption | #1119 |
| prevalences | #1122 |
| association exposure | #1123 |
| intermediate phenotypes | #1125 |
| newonset | #1126 |
| sscp analysis | #1127 |
| il12b | #1127 |
| lung function decline | #1127 |
| based clustering | #1128 |
| endotoxins | #1130 |
| taxonomies | #1130 |
| age birth | #1132 |
| expiratory flow | #1132 |
| 859 | #1134 |
| based birth | #1136 |
| pet ownership | #1144 |
| log2 | #1144 |
| gondii | #1145 |
| allergic asthma | #1145 |
| patients severe asthma | #1146 |
| pediatric asthma | #1146 |
| 837 | #1152 |
| skewness | #1152 |
| humans respiratory | #1153 |
| environmental tobacco | #1154 |
| regions china | #1154 |
| dust mite | #1156 |
| disease cohort | #1156 |
| 862 | #1158 |
| deciphering | #1159 |
| countries prevalence | #1160 |
| epidemiological evidence | #1164 |
| 027 | #1165 |
| anti ige | #1165 |
| rarer | #1168 |
| preschool cohort | #1169 |
| inbred balb receptors | #1172 |
| crowding | #1173 |
| genomewide | #1176 |
| receptors ige | #1178 |
| farmers | #1179 |
| phase behaviour | #1180 |
| croup | #1183 |
| serum immunoglobulin | #1184 |
| contre | #1184 |
| food allergens | #1186 |
| asthma bronchodilator | #1189 |
| new paradigm | #1189 |
| levels measured | #1190 |
| exhaled | #1194 |
| respiratory tract | #1196 |
| censored | #1197 |
| children association | #1200 |
| management children | #1206 |
| rorc | #1207 |
| bacterial taxa | #1208 |
| sedentary lifestyle | #1211 |
| fungi humans | #1211 |
| risk childhood | #1214 |
| flg | #1215 |
| regulatory cells tregs | #1216 |
| risk children | #1218 |
| food hypersensitivity | #1218 |
| orphan | #1219 |
| bradykinin | #1220 |
| eosinophilic inflammation | #1221 |
| day life | #1223 |
| factor activity | #1225 |
| 047 | #1229 |
| male pregnancy | #1233 |
| balb ovalbumin | #1234 |
| gene variants | #1236 |
| age menarche | #1236 |
| th1 th2 | #1236 |
| adult allergens | #1240 |
| european population | #1241 |
| antitrypsin | #1243 |
| small children | #1243 |
| ulm | #1247 |
| protective factors | #1250 |
| objective aim | #1251 |
| early years | #1252 |
| pertussis | #1252 |
| airway hyperreactivity | #1253 |
| peripheral blood leukocytes | #1253 |
| food items | #1253 |
| shop | #1256 |
| questionnaires | #1256 |
| debated | #1257 |
| telephone interviews | #1260 |
| lung function | #1260 |
| mite | #1262 |
| studies gene | #1263 |
| disease case | #1264 |
| yogurt | #1267 |
| temperature humidity | #1268 |
| overweight children | #1274 |
| occupational exposures | #1277 |
| fev1 forced | #1281 |
| pollution indoor | #1281 |
| children exposure | #1282 |
| shannon | #1284 |
| infections risk | #1284 |
| diseases occupational | #1289 |
| immunomodulating | #1289 |
| pollution exposure | #1292 |
| potential risk factors | #1293 |
| 182 | #1295 |
| body sites | #1296 |
| tests risk | #1299 |
| age baseline | #1301 |
| gme | #1302 |
| topic polymorphism | #1303 |
| explain | #1303 |
| venipuncture | #1306 |
| endotypes | #1309 |
| lymphocytes regulatory | #1312 |
| factor development | #1312 |
| industrially | #1314 |
| th1 cytokines | #1314 |
| 038 | #1318 |
| sought determine | #1320 |
| epidemiological survey | #1322 |
| cell numbers | #1322 |
| harmonization | #1322 |
| objective investigate | #1327 |
| cleaning | #1329 |
| neuraminic | #1329 |
| lrti | #1330 |
| concerted | #1330 |
| prevalence rural | #1331 |
| zusammenfassung | #1331 |
| respiratory allergy | #1332 |
| gambia | #1332 |
| induced sputum | #1335 |
| sponsorship | #1335 |
| loft | #1337 |
| passive smoking | #1340 |
| 897 | #1342 |
| mass breast | #1343 |
| multiple testing | #1346 |
| puberty | #1347 |
| airway function | #1349 |
| th2 cells | #1351 |
| expired | #1353 |
| irf1 | #1353 |
| oxide feno | #1353 |
| atopic humans | #1354 |
| toxoplasma gondii | #1355 |
| 267 | #1357 |
| 16 18 | #1358 |
| reduction risk | #1358 |
| science foundation | #1359 |
| asthmatics | #1359 |
| 2 innate | #1360 |
| lung microbiota | #1363 |
| france germany | #1366 |
| 279 | #1366 |
| maternal immune | #1367 |
| asthma female | #1369 |
| innate lymphoid | #1374 |
| whey proteins | #1378 |
| preventive strategies | #1381 |
| austria | #1382 |
| common forms | #1383 |
| total ige | #1383 |
| lactococcus | #1386 |
| studies lung | #1387 |
| management asthma | #1388 |
| environmental | #1389 |
| disagreement | #1389 |
| childhood adult | #1390 |
| early intervention | #1395 |
| milk proteins | #1403 |
| severe atopic | #1404 |
| risk developing | #1404 |
| q21 | #1404 |
| fef25 | #1406 |
| airway inflammation | #1407 |
| air samples | #1410 |
| indoor | #1412 |
| dust exposure | #1415 |
| sige | #1417 |
| baseline followup | #1417 |
| immune mechanisms | #1418 |
| bronchodilators | #1418 |
| microbial | #1419 |
| il13 | #1421 |
| hapmap | #1421 |
| longitudinal cohort | #1422 |
| bronchitis | #1422 |
| male multivariate | #1427 |
| pulmonary eosinophilia | #1429 |
| pair 17 | #1429 |
| asthmatic | #1433 |
| timepoint | #1433 |
| chronic inflammatory | #1435 |
| exhaled nitric | #1440 |
| irak4 | #1442 |
| induced airway | #1443 |
| centres | #1444 |
| inflammatory pathways | #1444 |
| overweight | #1445 |
| studies europe | #1445 |
| age 5 years | #1446 |
| bronchodilator response | #1448 |
| airway responses | #1451 |
| factors prevalence | #1454 |
| agricultural workers | #1460 |
| asthma clinical | #1460 |
| unique opportunity | #1461 |
| infancy | #1461 |
| immunizations | #1463 |
| barcelona | #1464 |
| 706 | #1464 |
| a20 | #1466 |
| hand eczema | #1468 |
| association polymorphism | #1468 |
| surveys questionnaires | #1470 |
| recognition receptors | #1470 |
| asthma compared | #1472 |
| immunity | #1473 |
| leur | #1474 |
| operating characteristics | #1474 |
| adolescence | #1475 |
| nod2 signaling | #1476 |
| 362 | #1477 |
| innate immune responses | #1478 |
| 1 levels | #1478 |
| meeting | #1479 |
| dgge | #1480 |
| otitis | #1482 |
| paediatricians | #1490 |
| immunologic mechanisms | #1493 |
| peptidases | #1494 |
| strongest predictor | #1494 |
| populationbased cohort | #1504 |
| flexural | #1505 |
| ionomycin | #1505 |
| tlr2 | #1506 |
| birch pollen | #1507 |
| structured interviews | #1508 |
| tlr2 tlr4 | #1509 |
| igg1 | #1511 |
| understood | #1512 |
| bacterial composition | #1514 |
| sulphur dioxide | #1514 |
| ergosterol | #1515 |
| living environment | #1517 |
| epidemiological data | #1517 |
| moderate asthma | #1517 |
| pasteurized | #1518 |
| latent class | #1520 |
| child welfare | #1521 |
| rôle | #1524 |
| pollution levels | #1524 |
| 153 | #1527 |
| hladq | #1527 |
| respiratory tract infections | #1530 |
| differences prevalence | #1533 |
| jia | #1536 |
| underlying mechanisms | #1536 |
| dust | #1542 |
| 245 | #1551 |
| factors development | #1552 |
| wisconsin | #1555 |
| birthday | #1558 |
| previous 12 months | #1558 |
| children aged | #1564 |
| children increased | #1566 |
| antibiotic exposure | #1567 |
| austrian | #1573 |
| born children | #1578 |
| china female humans | #1579 |
| licheniformis | #1584 |
| children risk | #1584 |
| current studies | #1588 |
| treatment asthma | #1595 |
| trans fatty | #1596 |
| explained | #1596 |
| breastfed infants | #1598 |
| study populations | #1599 |
| tract diseases | #1602 |
| development progression | #1603 |
| 775 | #1603 |
| air microbiology | #1604 |
| regulatory | #1605 |
| disease process | #1607 |
| ascariasis | #1610 |
| male prospective | #1611 |
| erythrocyte membranes | #1612 |
| neuropeptide | #1612 |
| peak expiratory | #1613 |
| cells1 | #1613 |
| familial aggregation | #1617 |
| candidate gene | #1622 |
| cells th2 | #1624 |
| ige antibodies | #1624 |
| early gene | #1626 |
| precision medicine | #1627 |
| short communication | #1627 |
| tolerogenic | #1628 |
| questionnaires young | #1632 |
| studies recurrence | #1634 |
| tcell responses | #1635 |
| newborn infants | #1641 |
| gata3 | #1641 |
| th2 cytokines | #1644 |
| th2 | #1645 |
| nutritional factors | #1647 |
| topic surveys | #1653 |
| population based study | #1653 |
| style male | #1653 |
| card | #1655 |
| 034 | #1656 |
| microbial diversity | #1656 |
| traffic volume | #1656 |
| smoke exposure | #1657 |
| cells transcription | #1661 |
| northern europe | #1661 |
| expiratory volume | #1664 |
| respiratory | #1666 |
| opportunity | #1667 |
| linear discriminant analysis | #1671 |
| followup study | #1677 |
| asthmatic agents | #1678 |
| cheese | #1688 |
| epidemiologic evidence | #1688 |
| employment | #1692 |
| microbiome | #1693 |
| early introduction | #1694 |
| obesity risk | #1694 |
| innate immune | #1694 |
| gitr | #1696 |
| health‐related quality | #1697 |
| aux | #1701 |
| th2 th17 | #1702 |
| phenotyping | #1704 |
| gene interaction | #1704 |
| adulthood | #1706 |
| 476 | #1710 |
| fungal diversity | #1712 |
| provocative | #1716 |
| singlenucleotide polymorphisms | #1717 |
| mere | #1718 |
| house dust mite | #1718 |
| 029 | #1723 |
| life hrqol | #1730 |
| airflow obstruction | #1732 |
| asthma control | #1733 |
| gabon | #1733 |
| genotyping | #1734 |
| anti asthmatic | #1735 |
| innate adaptive | #1739 |
| factors breast | #1742 |
| cytokine genes | #1746 |
| factors children | #1746 |
| 5 7 | #1748 |
| inverse relationship | #1749 |
| helminth parasites | #1749 |
| preschool clinical trials | #1751 |
| inconsistencies | #1753 |
| molds | #1754 |
| masks | #1756 |
| male polymorphism | #1756 |
| fivefold | #1760 |
| gstm1 gstt1 | #1760 |
| chronic airway | #1761 |
| refugees | #1761 |
| bacterial diversity | #1764 |
| susceptibility gene | #1767 |
| street | #1768 |
| environmental tobacco smoke | #1769 |
| association body mass | #1772 |
| cells airway | #1778 |
| soot | #1778 |
| helminth infections | #1779 |
| peptidoglycan | #1782 |
| occupational exposure | #1782 |
| cd4cd25 | #1782 |
| allergic reaction | #1788 |
| exposure assessment | #1789 |
| nucleotide polymorphisms | #1799 |
| generations | #1800 |
| key feature | #1801 |
| helminths | #1801 |
| 054 | #1801 |
| rubella | #1807 |
| life factors | #1809 |
| treg cells | #1812 |
| single nucleotide receptors | #1812 |
| feno | #1817 |
| protein 3 | #1821 |
| censoring | #1821 |
| factors health | #1822 |
| dna fingerprinting | #1823 |
| breastfeeding | #1825 |
| asthma morbidity | #1828 |
| signal transducer | #1828 |
| 112 | #1831 |
| respiratory illnesses | #1831 |
| leisure time | #1834 |
| generational | #1837 |
| vocational | #1838 |
| foxp3 expression | #1841 |
| regulatory cells | #1843 |
| heterogeneous disease | #1843 |
| il4 | #1843 |
| fetal growth | #1845 |
| otus | #1845 |
| forkhead transcription | #1849 |
| sampling methods | #1854 |
| causally | #1855 |
| idiopathic arthritis | #1857 |
| 95 risk factors | #1859 |
| disease incidence | #1878 |
| hypertonic | #1879 |
| friend | #1884 |
| unraveling | #1886 |
| diseases lung | #1886 |
| interleukin33 | #1891 |
| predispose | #1892 |
| age 4 | #1893 |
| aor | #1894 |
| age 2 | #1895 |
| life | #1898 |
| microbe | #1899 |
| lung male | #1900 |
| population level | #1901 |
| interleukin5 | #1901 |
| hrqol | #1903 |
| occupational stress | #1904 |
| jedoch | #1908 |
| brought | #1909 |
| vital capacity | #1909 |
| predictive models | #1914 |
| feeding practices | #1917 |
| coeliac disease | #1918 |
| confounded | #1924 |
| weight breast | #1929 |
| experimental models | #1932 |
| basics | #1932 |
| p0012 | #1933 |
| helminthiasis | #1934 |
| pregnancy prevalence | #1936 |
| child humans | #1938 |
| barrier function | #1941 |
| european commission | #1944 |
| aetiology | #1945 |
| percentiles | #1946 |
| juvenile idiopathic | #1946 |
| cell markers | #1949 |
| galactans | #1951 |
| raised | #1959 |
| moisture | #1959 |
| immune mediated | #1960 |
| blood eosinophil | #1960 |
| asthmatic subjects | #1960 |
| invading | #1960 |
| child female | #1966 |
| lps stimulation | #1966 |
| regulatory region | #1973 |
| 658 | #1975 |
| phenomena infant | #1977 |
| dwellings | #1985 |
| children severe | #1991 |
| dollar | #1994 |
| natural environments | #1997 |
| helper type | #1998 |
| studie | #1999 |
| agriculture | #2000 |
| descriptions | #2000 |
| 041 | #2004 |
| respiratory viral | #2010 |
| infectious agents | #2011 |
| richness | #2012 |
| physical activity pa | #2014 |
| lower frequencies | #2015 |
| life risk | #2018 |
| postnatal exposure | #2019 |
| diary | #2020 |
| children data | #2020 |
| regulation genetic | #2020 |
| physician diagnosis | #2021 |
| bedding | #2024 |
| underline | #2025 |
| relate | #2026 |
| age | #2027 |
| 939 | #2030 |
| bovine milk | #2038 |
| chymase | #2038 |
| ige mediated | #2040 |
| outdoor air | #2041 |
| subsamples | #2046 |
| mass child | #2047 |
| conflicting | #2056 |
| cx3c | #2057 |
| 858 | #2059 |
| schoolage children | #2063 |
| peanuts | #2068 |
| association snps | #2070 |
| standardize | #2072 |
| asthma diagnosis | #2073 |
| bronchial epithelial cells | #2075 |
| early childhood | #2075 |
| polarizing | #2076 |
| discrepant | #2080 |
| asthma quality | #2086 |
| women association | #2087 |
| gastrointestinal microbiome | #2095 |
| confounders | #2097 |
| clinical phenotypes | #2098 |
| abstracts | #2098 |
| dusts | #2099 |
| environment interaction | #2100 |
| symptoms age | #2101 |
| male maternal | #2103 |
| 19th century | #2103 |
| disequilibrium | #2104 |
| tregs | #2109 |
| reduced levels | #2111 |
| bacterial colonization | #2111 |
| dairy products | #2114 |
| permutation | #2116 |
| alternata | #2118 |
| prevalence children | #2118 |
| children higher | #2121 |
| 5q | #2125 |
| protection | #2128 |
| child preschool | #2128 |
| glucans | #2132 |
| year | #2133 |
| th2 cell | #2134 |
| common disease | #2139 |
| mild asthma | #2141 |
| dietary interventions | #2142 |
| exhalation | #2145 |
| animals child | #2145 |
| indoors | #2149 |
| sibling | #2153 |
| offspring mothers | #2154 |
| epigenetic regulation | #2155 |
| immune modulation | #2157 |
| schoolchildren | #2157 |
| ionization time | #2158 |
| studies food | #2161 |
| interleukin4 | #2163 |
| blood samples | #2166 |
| food allergy | #2173 |
| blood sampling | #2175 |
| stat6 | #2178 |
| west | #2178 |
| consumption | #2180 |
| spirometry | #2181 |
| forced expiratory | #2184 |
| utero exposure | #2186 |
| industrialized | #2190 |
| children age | #2192 |
| subsequent risk | #2193 |
| respiratory infections | #2196 |
| topic united states | #2207 |
| occupational diseases | #2208 |
| actinomycetales | #2210 |
| acinetobacter | #2212 |
| communicable | #2213 |
| 146 | #2213 |
| indoor outdoor | #2215 |
| lung epithelial cells | #2215 |
| early development | #2220 |
| onset disease | #2220 |
| female finland | #2221 |
| lung mice | #2229 |
| guardians | #2231 |
| preschool | #2232 |
| 079 | #2234 |
| 18 months | #2236 |
| 12th | #2242 |
| diesel exhaust | #2242 |
| childhood overweight | #2245 |
| th17 cell | #2246 |
| bacteria fungi | #2247 |
| spirometric | #2247 |
| immune regulation | #2248 |
| whooping | #2249 |
| preventive | #2249 |
| bacterial load | #2251 |
| functional relevance | #2252 |
| bmi risk | #2257 |
| christianity | #2258 |
| specific immunoglobulin | #2259 |
| 108 | #2259 |
| patients responders | #2267 |
| résultats | #2268 |
| environmental influences | #2271 |
| decanoic | #2274 |
| consistently | #2277 |
| preventative | #2280 |
| cla | #2282 |
| commensals | #2282 |
| 031 | #2286 |
| objective measures | #2287 |
| association childhood | #2292 |
| foxp3 cells | #2293 |
| avenues | #2296 |
| gene interactions | #2299 |
| 11 years | #2301 |
| asthma study | #2312 |
| normal children | #2318 |
| receptor 2 | #2322 |
| box protein | #2325 |
| 0042 | #2326 |
| limulus | #2329 |
| 056 | #2334 |
| studies children | #2336 |
| methodsthe | #2338 |
| 064 | #2338 |
| variation genotype | #2341 |
| ascaris | #2349 |
| omega3 fatty acids | #2352 |
| 922 | #2353 |
| prrs | #2353 |
| spss | #2354 |
| 035 | #2358 |
| treg | #2361 |
| strongest | #2364 |
| adaptive immune response | #2366 |
| regular | #2368 |
| throat | #2371 |
| microbial composition | #2376 |
| viral respiratory | #2377 |
| populationbased cohort study | #2379 |
| diseases respiratory | #2380 |
| expiratory | #2386 |
| immunologically | #2386 |
| breath | #2395 |
| genetic variation | #2396 |
| human immune | #2397 |
| urban environments | #2401 |
| blood institute | #2402 |
| bronchodilator agents | #2405 |
| diaries | #2405 |
| models male | #2413 |
| cord | #2416 |
| adequately | #2417 |
| ripk1 | #2419 |
| 7000 | #2422 |
| finnish | #2423 |
| gstt1 | #2428 |
| pathway genes | #2430 |
| early adulthood | #2435 |
| african ancestry | #2443 |
| partly | #2445 |
| toll receptor | #2457 |
| attributable | #2459 |
| motor vehicles | #2461 |
| questionnaires sweden | #2462 |
| luciferase reporter | #2464 |
| disease review | #2468 |
| vitamin intake | #2468 |
| enhancer elements | #2474 |
| genetic ancestry | #2477 |
| crosssectional survey | #2479 |
| 095 | #2496 |
| peers | #2497 |
| case control study | #2498 |
| questionnaire | #2500 |
| children adolescent | #2508 |
| cytokines humans | #2508 |
| forkhead box | #2509 |
| tolllike receptors | #2512 |
| tolllike receptor | #2525 |
| interleukin13 | #2525 |
| airway responsiveness | #2525 |
| 239 | #2527 |
| style | #2528 |
| common cold | #2528 |
| artemisia | #2530 |
| uncontrolled | #2540 |
| forced expiratory volume | #2541 |
| young adulthood | #2552 |
| switzerland | #2553 |
| inverse | #2553 |
| modify | #2556 |
| european countries | #2564 |
| pregnancy prenatal | #2568 |
| 060 | #2569 |
| siblings | #2572 |
| th2 response | #2576 |
| suggested | #2584 |
| activator | #2584 |
| myristate | #2585 |
| sectional survey | #2586 |
| disease development | #2586 |
| human microbiome | #2588 |
| 030 | #2590 |
| ω3 | #2590 |
| air pollutant | #2602 |
| immunoglobulin levels | #2603 |
| damp | #2605 |
| large sample | #2608 |
| health children | #2616 |
| viral infections | #2623 |
| humans immunoglobulin | #2624 |
| 241 | #2625 |
| mold | #2626 |
| adverse health effects | #2628 |
| polymorphism | #2633 |
| chronic respiratory diseases | #2637 |
| prenatal exposure | #2638 |
| illness surveys | #2638 |
| translate | #2640 |
| molecular patterns | #2641 |
| imputation | #2641 |
| 141 | #2643 |
| cb | #2643 |
| early | #2646 |
| evenness | #2647 |
| life illness | #2651 |
| stockholm | #2652 |
| exhaled nitric oxide | #2657 |
| virus diseases | #2657 |
| groups children | #2665 |
| 739 | #2668 |
| urban rural | #2672 |
| il4 il5 | #2673 |
| confounder | #2678 |
| gene expression levels | #2678 |
| girls boys | #2684 |
| urgently | #2684 |
| categorised | #2687 |
| onwards | #2687 |
| positive association | #2689 |
| 0048 | #2696 |
| host factors | #2699 |
| 061 | #2699 |
| effects prenatal | #2700 |
| 793 | #2703 |
| 063 | #2712 |
| leukocytes mononuclear | #2717 |
| prenatally | #2721 |
| il23r | #2721 |
| respiratory function | #2731 |
| progression disease | #2732 |
| interaction genetic | #2738 |
| reaction polymorphism | #2739 |
| worldwide | #2739 |
| risk allele | #2739 |
| contacted | #2742 |
| 95 children | #2754 |
| preschool chromosomes | #2755 |
| complete data | #2756 |
| female fetal | #2760 |
| modern | #2764 |
| milk | #2766 |
| species level | #2770 |
| effects air | #2770 |
| potential benefits | #2771 |
| rhinovirus | #2775 |
| urban health | #2778 |
| centile | #2786 |
| messenger receptors | #2787 |
| gstm1 | #2787 |
| questionnaire study | #2796 |
| prematurely | #2800 |
| emergency department visits | #2801 |
| 893 | #2802 |
| prospective longitudinal | #2809 |
| functional variants | #2810 |
| personalized treatment | #2812 |
| 812 | #2815 |
| detailed | #2816 |
| package | #2826 |
| stat1 | #2827 |
| standardized | #2829 |
| nocturnal | #2831 |
| toll | #2843 |
| dietary factors | #2848 |
| asthma patients | #2853 |
| alternaria | #2854 |
| infant formula | #2856 |
| children mothers | #2861 |
| antibiotic treatment | #2871 |
| tobacco smoke | #2878 |
| deubiquitinating | #2878 |
| lci | #2886 |
| living | #2887 |
| respondent | #2888 |
| human bronchial | #2894 |
| persistence | #2899 |
| east | #2902 |
| complement receptors | #2906 |
| male parents | #2911 |
| intrapulmonary | #2914 |
| life span | #2915 |
| 3 mm | #2916 |
| epidemiologic methods | #2917 |
| 645 | #2919 |
| 913 | #2923 |
| transitioning | #2925 |
| virtually | #2928 |
| male gender | #2928 |
| il33 | #2940 |
| listeria | #2942 |
| matrix assisted | #2944 |
| antibiotic | #2947 |
| clinical manifestation | #2956 |
| pollen | #2957 |
| visiting | #2958 |
| reduced risk | #2961 |
| written | #2965 |
| notification | #2966 |
| 074 | #2968 |
| asthma management | #2969 |
| birth | #2974 |
| study prevalence | #2975 |
| mould | #2979 |
| 073 | #2982 |
| 8th | #2983 |
| patients asthma | #2985 |
| 804 | #2985 |
| primary prevention | #2989 |
| 2 months | #2990 |
| critical period | #2996 |
| year age | #2996 |
| forced vital | #3004 |
| 293 | #3010 |
| allergic inflammation | #3011 |
| genetic receptor | #3013 |
| tlr5 | #3022 |
| forced | #3024 |
| confounding factors | #3040 |
| methodological issues | #3047 |
| polymorphism single | #3050 |
| fungal dna | #3054 |
| frequency genetic | #3059 |
| 3 years | #3060 |
| epigenetic mechanisms | #3065 |
| doubt | #3065 |
| tlrs | #3068 |
| findings studies | #3069 |
| dna extraction | #3069 |
| snps genes | #3071 |
| vaccinations | #3079 |
| economic development | #3082 |
| adaptive immune responses | #3087 |
| preschool children | #3087 |
| rural area | #3089 |
| rapid increase | #3089 |
| viewpoints | #3090 |
| overweight obesity | #3093 |
| 066 | #3096 |
| genetic variations | #3098 |
| homes | #3099 |
| analysed | #3103 |
| malditof | #3106 |
| invited | #3110 |
| delayed effects | #3119 |
| environment | #3123 |
| 0036 | #3125 |
| inhalation exposure | #3126 |
| europe humans | #3126 |
| menarche | #3129 |
| hdm | #3131 |
| 12 months | #3141 |
| filaggrin | #3142 |
| cow | #3143 |
| preschool dna | #3154 |
| vital | #3157 |
| pha | #3159 |
| baseline follow | #3182 |
| multifaceted | #3184 |
| clarified | #3188 |
| distinct | #3192 |
| bronchodilator | #3194 |
| pleiotropy | #3196 |
| monitoring female | #3197 |
| genetic receptors | #3197 |
| aor 95 | #3198 |
| 037 | #3201 |
| development disease | #3206 |
| disease genotype | #3207 |
| volume 1 | #3208 |
| 069 | #3209 |
| suburban | #3211 |
| bronchial asthma | #3213 |
| surveys | #3214 |
| messages | #3216 |
| university students | #3218 |
| epidemiological | #3227 |
| housekeeping | #3227 |
| catarrhalis | #3235 |
| functional effects | #3245 |
| 050 | #3251 |
| agents child | #3252 |
| beds | #3257 |
| health surveys | #3257 |
| 08 | #3258 |
| 360 | #3259 |
| genetic epigenesis | #3260 |
| systemic inflammation | #3261 |
| missing data | #3261 |
| prospective cohort | #3264 |
| eventually | #3266 |
| enhanced expression | #3270 |
| spores | #3271 |
| automobiles | #3272 |
| 3rd | #3275 |
| nested case | #3280 |
| premature birth | #3283 |
| 4th | #3289 |
| appreciation | #3296 |
| 19th | #3300 |
| european ancestry | #3301 |
| 098 | #3306 |
| lab | #3308 |
| cells toll | #3314 |
| influential | #3317 |
| surveys humans | #3318 |
| corynebacterium | #3318 |
| weight children | #3327 |
| child | #3332 |
| idiotypic | #3338 |
| subtle | #3341 |
| logistic regression models | #3343 |
| th17 cells | #3349 |
| age children | #3352 |
| noncommunicable diseases | #3354 |
| acid receptor | #3354 |
| influencing | #3358 |
| 509 | #3361 |
| 086 | #3367 |
| ifn γ | #3371 |
| 166 | #3372 |
| manifests | #3374 |
| polymorphisms genes | #3377 |
| 566 | #3377 |
| genetic variants | #3379 |
| rooms | #3380 |
| gut microbiome | #3384 |
| genetic background | #3388 |
| differed | #3397 |
| 0004 | #3398 |
| genetic protein structure | #3408 |
| benzene | #3408 |
| protecting | #3409 |
| turn | #3409 |
| alternaria alternata | #3418 |
| tlr | #3421 |
| gg | #3421 |
| occupational asthma | #3423 |
| maternal health | #3433 |
| sociodemographics | #3436 |
| 092 | #3443 |
| factors smoking | #3445 |
| air pollution | #3445 |
| guangzhou | #3448 |
| epithelial barrier | #3461 |
| disease genetic | #3465 |
| trends prevalence | #3467 |
| airflow limitation | #3468 |
| 049 | #3468 |
| cytokine responses | #3469 |
| th2 cytokine | #3470 |
| omega6 | #3470 |
| rye | #3480 |
| 089 | #3484 |
| 043 | #3484 |
| humans linkage | #3484 |
| 18s | #3488 |
| ambient air pollution | #3494 |
| counselling | #3496 |
| skin patients | #3497 |
| aged children | #3500 |
| total population | #3501 |
| evidences | #3507 |
| postal | #3507 |
| raw | #3512 |
| heating | #3515 |
| onset symptoms | #3519 |
| 95th | #3523 |
| 032 | #3525 |
| respiratory mucosa | #3525 |
| analysing | #3529 |
| schoolaged children | #3540 |
| innate immune response | #3541 |
| older children | #3542 |
| microbiota | #3544 |
| 059 | #3548 |
| bronchial epithelial | #3550 |
| seasonal | #3551 |
| parent | #3557 |
| 5p | #3565 |
| molecular biomarkers | #3566 |
| microbiota composition | #3568 |
| 042 | #3570 |
| coevolution | #3578 |
| tract humans | #3594 |
| minor allele | #3596 |
| plausibility | #3603 |
| children parents | #3604 |
| birch | #3605 |
| parents children | #3606 |
| linkage disequilibrium | #3610 |
| cough | #3612 |
| association polymorphisms | #3618 |
| objectively | #3623 |
| genotype humans | #3626 |
| cats | #3627 |
| claimed | #3628 |
| relating | #3629 |
| environment female | #3630 |
| pollution | #3634 |
| risk alleles | #3638 |
| broad spectrum | #3641 |
| hej | #3643 |
| odds | #3644 |
| 0011 | #3652 |
| lung volume | #3654 |
| skewed | #3670 |
| contact | #3674 |
| publication child child | #3677 |
| resides | #3679 |
| complex diseases | #3680 |
| 251 | #3681 |
| 1995 | #3684 |
| disequilibrium male | #3686 |
| genetic control | #3686 |
| toxoplasma | #3686 |
| 046 | #3688 |
| adult blood | #3691 |
| host immune | #3691 |
| monocytogenes | #3691 |
| 655 | #3695 |
| gene frequency | #3697 |
| il17 | #3701 |
| biological agents | #3703 |
| 456 | #3704 |
| gloves | #3704 |
| study gwas | #3705 |
| cette | #3725 |
| mice models | #3726 |
| 577 | #3727 |
| allocate | #3730 |
| desorption ionization | #3735 |
| genetic gene | #3735 |
| hyper | #3748 |
| ovalbumin ova | #3753 |
| glutathione transferase | #3755 |
| 094 | #3755 |
| vehicle emissions | #3759 |
| helperinducer | #3763 |
| adaptive immunity | #3764 |
| coeliac | #3765 |
| regressions | #3766 |
| positive bacteria | #3766 |
| function decline | #3771 |
| 824 | #3786 |
| housing | #3795 |
| gm csf | #3797 |
| time trends | #3798 |
| sympathomimetics | #3802 |
| multicenter studies | #3807 |
| nutrition examination | #3820 |
| weight child | #3825 |
| tcells | #3832 |
| girls | #3834 |
| bethesda | #3837 |
| relation | #3838 |
| health problem | #3838 |
| receptors immunologic | #3843 |
| 076 | #3846 |
| models immunological | #3854 |
| exposure risk | #3861 |
| epistasis | #3865 |
| tremendous | #3867 |
| loci genetic | #3869 |
| utero | #3873 |
| immunoglobulin | #3873 |
| berlin | #3876 |
| respiratory diseases | #3876 |
| maternal smoking | #3881 |
| lymphoid cells | #3891 |
| parental | #3899 |
| positively | #3912 |
| 368 | #3920 |
| 319 | #3920 |
| colonisation | #3922 |
| volatile organic compounds | #3934 |
| confounding | #3940 |
| arthropod | #3942 |
| 051 | #3943 |
| maternal serum | #3946 |
| airway resistance | #3947 |
| maternal fetal | #3948 |
| human milk | #3950 |
| denaturing | #3950 |
| progeny | #3957 |
| asthma exacerbations | #3957 |
| faced | #3958 |
| genetic predisposition | #3958 |
| exacerbations | #3960 |
| epigenetic modifications | #3970 |
| culturing | #3971 |
| viable | #3982 |
| ecuador | #3991 |
| congresses | #3995 |
| health utilization | #3999 |
| ndvi | #4004 |
| 381 | #4005 |
| r5 | #4019 |
| newborn infant premature | #4023 |
| messenger reverse | #4026 |
| variation humans | #4026 |
| capita | #4029 |
| infant nutritional | #4032 |
| pellucida | #4033 |
| phase 2 | #4035 |
| environments | #4036 |
| ema | #4036 |
| single nucleotide | #4050 |
| occupational | #4052 |
| dipeptidyl | #4055 |
| genetic risk | #4060 |
| positive associations | #4061 |
| tlr9 | #4064 |
| humans polymorphism | #4069 |
| reverse | #4070 |
| prevotella | #4081 |
| dairy | #4093 |
| 493 | #4094 |
| 023 | #4107 |
| unbalanced | #4109 |
| clarification | #4112 |
| coding region | #4113 |
| 052 | #4118 |
| chronic disease | #4118 |
| ethnically | #4120 |
| effects exposure | #4120 |
| children 2 | #4126 |
| positional | #4136 |
| 087 | #4136 |
| salmeterol | #4139 |
| urban population | #4151 |
| luminex | #4154 |
| th17 | #4162 |
| chronic respiratory | #4163 |
| researcher | #4163 |
| 011 | #4170 |
| husbandry | #4180 |
| mrna expression | #4180 |
| sulfur dioxide | #4182 |
| th1 cells | #4183 |
| 424 | #4185 |
| rgs | #4187 |
| ruled | #4189 |
| respiratory infection | #4193 |
| protected | #4194 |
| zealand | #4204 |
| lifestyle | #4210 |
| risk loci | #4212 |
| finland | #4213 |
| preterm delivery | #4220 |
| populationbased sample | #4221 |
| growing body | #4222 |
| whey | #4236 |
| androstadienes | #4237 |
| inflammatory disease | #4243 |
| disease genotype humans | #4247 |
| body height | #4248 |
| adult onset | #4250 |
| increasing trend | #4252 |
| inhaled | #4253 |
| participated | #4256 |
| indoor environments | #4256 |
| neonatal mice | #4262 |
| children born | #4269 |
| healthy individuals | #4289 |
| metagenome | #4300 |
| ordinal | #4303 |
| influenced | #4314 |
| ephedrine | #4318 |
| cx3cl1 | #4318 |
| immunologic receptors | #4322 |
| activity pa | #4324 |
| 1 gene | #4337 |
| male mothers | #4339 |
| male obesity | #4345 |
| years life | #4346 |
| phytohemagglutinins | #4349 |
| nucleotide | #4353 |
| children study | #4356 |
| 093 | #4358 |
| diagnostics | #4359 |
| healthy children | #4370 |
| 410 | #4375 |
| urban area | #4379 |
| rationale | #4393 |
| poaceae | #4397 |
| protects | #4404 |
| age 12 | #4405 |
| fluticasone | #4405 |
| stratified | #4414 |
| lpa | #4417 |
| exposure levels | #4418 |
| cephalometry | #4418 |
| percentile | #4421 |
| hypopharynx | #4424 |
| 95ci | #4425 |
| female sex | #4428 |
| 15 years | #4429 |
| onset | #4434 |
| crohn disease | #4437 |
| participating | #4439 |
| pupils | #4442 |
| dr3 | #4449 |
| secondary prevention | #4449 |
| receptors protein | #4451 |
| chances | #4457 |
| rash | #4457 |
| goblet | #4459 |
| confers | #4461 |
| patients cystic fibrosis | #4466 |
| increased prevalence | #4468 |
| respiratory viruses | #4468 |
| 457 | #4474 |
| 0022 | #4496 |
| culture techniques | #4499 |
| prevalence risk factors | #4499 |
| severe asthma | #4499 |
| microorganisms | #4511 |
| genetic effects | #4516 |
| infant | #4517 |
| trajectories | #4530 |
| no2 | #4538 |
| inflammatory diseases | #4542 |
| statistical | #4545 |
| butter | #4551 |
| assisted laser | #4555 |
| gramnegative bacteria | #4558 |
| structural equation modeling | #4559 |
| receptor alpha | #4564 |
| control children | #4572 |
| 49 | #4573 |
| ahr | #4583 |
| population prevalence | #4583 |
| prevalence estimates | #4588 |
| 080 | #4591 |
| neutrophilic | #4598 |
| haplotypes humans | #4600 |
| adaptor protein | #4600 |
| airway | #4601 |
| knowledge gaps | #4603 |
| strikingly | #4630 |
| daily practice | #4632 |
| lactis | #4634 |
| detectability | #4660 |
| str | #4661 |
| aiming | #4676 |
| random | #4676 |
| pef | #4683 |
| 299 | #4688 |
| accumulating | #4695 |
| measles | #4697 |
| 1014 | #4699 |
| hscrp | #4700 |
| gstp1 | #4725 |
| current evidence | #4730 |
| tlc | #4741 |
| associations | #4745 |
| bacterial communities | #4747 |
| immune | #4749 |
| obstructive lung | #4753 |
| lactic acid bacteria | #4754 |
| genetic risk factors | #4755 |
| transcriptomics | #4768 |
| lifestyle factors | #4772 |
| pathophysiologic | #4775 |
| lung development | #4777 |
| unclear | #4782 |
| exposure air | #4785 |
| immune responses | #4795 |
| quantity | #4804 |
| pulmonary function | #4809 |
| filament proteins | #4812 |
| plateau | #4814 |
| helminth | #4821 |
| albuterol | #4823 |
| respects | #4823 |
| adult air | #4837 |
| 399 | #4838 |
| female food | #4841 |
| implicating | #4844 |
| pointed | #4848 |
| feeding | #4851 |
| new cases | #4858 |
| haplotype analysis | #4874 |
| ont | #4886 |
| hcs | #4889 |
| 624 | #4896 |
| occupations | #4896 |
| respiratory illness | #4897 |
| newborn male | #4902 |
| studies effects | #4919 |
| hyperventilation | #4927 |
| asthma chronic | #4928 |
| dans | #4930 |
| contributors | #4940 |
| postnatal development | #4944 |
| respective | #4955 |
| starts | #4964 |
| tolerance induction | #4965 |
| blood mononuclear | #4969 |
| natal | #4973 |
| airway disease | #4975 |
| 322 | #4975 |
| predisposition disease | #4986 |
| eosinophils | #4994 |
| potential effects | #5005 |
| explore | #5011 |
| adaptor | #5012 |
| epidemiology | #5018 |
| laser desorption | #5018 |
| serine protease | #5020 |
| functionality | #5023 |
| inbred c57bl models | #5024 |
| inhalation | #5049 |
| livestock | #5058 |
| 95 | #5062 |
| paediatric | #5065 |
| manifestation | #5069 |
| milk human | #5071 |
| grass | #5072 |
| inflammatory markers | #5072 |
| 219 | #5083 |
| genetic analyses | #5084 |
| covariates | #5089 |
| hormonal | #5091 |
| held | #5091 |
| alpha1 | #5092 |
| urgent | #5094 |
| habits | #5099 |
| unexposed | #5099 |
| 097 | #5100 |
| genomewide significance | #5100 |
| il3 | #5102 |
| highrisk | #5105 |
| lysate | #5106 |
| gwas | #5119 |
| latent | #5125 |
| smoke | #5126 |
| 103 | #5130 |
| crucial | #5133 |
| 12 years | #5134 |
| regional differences | #5144 |
| mononuclear | #5153 |
| decades | #5159 |
| traffic | #5159 |
| dysbiosis | #5183 |
| 383 | #5186 |
| fingerprinting | #5191 |
| lung epithelial | #5191 |
| reflect | #5193 |
| p40 | #5196 |
| butyrates | #5200 |
| 070 | #5204 |
| age onset | #5209 |
| airways | #5210 |
| window | #5232 |
| hallmarks | #5241 |
| taxa | #5242 |
| recruited | #5243 |
| bronchopulmonary | #5247 |
| isotype | #5247 |
| crp levels | #5256 |
| psychosocial factors | #5267 |
| quartile | #5274 |
| inflammatory disorders | #5279 |
| dietary supplementation | #5280 |
| gprotein | #5283 |
| international | #5289 |
| early phase | #5305 |
| 123 | #5306 |
| environmental variables | #5314 |
| cutoff | #5318 |
| coupled receptor | #5329 |
| excessive | #5333 |
| 136 | #5336 |
| comprehensively | #5339 |
| immunology | #5348 |
| suppressive | #5348 |
| gene expression | #5348 |
| meat | #5350 |
| disease susceptibility | #5359 |
| supernatants | #5369 |
| new strategies | #5380 |
| illumina | #5384 |
| serum proteins | #5392 |
| 233 | #5406 |
| substantial | #5412 |
| discussions | #5423 |
| smad3 | #5429 |
| vitamin supplementation | #5436 |
| sensitized | #5441 |
| certainty | #5443 |
| 337 | #5450 |
| geometric | #5456 |
| 224 | #5465 |
| marks | #5470 |
| hypothesis | #5473 |
| growing evidence | #5475 |
| epidemiologic | #5476 |
| challenge | #5476 |
| phenotype | #5481 |
| healthy control subjects | #5495 |
| floor | #5496 |
| 373 | #5496 |
| cytokines disease | #5496 |
| road | #5504 |
| aged asthma | #5537 |
| alter | #5539 |
| 556 | #5544 |
| term exposure | #5547 |
| 454 | #5550 |
| coexpression | #5570 |
| predisposition | #5574 |
| 512 | #5578 |
| 45 | #5580 |
| lose | #5584 |
| 321 | #5595 |
| figures | #5602 |
| methacholine | #5602 |
| 258 | #5610 |
| 2nd | #5610 |
| 062 | #5630 |
| ld | #5634 |
| 14 years | #5637 |
| airflow | #5642 |
| contribute | #5645 |
| aa | #5661 |
| bacterial species | #5667 |
| 081 | #5668 |
| protein coupled | #5668 |
| notable | #5679 |
| contraceptives | #5682 |
| hints | #5688 |
| cytokine expression | #5693 |
| prebiotics | #5694 |
| commission | #5700 |
| 134 | #5704 |
| offspring | #5704 |
| cows | #5713 |
| cytokine production | #5722 |
| tlr7 | #5725 |
| presentations | #5727 |
| stepwise | #5729 |
| fecal samples | #5753 |
| animal humans | #5764 |
| 021 | #5770 |
| house | #5777 |
| rna expression | #5788 |
| cold | #5790 |
| maternal | #5797 |
| predominance | #5812 |
| persists | #5817 |
| comprehensive | #5824 |
| humans immunity | #5824 |
| cholecalciferol | #5831 |
| snps | #5833 |
| hen | #5848 |
| commensal | #5856 |
| 384 | #5863 |
| mites | #5878 |
| 078 | #5881 |
| bangladesh | #5887 |
| study genotype | #5888 |
| drug development | #5891 |
| sleeping | #5898 |
| workplace | #5900 |
| immunoglobulin igg | #5902 |
| paf | #5910 |
| study associations | #5924 |
| encourage | #5930 |
| adjust | #5930 |
| helper | #5938 |
| differ | #5944 |
| western europe | #5945 |
| investigate association | #5947 |
| questionnaire survey | #5947 |
| male risk | #5953 |
| 0017 | #5958 |
| 216 | #5963 |
| eastern europe | #5978 |
| promoter polymorphism | #5989 |
| disease prevalence | #5991 |
| longitudinal data | #5995 |
| interleukin15 | #5996 |
| adaptive immune | #5999 |
| calling | #6002 |
| 367 | #6008 |
| patients symptoms | #6008 |
| panels | #6009 |
| doseresponse relationship | #6012 |
| box | #6020 |
| pathogen interactions | #6022 |
| immune tolerance | #6023 |
| tract infections | #6029 |
| obese children | #6032 |
| adult population | #6032 |
| diversity | #6047 |
| existing methods | #6054 |
| risk variants | #6060 |
| prevalent | #6063 |
| gmcsf | #6064 |
| eastern | #6064 |
| modifier | #6066 |
| persisted | #6067 |
| restricted | #6068 |
| comparability | #6070 |
| 122 | #6072 |
| implication | #6077 |
| unselected | #6082 |
| ors | #6082 |
| ovalbumin | #6086 |
| microflora | #6091 |
| interleukin17 | #6094 |
| time flight | #6103 |
| 099 | #6113 |
| conferred | #6117 |
| recruiting | #6117 |
| genetic polymorphisms | #6122 |
| causality | #6128 |
| repeated | #6132 |
| fev1 | #6134 |
| fecal | #6135 |
| ahead | #6140 |
| 24 years | #6146 |
| programme | #6152 |
| 16 years | #6157 |
| town | #6158 |
| intermediate filament | #6161 |
| avec | #6163 |
| welfare | #6164 |
| gathered | #6166 |
| keeping | #6173 |
| constituent | #6182 |
| toluene | #6192 |
| determining | #6193 |
| genomewide association study | #6196 |
| narcotic | #6202 |
| conferring | #6205 |
| gross | #6216 |
| genuine | #6233 |
| populations | #6233 |
| illnesses | #6241 |
| institute | #6243 |
| administration inhalation | #6246 |
| prematurity | #6246 |
| protease inhibitor | #6252 |
| odds ratio 95 | #6262 |
| parents | #6266 |
| indoor environment | #6270 |
| study groups | #6270 |
| proposal | #6285 |
| offers | #6287 |
| irr | #6291 |
| communicable diseases | #6301 |
| nested | #6303 |
| alpha 1 | #6304 |
| tests | #6307 |
| young age | #6316 |
| outdoor | #6321 |
| allele frequencies | #6326 |
| infrequent | #6326 |
| interferons | #6343 |
| peptidase | #6346 |
| immunity mucosal | #6349 |
| 067 | #6355 |
| lymphocytes helper | #6360 |
| studies association | #6370 |
| 090 | #6375 |
| adjustments | #6385 |
| bivariate | #6388 |
| protective factor | #6390 |
| iu | #6394 |
| levels serum | #6400 |
| decreased risk | #6401 |
| immunological | #6409 |
| selection bias | #6410 |
| cell subsets | #6411 |
| genetic determinants | #6417 |
| infant premature | #6418 |
| 119 | #6439 |
| questions | #6448 |
| hypothesized | #6466 |
| mmp9 | #6467 |
| adverse health | #6475 |
| lower respiratory | #6475 |
| 287 | #6486 |
| 274 | #6490 |
| premature | #6493 |
| omalizumab | #6501 |
| sleep disturbance | #6507 |
| 238 | #6507 |
| gst | #6507 |
| links | #6512 |
| murine model | #6515 |
| infant feeding | #6523 |
| adam | #6524 |
| repeated measurements | #6527 |
| increased expression | #6529 |
| fev1 fvc | #6530 |
| diseases risk | #6548 |
| implied | #6555 |
| centers | #6567 |
| 1012 | #6571 |
| statements | #6572 |
| completion | #6598 |
| 283 | #6602 |
| disease onset | #6602 |
| children adults | #6604 |
| pollutant | #6605 |
| hospital admissions | #6617 |
| promoter region | #6624 |
| consumed | #6647 |
| accessible | #6653 |
| host pathogen | #6653 |
| adjusted 95 | #6654 |
| intervention studies | #6660 |
| playing | #6672 |
| candidate genes | #6684 |
| 138 | #6684 |
| bacterium | #6709 |
| cell responses | #6711 |
| systematic search | #6715 |
| cytokines dendritic | #6716 |
| washout | #6720 |
| nod2 | #6730 |
| haplotypes | #6732 |
| impulse | #6732 |
| cells disease | #6734 |
| 0009 | #6734 |
| ova | #6739 |
| focuses | #6745 |
| 126 | #6750 |
| n10 | #6757 |
| cities | #6761 |
| quartiles | #6763 |
| height weight | #6765 |
| mumps | #6769 |
| plethysmography | #6771 |
| eosinophilic | #6783 |
| disease mechanisms | #6787 |
| 065 | #6794 |
| developing | #6798 |
| 330 | #6807 |
| remained | #6813 |
| chronic exposure | #6823 |
| microbiology | #6831 |
| elucidated | #6846 |
| growing | #6846 |
| mz | #6852 |
| microorganism | #6861 |
| 305 | #6868 |
| cream | #6874 |
| lower incidence | #6887 |
| functional studies | #6890 |
| beef | #6896 |
| incidences | #6900 |
| inert | #6911 |
| academia | #6924 |
| supplementary | #6934 |
| zona | #6939 |
| multivariate logistic | #6941 |
| tertiles | #6948 |
| specific effects | #6949 |
| 1 diabetes | #6962 |
| 044 | #6965 |
| pathogenic bacteria | #6972 |
| lung | #6972 |
| maturation | #6975 |
| specialists | #6986 |
| infections | #6991 |
| transducer | #6998 |
| obesity bmi | #6999 |
| attendance | #7012 |
| summarizes | #7024 |
| infectious diseases | #7025 |
| shaping | #7027 |
| ribosomal 16s | #7033 |
| organic compounds | #7037 |
| 231 | #7041 |
| 028 | #7042 |
| confirming | #7043 |
| evidence association | #7046 |
| explaining | #7053 |
| amelioration | #7060 |
| concert | #7095 |
| 313 | #7102 |
| 019 | #7109 |
| type 1 diabetes | #7111 |
| linoleic acid | #7111 |
| triggering | #7114 |
| serum total | #7117 |
| breath tests | #7117 |
| 164 | #7122 |
| increased incidence | #7128 |
| th1 | #7132 |
| homeobox | #7134 |
| male membrane | #7135 |
| health humans | #7136 |
| homozygote | #7150 |
| consenting | #7153 |
| compare | #7155 |
| daily life | #7165 |
| increased risks | #7167 |
| agents anti | #7184 |
| likewise | #7184 |
| spatial variation | #7197 |
| develop | #7209 |
| health nutrition | #7223 |
| irritable bowel syndrome | #7227 |
| helper cell | #7228 |
| discusses | #7228 |
| spore | #7229 |
| cohort | #7231 |
| grow | #7238 |
| 163 | #7243 |
| influences | #7244 |
| beta1 | #7244 |
| analyses | #7255 |
| 0015 | #7268 |
| standardised | #7277 |
| 058 | #7278 |
| 053 | #7283 |
| handling | #7288 |
| herpesviridae | #7299 |
| urbanization | #7299 |
| 022 | #7309 |
| internationality | #7310 |
| single nucleotide polymorphisms | #7317 |
| personalized | #7355 |
| attending | #7374 |
| air pollutants | #7376 |
| 199 | #7387 |
| rome | #7392 |
| university | #7411 |
| linoleic | #7424 |
| potential risk | #7443 |
| histories | #7457 |
| 9 months | #7467 |
| human body | #7474 |
| boiling | #7486 |
| stratification | #7488 |
| bronchi | #7493 |
| spp | #7515 |
| alps | #7515 |
| enrollment | #7519 |
| intestinal diseases | #7523 |
| pediatrics | #7535 |
| toxoplasmosis | #7551 |
| bowel diseases | #7561 |
| allele | #7582 |
| eosinophil | #7586 |
| oropharyngeal | #7591 |
| considerably | #7612 |
| overt | #7613 |
| diseases animals | #7613 |
| worked | #7643 |
| school | #7649 |
| 316 | #7658 |
| haemophilus | #7669 |
| health conditions | #7671 |
| prenatal | #7684 |
| peanut | #7684 |
| rna ribosomal | #7700 |
| 161 | #7725 |
| nox | #7726 |
| europe | #7728 |
| leukocytes | #7731 |
| population | #7736 |
| characterised | #7744 |
| vehicles | #7748 |
| 308 | #7763 |
| single | #7777 |
| flora | #7792 |
| clinical examination | #7797 |
| infant male | #7799 |
| attended | #7802 |
| sputum | #7804 |
| reader | #7805 |
| lymphocyte subsets | #7808 |
| 66 | #7809 |
| 171 | #7839 |
| pyrosequencing | #7845 |
| conjunction | #7848 |
| m3 | #7856 |
| pa | #7859 |
| participation | #7865 |
| 1996 | #7881 |
| investigators | #7882 |
| specific | #7895 |
| deficiencies | #7898 |
| asked | #7899 |
| specificities | #7907 |
| months age | #7912 |
| parasitic | #7915 |
| epigenesis genetic | #7919 |
| neisseria | #7922 |
| 160 | #7928 |
| protective role | #7929 |
| egg | #7933 |
| therapeutic intervention | #7939 |
| listeria monocytogenes | #7941 |
| pbmcs | #7944 |
| fall | #7947 |
| unresolved | #7949 |
| lockdown | #7950 |
| prevalence incidence | #7950 |
| immune function | #7953 |
| altering | #7959 |
| human subjects | #7966 |
| collecting | #7980 |
| explanatory | #7997 |
| fatty acid composition | #8002 |
| lacking | #8024 |
| 264 | #8040 |
| bordetella | #8049 |
| phorbol | #8077 |
| separately | #8084 |
| rising | #8086 |
| 304 | #8087 |
| helper inducer | #8091 |
| weight infant | #8101 |
| 088 | #8109 |
| determinants | #8119 |
| regarded | #8119 |
| multiple logistic | #8132 |
| career | #8149 |
| factor binding | #8160 |
| polymorphism genetic | #8162 |
| gene regulation | #8172 |
| etiologies | #8201 |
| omega3 | #8202 |
| mutually | #8209 |
| initiative | #8212 |
| sophisticated | #8214 |
| 140 | #8224 |
| community based | #8228 |
| epigenesis | #8236 |
| emerged | #8237 |
| 266 | #8255 |
| hypotheses | #8257 |
| cars | #8265 |
| examination | #8283 |
| modifiable | #8285 |
| adolescent | #8294 |
| 242 | #8295 |
| hc | #8303 |
| belonged | #8306 |
| humans immunization | #8308 |
| based cohort | #8312 |
| nights | #8331 |
| objectives | #8337 |
| critical roles | #8342 |
| 111 | #8348 |
| nasal mucosa | #8351 |
| genera | #8357 |
| nineteen | #8357 |
| pylori infection | #8359 |
| normal weight | #8367 |
| instillation | #8385 |
| interleukin10 | #8388 |
| relative abundance | #8412 |
| latest | #8415 |
| author | #8420 |
| spearman | #8422 |
| infant low | #8429 |
| covariate | #8435 |
| authorities | #8438 |
| aspergillosis | #8440 |
| reduce risk | #8441 |
| 16s | #8447 |
| 113 | #8460 |
| multifactorial | #8460 |
| syncytial | #8462 |
| anhydride | #8462 |
| contrasting | #8463 |
| minor | #8478 |
| similarities | #8478 |
| profound | #8479 |
| investigate | #8497 |
| asthmatic patients | #8506 |
| resembles | #8511 |
| mass body | #8521 |
| genetic factors | #8538 |
| relations | #8543 |
| cytokines | #8544 |
| so2 | #8558 |
| prospective cohort study | #8565 |
| extract | #8568 |
| 4 years | #8590 |
| inclusion | #8598 |
| genetic loci | #8618 |
| humidity | #8633 |
| facilitates | #8642 |
| strong evidence | #8645 |
| logistic | #8648 |
| animal | #8656 |
| dendritic cells dcs | #8665 |
| adaptive | #8676 |
| 101 | #8677 |
| oropharynx | #8681 |
| defines | #8685 |
| histamine | #8716 |
| responsiveness | #8726 |
| increased odds | #8730 |
| choosing | #8732 |
| prevention | #8737 |
| 193 | #8776 |
| exploring | #8780 |
| 30 years | #8799 |
| airborne | #8805 |
| vdr | #8811 |
| incidence infant | #8815 |
| integrates | #8824 |
| unknown | #8840 |
| alveoli | #8852 |
| antibody levels | #8861 |
| traditional | #8865 |
| 155 | #8867 |
| association analysis | #8868 |
| humans logistic | #8879 |
| ears | #8884 |
| burden disease | #8884 |
| cesarean | #8884 |
| utilization | #8888 |
| residence | #8903 |
| bdnf | #8911 |
| pools | #8916 |
| 273 | #8926 |
| processed | #8935 |
| reactive protein | #8944 |
| pattern recognition | #8957 |
| lipopolysaccharide lps | #8958 |
| olive | #8963 |
| phase | #8966 |
| 177 | #8983 |
| 194 | #8996 |
| 0007 | #8998 |
| underlying | #9006 |
| 172 | #9017 |
| preschool humans | #9028 |
| surveyed | #9029 |
| humans lung | #9031 |
| sequelae | #9032 |
| receptor 4 | #9040 |
| population surveillance | #9046 |
| transferase | #9049 |
| cytokine | #9057 |
| boys girls | #9070 |
| london | #9088 |
| lower risk | #9095 |
| median duration | #9096 |
| parturition | #9101 |
| flanking | #9109 |
| nutritional physiological | #9139 |
| determinant | #9154 |
| statistical methods | #9170 |
| differing | #9175 |
| study selection | #9180 |
| butyrate | #9182 |
| secretions | #9187 |
| food | #9198 |
| exert | #9209 |
| dogs | #9217 |
| fungi | #9222 |
| 186 | #9234 |
| accompanying | #9239 |
| pattern | #9248 |
| human skin | #9259 |
| multivariate analyses | #9269 |
| popularity | #9269 |
| 04 | #9278 |
| 275 | #9282 |
| counts | #9296 |
| quintile | #9297 |
| controversial | #9299 |
| tract | #9302 |
| 95 women | #9304 |
| haplotype | #9306 |
| allele frequency | #9306 |
| outcome measures | #9309 |
| 345 | #9313 |
| anova | #9328 |
| prospectively | #9334 |
| eosinophilia | #9338 |
| vocs | #9351 |
| logistic regression analysis | #9353 |
| funded | #9360 |
| responders | #9364 |
| olds | #9364 |
| proteinase | #9366 |
| urban | #9376 |
| tlr4 | #9383 |
| infantile | #9386 |
| numerous | #9388 |
| 232 | #9392 |
| maldi | #9404 |
| ages | #9407 |
| newborn | #9409 |
| incidence | #9412 |
| 286 | #9422 |
| 5000 | #9432 |
| streptococcus | #9438 |
| extrinsic | #9445 |
| sick | #9460 |
| countries | #9478 |
| 016 | #9481 |
| anthropometric | #9495 |
| worker | #9498 |
| fatty acids | #9509 |
| longitudinally | #9512 |
| comprise | #9517 |
| markers | #9532 |
| antigen presenting | #9554 |
| 256 | #9559 |
| body composition | #9561 |
| airway obstruction | #9573 |
| 165 | #9574 |
| pharyngeal | #9579 |
| global health | #9583 |
| social class | #9585 |
| ifn gamma | #9589 |
| actinobacteria | #9597 |
| nutritive | #9598 |
| replicated | #9599 |
| occurrence | #9605 |
| lessons | #9617 |
| increases risk | #9627 |
| substances | #9659 |
| mucous | #9666 |
| adult mice | #9669 |
| dietary supplements | #9672 |
| crude | #9672 |
| child child | #9678 |
| reference | #9687 |
| obesity | #9698 |
| common genetic | #9743 |
| diagnoses | #9743 |
| populationbased study | #9744 |
| 9 | #9746 |
| p004 | #9752 |
| mothers | #9753 |
| mononuclear cells | #9760 |
| il10 | #9761 |
| proinflammatory | #9761 |
| publications | #9772 |
| directly | #9772 |
| 1 protein | #9773 |
| obstruction | #9774 |
| body mass bmi | #9788 |
| reliable | #9790 |
| 158 | #9800 |
| electrophoretic | #9807 |
| therapeutic strategies | #9818 |
| prove | #9826 |
| 20th | #9843 |
| random allocation | #9844 |
| cluster | #9849 |
| 102 | #9849 |
| modifying | #9850 |
| rrna | #9873 |
| nps | #9884 |
| restrictive | #9899 |
| altogether | #9903 |
| reality | #9904 |
| receptors | #9909 |
| immunomodulatory | #9920 |
| tagging | #9925 |
| intranasal | #9929 |
| century | #9933 |
| 39 | #9935 |
| southern | #9938 |
| 1991 | #9964 |
| bacterial infections | #9964 |
| tnf α | #9973 |
| 0002 | #9995 |
| exclusively | #10002 |
| 152 | #10006 |
| lavage fluid | #10012 |
| presenting cells | #10012 |
| particulate matter | #10015 |
| mass bmi | #10020 |
| health outcomes | #10050 |
| reproducible | #10052 |
| 57 | #10065 |
| disappeared | #10087 |
| 87 | #10096 |
| elucidation | #10099 |
| parts | #10121 |
| superoxide dismutase | #10123 |
| immune cell | #10127 |
| 072 | #10143 |
| nasal | #10159 |
| exist | #10160 |
| bias | #10162 |
| expression genes | #10164 |
| ascertained | #10166 |
| sedentary behavior | #10168 |
| exclusions | #10169 |
| 4 months | #10169 |
| timing | #10174 |
| incidence prevalence | #10175 |
| discover | #10203 |
| western | #10210 |
| microbial communities | #10218 |
| fungal | #10222 |
| adaptor proteins | #10226 |
| alpha subunit | #10236 |
| weaker | #10259 |
| influenzae | #10264 |
| 212 | #10290 |
| study children | #10303 |
| ghana | #10324 |
| aim | #10332 |
| analyze | #10356 |
| interleukin12 | #10361 |
| factorial | #10361 |
| 142 | #10364 |
| centrally | #10386 |
| concepts | #10386 |
| methodologies | #10387 |
| ulcerative colitis | #10399 |
| respiratory disease | #10403 |
| 17 | #10408 |
| polyunsaturated | #10422 |
| parasites | #10430 |
| scientific | #10436 |
| modelled | #10448 |
| nose | #10465 |
| flow rate | #10471 |
| bronchiolitis | #10473 |
| exposed | #10477 |
| 07 | #10499 |
| realtime pcr | #10503 |
| c3h | #10522 |
| twothirds | #10527 |
| interquartile range | #10528 |
| adjusted | #10532 |
| acetates | #10561 |
| 94 | #10565 |
| new zealand | #10576 |
| biodiversity | #10595 |
| 010 | #10595 |
| societal | #10603 |
| france | #10605 |
| priming | #10614 |
| homeodomain | #10623 |
| time pcr | #10638 |
| boys | #10643 |
| indirectly | #10650 |
| bacteriological | #10653 |
| 206 | #10664 |
| 004 | #10665 |
| ribosomal | #10691 |
| vitamins | #10703 |
| bidirectional | #10706 |
| positivity | #10711 |
| possibilities | #10723 |
| 008 | #10728 |
| items | #10729 |
| newborn infant | #10763 |
| ancestry female | #10768 |
| nitrous | #10770 |
| swabs | #10771 |
| entered | #10774 |
| regulation humans | #10776 |
| female gastrointestinal | #10776 |
| responses | #10786 |
| skin | #10787 |
| transferases | #10789 |
| increased production | #10799 |
| national institute | #10805 |
| suppressing | #10825 |
| workshop | #10850 |
| physical activity | #10855 |
| postnatal | #10859 |
| prevent | #10862 |
| bronchoalveolar | #10864 |
| fvc | #10873 |
| km2 | #10911 |
| functional role | #10915 |
| standardization | #10926 |
| 2002 | #10934 |
| 036 | #10944 |
| carriers | #10949 |
| subclinical | #10957 |
| microbiological | #10968 |
| subsequent | #10971 |
| 16s rrna | #10983 |
| immunoglobulins | #10986 |
| lps | #10988 |
| roc | #10992 |
| 217 | #10992 |
| 191 | #10993 |
| constituents | #10993 |
| harm | #10994 |
| 197 | #10996 |
| aerosol | #11002 |
| swiss | #11006 |
| inconsistent | #11009 |
| chance | #11022 |
| poland | #11028 |
| antibody responses | #11043 |
| amniotic | #11054 |
| 6 12 | #11055 |
| serology | #11092 |
| low birth | #11092 |
| passive | #11120 |
| chromosomes human | #11127 |
| ulcerative | #11134 |
| disturbed | #11159 |
| 235 | #11177 |
| crohn | #11187 |
| community | #11188 |
| 144 | #11222 |
| gut | #11232 |
| il12 | #11233 |
| confined | #11247 |
| environmental pollutants | #11258 |
| fourth | #11270 |
| 157 | #11286 |
| rna messenger | #11289 |
| duration | #11314 |
| regulatory mechanisms | #11327 |
| highest risk | #11328 |
| intron | #11330 |
| studies diet | #11351 |
| persistent | #11353 |
| chronic diseases | #11376 |
| 040 | #11389 |
| birth weight | #11397 |
| juvenile | #11415 |
| nitrogen dioxide | #11427 |
| cell function | #11428 |
| modulate | #11435 |
| supplements | #11440 |
| 18 years | #11446 |
| discuss | #11455 |
| female | #11457 |
| 105 | #11459 |
| epigenetics | #11463 |
| gut microbiota | #11475 |
| quinolines | #11485 |
| genetic susceptibility | #11493 |
| 128 | #11502 |
| factor1 | #11515 |
| 86 | #11521 |
| haemophilus influenzae | #11522 |
| late onset | #11524 |
| helicobacter | #11533 |
| biomarker | #11536 |
| 012 | #11542 |
| cd28 | #11550 |
| interact | #11564 |
| 78 | #11583 |
| proteases | #11587 |
| households | #11587 |
| variant | #11588 |
| physiological phenomena | #11594 |
| healthy control | #11597 |
| 130 | #11601 |
| celiac | #11633 |
| risk disease | #11636 |
| dispersion | #11666 |
| narrative | #11668 |
| interquartile | #11709 |
| gene polymorphisms | #11736 |
| introduction | #11752 |
| trimester pregnancy | #11755 |
| confirmation | #11758 |
| harmful | #11806 |
| lipopolysaccharides | #11813 |
| 222 | #11824 |
| gram negative | #11824 |
| irrespective | #11831 |
| 075 | #11858 |
| subtypes | #11860 |
| episodes | #11867 |
| incident | #11881 |
| insight | #11899 |
| fetal | #11900 |
| 230 | #11904 |
| air | #11924 |
| started | #11931 |
| genetic | #11936 |
| ifn | #11939 |
| 1990 | #11944 |
| autoantigens | #11967 |
| natural | #11982 |
| lowest | #11990 |
| genetic association | #11992 |
| protein levels | #11997 |
| finding | #12007 |
| initially | #12014 |
| 151 | #12047 |
| solely | #12055 |
| quantifying | #12075 |
| pcr | #12106 |
| case control | #12121 |
| ultimately | #12124 |
| upregulation | #12127 |
| immunologic factors | #12176 |
| subsets | #12179 |
| estimating | #12184 |
| country | #12201 |
| young children | #12219 |
| 149 | #12221 |
| inflammatory response | #12238 |
| leukocyte count | #12248 |
| fish oil | #12249 |
| december | #12256 |
| sle | #12270 |
| shifted | #12297 |
| began | #12327 |
| relapsing | #12330 |
| antibiotics | #12339 |
| 006 | #12341 |
| gm | #12351 |
| completed | #12354 |
| european continental | #12371 |
| minority | #12421 |
| linkage | #12422 |
| reasons | #12444 |
| ifngamma | #12445 |
| relevance | #12447 |
| lung tissue | #12462 |
| colonization | #12463 |
| 170 | #12467 |
| european | #12469 |
| inflammatory cytokine | #12469 |
| lymphocyte activation | #12520 |
| saline | #12546 |
| scarce | #12583 |
| 17 years | #12583 |
| 117 | #12590 |
| defense | #12609 |
| length polymorphism | #12616 |
| predictors | #12620 |
| tobacco | #12634 |
| crohns disease | #12638 |
| discriminating | #12641 |
| 203 | #12655 |
| residence characteristics | #12657 |
| tested | #12664 |
| collect | #12680 |
| detectable | #12682 |
| 156 | #12683 |
| cd3 | #12684 |
| total | #12687 |
| child development | #12695 |
| cystic fibrosis | #12696 |
| contributing | #12697 |
| residential | #12708 |
| multicentre | #12731 |
| beta2 | #12735 |
| aspect | #12741 |
| swedish | #12751 |
| enhancer | #12752 |
| 204 | #12773 |
| clinical manifestations | #12796 |
| 184 | #12815 |
| lung diseases | #12819 |
| combinations | #12856 |
| 104 | #12860 |
| pregnancy | #12873 |
| aspects | #12899 |
| sedentary | #12908 |
| translated | #12918 |
| infants | #12943 |
| elevated levels | #12943 |
| united kingdom | #12946 |
| debate | #12955 |
| human genome | #12959 |
| inflammatory bowel | #12963 |
| coded | #12998 |
| 154 | #13016 |
| 52 | #13056 |
| annually | #13056 |
| 220 | #13057 |
| elusive | #13067 |
| extracellular vesicles | #13082 |
| suffer | #13086 |
| future | #13086 |
| glucocorticoids humans | #13096 |
| genetic rna | #13096 |
| intrauterine | #13097 |
| measurable | #13120 |
| delayed | #13147 |
| conversely | #13160 |
| schistosomiasis | #13161 |
| differential effects | #13191 |
| strong association | #13209 |
| glucocorticoid | #13217 |
| methodological | #13236 |
| great | #13255 |
| developing countries | #13257 |
| 127 | #13262 |
| consultation | #13264 |
| 276 | #13267 |
| 018 | #13274 |
| proportions | #13279 |
| stimulated | #13297 |
| weaning | #13299 |
| hallmark | #13313 |
| 017 | #13323 |
| manifestations | #13333 |
| gene | #13338 |
| odds ratios | #13351 |
| nucleotide risk | #13354 |
| pediatric | #13397 |
| crp | #13407 |
| initiate | #13419 |
| 11 | #13424 |
| burden | #13446 |
| bowel | #13447 |
| kingdom | #13448 |
| auc | #13449 |
| mechanisms underlying | #13450 |
| 210 | #13457 |
| 20th century | #13476 |
| younger | #13480 |
| secretion | #13500 |
| 129 | #13518 |
| considerable | #13527 |
| 045 | #13543 |
| relevant | #13545 |
| confirm | #13567 |
| beijing | #13578 |
| visits | #13581 |
| 188 | #13602 |
| statistically | #13612 |
| respiratory syncytial | #13621 |
| 1989 | #13652 |
| inheritance | #13663 |
| 181 | #13690 |
| argue | #13695 |
| 020 | #13702 |
| depending | #13723 |
| lavage | #13735 |
| 014 | #13736 |
| pneumonia | #13774 |
| study association | #13782 |
| neighboring | #13790 |
| impairment | #13810 |
| sweden | #13833 |
| schistosoma | #13835 |
| severe | #13852 |
| concerns | #13856 |
| cohorts | #13856 |
| establishing | #13859 |
| genomics humans | #13875 |
| human pair | #13893 |
| ranged | #13900 |
| multiplex | #13937 |
| loci | #13953 |
| membrane glycoproteins | #14048 |
| mental health | #14054 |
| additionally | #14064 |
| chromosomes | #14069 |
| fat mass | #14090 |
| restore | #14107 |
| tendency | #14138 |
| nucleotide polymorphism | #14141 |
| establish | #14142 |
| subgroups | #14166 |
| immigrants | #14182 |
| randomly selected | #14189 |
| examples | #14202 |
| fetal development | #14226 |
| expand | #14234 |
| 183 | #14237 |
| concomitant | #14257 |
| socioeconomic status | #14258 |
| multigene | #14259 |
| disease genome | #14278 |
| refined | #14314 |
| breast | #14318 |
| unsaturated | #14320 |
| addresses | #14337 |
| independently | #14350 |
| health organization | #14355 |
| tightly | #14399 |
| amniotic fluid | #14424 |
| severity | #14432 |
| 121 | #14439 |
| penicillium | #14441 |
| epidemiologic studies | #14443 |
| tuberculosis | #14444 |
| 1 month | #14454 |
| studying | #14492 |
| 007 | #14492 |
| derivation | #14517 |
| tolerance | #14521 |
| contributed | #14529 |
| conclude | #14532 |
| systematically | #14533 |
| elevated | #14573 |
| humans | #14580 |
| factors socioeconomic | #14586 |
| cystic | #14593 |
| stranded | #14599 |
| food intake | #14600 |
| horse | #14606 |
| animals antigens | #14624 |
| 6 | #14638 |
| differentially expressed | #14641 |
| effector cells | #14675 |
| 205 | #14693 |
| striking | #14700 |
| lymphocyte count | #14703 |
| lipopolysaccharide | #14704 |
| filament | #14706 |
| transcription | #14707 |
| representative | #14726 |
| tetradecanoylphorbol | #14755 |
| classify | #14766 |
| trimester | #14772 |
| operate | #14777 |
| represents | #14788 |
| glycoproteins | #14799 |
| maximal | #14801 |
| cells patients | #14821 |
| determines | #14831 |
| 2 years | #14850 |
| seropositivity | #14866 |
| genetic analysis | #14890 |
| mice mice | #14912 |
| 002 | #14917 |
| ancestry | #14925 |
| maternal age | #14929 |
| clostridium | #14981 |
| marker | #14999 |
| ctla4 | #15005 |
| 162 | #15012 |
| ethnic | #15032 |
| male | #15042 |
| receptor | #15068 |
| compared healthy | #15084 |
| modulates | #15087 |
| disparities | #15118 |
| 00001 | #15123 |
| stronger | #15140 |
| p00001 | #15177 |
| luciferase | #15184 |
| gram | #15200 |
| longitudinal studies | #15223 |
| immune cells | #15233 |
| 131 | #15264 |
| hong kong | #15269 |
| cumulative | #15330 |
| copd | #15346 |
| nfkappab | #15356 |
| environmental monitoring | #15362 |
| socioeconomic | #15368 |
| gestational age | #15392 |
| curve | #15407 |
| physician | #15419 |
| integrate | #15467 |
| induce | #15469 |
| assessing | #15476 |
| modulated | #15501 |
| cells dcs | #15509 |
| perinatal | #15516 |
| pregnancy risk | #15527 |
| gonadal | #15550 |
| marked | #15553 |
| feces | #15556 |
| 003 | #15556 |
| dysregulation | #15556 |
| 110 | #15569 |
| built | #15581 |
| archaea | #15621 |
| tgfβ | #15667 |
| cytometry | #15669 |
| controlling | #15688 |
| inflammatory agents | #15708 |
| dietary fats | #15739 |
| cell surface receptors | #15743 |
| igg | #15765 |
| genotype | #15766 |
| il1 | #15772 |
| imply | #15830 |
| pregnant | #15831 |
| exclusive | #15843 |
| developed countries | #15863 |
| 47 | #15874 |
| cells animals | #15894 |
| 116 | #15895 |
| socioeconomic factors | #15901 |
| sensitivity specificity | #15922 |
| reflected | #15966 |
| humans inflammation | #15992 |
| agreement | #16016 |
| varies | #16017 |
| diagnosed | #16043 |
| unrelated | #16046 |
| casecontrol study | #16049 |
| filled | #16050 |
| transient | #16060 |
| conditional | #16084 |
| interleukin1beta | #16103 |
| major | #16105 |
| 12 | #16129 |
| located | #16168 |
| homozygous | #16182 |
| effector | #16208 |
| inducer | #16232 |
| anti inflammatory | #16238 |
| transducing | #16239 |
| psychosocial | #16242 |
| 93 | #16314 |
| born | #16347 |
| dendritic cells | #16365 |
| define | #16372 |
| causing | #16382 |
| bacterial | #16387 |
| 7 | #16394 |
| genome wide | #16420 |
| varied | #16428 |
| squared | #16431 |
| volatile | #16432 |
| 082 | #16433 |
| bacteria | #16447 |
| represented | #16476 |
| height | #16488 |
| ibd | #16518 |
| established | #16536 |
| identifying | #16549 |
| participants | #16561 |
| thought | #16634 |
| triggered | #16636 |
| areas | #16662 |
| broad | #16671 |
| academic | #16675 |
| functionally | #16694 |
| microsatellite | #16697 |
| genetic polymorphism | #16725 |
| characterizing | #16726 |
| 0006 | #16756 |
| dendritic | #16762 |
| centre | #16765 |
| 084 | #16783 |
| distributed | #16795 |
| agricultural | #16798 |
| dead | #16800 |
| nitric oxide | #16855 |
| chromosome | #16895 |
| bowel disease | #16898 |
| personal | #16912 |
| 09 | #16918 |
| 91 | #16918 |
| investigating | #16978 |
| utilize | #16980 |
| opportunities | #17033 |
| promoter | #17034 |
| steroid | #17056 |
| anti bacterial | #17061 |
| dna bacterial | #17074 |
| 81 | #17089 |
| mother | #17091 |
| epigenetic | #17095 |
| continuing | #17105 |
| messenger | #17106 |
| progression | #17115 |
| monocytes | #17130 |
| genotypes | #17190 |
| confirms | #17201 |
| individual | #17225 |
| seasons | #17244 |
| 53 | #17287 |
| untranslated | #17292 |
| denmark | #17301 |
| 137 | #17321 |
| retinoic | #17351 |
| drug therapy | #17361 |
| earlier | #17361 |
| cross | #17377 |
| encountered | #17387 |
| taxonomic | #17423 |
| visible | #17455 |
| strong | #17549 |
| excluding | #17551 |
| tnfalpha | #17598 |
| heterozygote | #17605 |
| alleles | #17619 |
| avoidance | #17647 |
| bronchoalveolar lavage | #17656 |
| bacterial agents | #17666 |
| introduced | #17690 |
| cd4 cells | #17717 |
| dcs | #17724 |
| initiating | #17727 |
| comparing | #17740 |
| newborns | #17784 |
| quantified | #17787 |
| regression | #17798 |
| lesser | #17810 |
| geographical | #17857 |
| interviewed | #17866 |
| 84 | #17903 |
| covering | #17927 |
| prospective | #17949 |
| bmi | #17963 |
| animals | #17994 |
| 009 | #18003 |
| drawn | #18014 |
| disease chronic | #18024 |
| longitudinal | #18047 |
| particulate | #18073 |
| monthly | #18086 |
| 77 | #18100 |
| altered | #18146 |
| 085 | #18150 |
| publication administration | #18171 |
| children adolescents | #18178 |
| snp | #18187 |
| neurotrophic | #18224 |
| systemic lupus erythematosus | #18235 |
| samples | #18263 |
| restriction fragment | #18268 |
| negative | #18269 |
| dismutase | #18321 |
| susceptibility | #18324 |
| demographics | #18339 |
| recognize | #18347 |
| inflammatory responses | #18460 |
| inflammatory bowel disease | #18499 |
| chemokines | #18511 |
| served | #18518 |
| difference | #18526 |
| mast cell | #18536 |
| 148 | #18545 |
| replication | #18548 |
| exists | #18580 |
| immunization | #18589 |
| remain | #18590 |
| intervals | #18593 |
| secretory | #18604 |
| carried | #18634 |
| fold | #18655 |
| provided | #18675 |
| 83 | #18683 |
| 36 | #18709 |
| symptom | #18710 |
| differentially | #18718 |
| variation genome | #18742 |
| rise | #18757 |
| weight | #18797 |
| epithelial cells | #18798 |
| sum | #18807 |
| candidate | #18807 |
| additional | #18812 |
| immunophenotyping | #18818 |
| families | #18838 |
| 1997 | #18843 |
| basis | #18843 |
| 28 | #18854 |
| maintain | #18856 |
| variants | #18858 |
| 13 | #18882 |
| fragment length | #18919 |
| missing | #18966 |
| lower | #18985 |
| sampling | #19004 |
| receptors cell | #19024 |
| intake | #19030 |
| vitamin | #19034 |
| experiencing | #19122 |
| susceptible | #19133 |
| fats | #19173 |
| balb mice | #19208 |
| crosssectional study | #19250 |
| c57bl mice | #19256 |
| promoter regions | #19283 |
| polymerase | #19291 |
| locus | #19302 |
| clinical presentation | #19308 |
| 1992 | #19352 |
| contributes | #19382 |
| termed | #19414 |
| trait loci | #19415 |
| mouse model | #19415 |
| clear | #19476 |
| partially | #19504 |
| completely | #19506 |
| elucidate | #19510 |
| socio | #19512 |
| × 10 | #19521 |
| pollutants | #19552 |
| validated | #19554 |
| necrosis | #19582 |
| illustrate | #19602 |
| lasting | #19718 |
| time polymerase | #19720 |
| healthrelated quality | #19789 |
| polymerase chain | #19797 |
| 1998 | #19855 |
| inbred balb mice | #19855 |
| chronic obstructive | #19868 |
| 5 years | #19869 |
| selecting | #19937 |
| carrying | #19967 |
| baseline | #19977 |
| context | #19977 |
| negatively | #19998 |
| 95 confidence interval | #20023 |
| inbred balb | #20051 |
| interferon gamma | #20056 |
| easy | #20065 |
| acetaminophen | #20066 |
| shared | #20130 |
| 74 | #20150 |
| 64 | #20157 |
| health | #20163 |
| activates | #20164 |
| summary | #20181 |
| reporter | #20212 |
| serological | #20244 |
| adjusting | #20271 |
| 1 year | #20289 |
| interacting | #20295 |
| autoimmune diseases | #20301 |
| 61 | #20339 |
| stimulation | #20363 |
| 14 | #20418 |
| identifies | #20457 |
| demonstrating | #20473 |
| 2003 | #20528 |
| humans longitudinal | #20557 |
| returned | #20566 |
| ratio | #20593 |
| 26 | #20613 |
| inflammatory | #20615 |
| interactions | #20618 |
| behavior female | #20629 |
| nitric | #20636 |
| chain reaction | #20655 |
| upregulated | #20694 |
| highest | #20707 |
| genetically | #20746 |
| immunologic | #20771 |
| recurrent | #20779 |
| cells female | #20794 |
| interleukin | #20806 |
| wide | #20813 |
| clarify | #20844 |
| blood | #20864 |
| 51 | #20870 |
| cd4 cell | #20884 |
| rodents | #20894 |
| infectious | #20895 |
| causal | #20898 |
| create | #20974 |
| mucosal | #20983 |
| named | #20988 |
| obstructive | #20991 |
| interval | #21015 |
| suggesting | #21054 |
| 59 | #21130 |
| hereditary | #21187 |
| identical | #21192 |
| followup | #21199 |
| regulation | #21207 |
| epithelial cell | #21236 |
| essentially | #21325 |
| kappab | #21354 |
| variety | #21563 |
| mast | #21565 |
| celiac disease | #21617 |
| infection | #21622 |
| endpoint | #21718 |
| tumor necrosis | #21799 |
| reduced | #21829 |
| 10 years | #21837 |
| measures | #21851 |
| stress psychological | #21874 |
| alterations | #22024 |
| definitive | #22102 |
| assess | #22118 |
| continued | #22161 |
| correlate | #22201 |
| familial | #22235 |
| ensure | #22257 |
| frequency | #22288 |
| abolished | #22332 |
| continental ancestry | #22431 |
| reflecting | #22432 |
| unchanged | #22438 |
| validation | #22455 |
| score | #22546 |
| frequent | #22558 |
| tumor necrosis factor | #22615 |
| 95 confidence | #22620 |
| balb | #22645 |
| closely | #22684 |
| genes | #22753 |
| coupled | #22803 |
| continuously | #22829 |
| reactive | #22841 |
| indicating | #22843 |
| comparable | #22875 |
| murine | #22957 |
| 22 | #22977 |
| neonatal | #22988 |
| supported | #23008 |
| introduce | #23009 |
| type 1 | #23013 |
| report | #23048 |
| ifnγ | #23104 |
| necrosis factor | #23137 |
| predict | #23148 |
| lived | #23179 |
| increasingly | #23205 |
| rich | #23217 |
| count | #23292 |
| smoking | #23305 |
| modulating | #23348 |
| late | #23357 |
| mechanisms | #23394 |
| confidence | #23438 |
| 1 | #23526 |
| young | #23528 |
| adjustment | #23611 |
| exclude | #23665 |
| endopeptidases | #23709 |
| adolescents | #23720 |
| factors united | #23849 |
| defined | #23927 |
| extensive | #23929 |
| body | #24002 |
| dietary | #24027 |
| intracellular | #24110 |
| 5 | #24167 |
| 3 | #24232 |
| lymphocytes | #24242 |
| aimed | #24342 |
| increasing | #24355 |
| symptomatic | #24455 |
| depend | #24530 |
| reduces | #24548 |
| interaction | #24609 |
| collected | #24626 |
| adults | #24658 |
| remains | #24734 |
| needed | #24798 |
| responsible | #24851 |
| rsv | #24888 |
| 15 | #24969 |
| putative | #25032 |
| identification | #25068 |
| enrolled | #25223 |
| representing | #25239 |
| yielded | #25263 |
| determine | #25273 |
| extracellular | #25281 |
| analysis performed | #25297 |
| sex factors | #25359 |
| documented | #25522 |
| anti | #25535 |
| describing | #25574 |
| comprised | #25660 |
| matter | #25795 |
| transcriptase polymerase | #25871 |
| continue | #25896 |
| lymphocyte | #25994 |
| decreased | #26047 |
| enabling | #26157 |
| diminished | #26261 |
| previous | #26271 |
| healthy | #26310 |
| 16 | #26319 |
| profiling gene | #26374 |
| implicated | #26377 |
| dioxide | #26380 |
| inflammation | #26386 |
| tended | #26519 |
| applied | #26644 |
| contained | #26780 |
| describes | #26787 |
| generally | #26891 |
| multivariate | #26969 |
| capable | #27003 |
| unaffected | #27064 |
| presenting | #27110 |
| moderate | #27144 |
| 18 | #27195 |
| heterozygous | #27203 |
| acquired | #27213 |
| oligonucleotide | #27226 |
| concluded | #27331 |
| undergone | #27359 |
| topic | #27376 |
| proteins signal | #27393 |
| reached | #27432 |
| large | #27637 |
| recognized | #27654 |
| positive lymphocytes | #27691 |
| 001 | #27802 |
| linked | #27832 |
| preschool female | #27932 |
| models genetic | #27987 |
| predicted | #28046 |
| 0005 | #28071 |
| subsequently | #28087 |
| quantitative | #28099 |
| respect | #28131 |
| represent | #28157 |
| impaired | #28234 |
| reverse transcriptase | #28434 |
| continental | #28581 |
| plays | #28633 |
| positive | #28648 |
| immunoenzyme | #28655 |
| occurring | #28707 |
| screened | #28708 |
| square distribution | #28750 |
| transcriptase | #29017 |
| quantitative trait | #29137 |
| versus | #29158 |
| allowed | #29194 |
| comparison | #29267 |
| affect | #29339 |
| administered | #29469 |
| easily | #29520 |
| human | #29690 |
| weak | #29736 |
| possess | #29786 |
| physical | #29792 |
| pair | #29885 |
| correlated | #29909 |
| chain | #29911 |
| characterize | #29984 |
| gastrointestinal | #30316 |
| providing | #30537 |
| 005 | #30590 |
| aims | #30608 |
| factual | #30658 |
| 2 | #30659 |
| confirmed | #30719 |
| markedly | #30761 |
| 4 | #30907 |
| eligible | #31311 |
| fatty | #31332 |
| upper | #31437 |
| frequently | #32564 |
| mice knockout | #32696 |
| predictive tests | #32836 |
| peripheral | #32944 |
| humanized | #33092 |
| expression | #33163 |
| registered | #33261 |
| functional | #33617 |
| dominated | #33759 |
| selected | #33999 |
| mediated | #34372 |
| independent | #34407 |
| activate | #34542 |
| acids | #34703 |
| occur | #34769 |
| mediate | #35225 |
| conducted | #35568 |
| national | #35610 |
| evaluate | #35821 |
| 0001 | #35859 |
| developed | #36145 |
| characterized | #36394 |
| measurements | #36573 |
| express | #37054 |
| measured | #37778 |
| follow studies | #37967 |
| appears | #37978 |
| biological | #38141 |
| examined | #38373 |
| include | #39853 |
| adult | #39859 |
| clinically | #40140 |
| united | #42200 |
| mice inbred | #42559 |
| consistent | #42590 |
| excluded | #42832 |
| expression regulation | #43143 |
| inbred | #45657 |
レポートを実行します | |
Prominent publications by Erika RM von Mutius
KOL-Index: 23349
BACKGROUND: Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma.
METHODS: As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, ...
| で知られている Risk Asthma | 7 Years | Year Life | Children Aged | Rhinoconjunctivitis Eczema |
KOL-Index: 18397
BACKGROUND: Phase III of the International Study of Asthma and Allergies in Childhood measured the global prevalence of symptoms of asthma, rhinoconjunctivitis, and eczema in children.
OBJECTIVE: To investigate the associations between the use of antibiotics in the first year of life and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old.
METHODS: Parents or guardians of children 6 and 7 years old completed written questionnaires on current symptoms and ...
| で知られている International Study | Rhinoconjunctivitis Eczema | Year Life | Symptoms Asthma | 95 Risk Factors |
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
[ PUBLICATION ]
Importance: Atopic dermatitis is an inflammatory, pruritic skin disease that often occurs in early infancy with a chronic course. However, a specific description of subtypes of atopic dermatitis depending on the timing of onset and progression of the disease in childhood is lacking.
Objective: To identify different phenotypes of atopic dermatitis using a definition based on symptoms before age 6 years and to determine whether some subtypes are more at risk for developing other allergic ...
| で知られている Atopic Dermatitis | 6 Years | Age Children | Allergic Diseases | Food Allergy |
KOL-Index: 17686
BACKGROUND: Associations between exposure to cats and dogs and respiratory and allergic outcomes in children have been reported in affluent countries, but little is known about such associations in less-affluent countries.
METHODS: The International Study of Asthma and Allergies in Childhood, phase 3 was carried out in children aged 6-7 years and adolescents aged 13-14 years across the world. Questions about cats and dogs in the home were included in an additional questionnaire. Using ...
| で知られている Cats Dogs | Asthma Rhinoconjunctivitis | Affluent Countries | Children Adolescents | International Study |
KOL-Index: 15451
BACKGROUND: There is increasing evidence that environmental exposures determining childhood illnesses operate early in life. Prenatal exposure to a farming environment through the mother might also play an important role.
OBJECTIVE: We sought to investigate the role of maternal exposures to environments rich in microbial compounds for the development of atopic sensitization, asthma, and corresponding alterations in the innate immune system in offspring.
METHODS: In the children of the ...
| で知られている Atopic Sensitization | Innate Immunity | Farm Exposure | Microbial Compounds | Expression Receptors |
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
[ PUBLICATION ]
BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.
METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...
| で知られている Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure |
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
[ PUBLICATION ]
OBJECTIVES: To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.
DESIGN: Prevalence surveys among school-children aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function ...
| で知られている Allergic Disorders | Munich Leipzig | Prevalence Asthma | Seasonal Surveys | Living Conditions |
KOL-Index: 14833
BACKGROUND: Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
METHODS: We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an ...
| で知られている European Ancestry | Association Asthma | Single Nucleotide Receptors | Tumor Necrosis Factor | Human Pair |
Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study
[ PUBLICATION ]
BACKGROUND: Associations between early life exposure to farm animals and respiratory symptoms and allergy in children have been reported in developed countries, but little is known about such associations in developing countries.
OBJECTIVE: To study the association between early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema in a worldwide study.
METHODS: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) was carried ...
| で知られている Farm Animals | Asthma Rhinoconjunctivitis | Isaac Phase | Early Life | Affluent Countries |
KOL-Index: 14598
The German reunification offers a unique opportunity to study the impact of environmental factors on the development of childhood respiratory and allergic disorders in ethnically similar populations. We investigated the prevalence of asthma, hay fever, atopy, and bronchial hyperresponsiveness (BHR) in 9- to 11-year old children in West Germany (n = 5,030) and East Germany (n = 2,623). A self-administered questionnaire was distributed to the parents. Children underwent cold air challenge ...
| で知られている East Germany | Asthma Fever | Prevalence Bhr | Environmental Factors | Atopic Sensitization |
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
[ PUBLICATION ]
International comparative studies, investigating whether disease incidence or prevalence rates differ between populations and, if so, which factors explain the observed differences, have made important contributions to the understanding of disease aetiology in many areas. In Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence rates of symptoms of asthma, allergic rhinitis and atopic eczema in 13-14-yr-olds, assessed by standardised ...
| で知られている International Study | Asthma Allergies | Prevalence Rates | Atopic Eczema | Childhood Isaac |
KOL-Index: 13844
BACKGROUND: Mutations in the filaggrin gene (FLG) have been shown to play a significant role in ichthyosis vulgaris and eczema, 2 common chronic skin diseases. However, their role in the development of other atopic diseases such as asthma and rhinitis has not yet been clarified in large population-based studies.
OBJECTIVES: To study the effect of FLG mutations at the population level and their effect on other atopic phenotypes.
METHODS: Association analysis of the 2 common FLG-null ...
| で知られている Filaggrin Mutations | Atopic Eczema | Allergic Rhinitis Asthma | Role Development | Disease Genotype Humans |
Increased food diversity in the first year of life is inversely associated with allergic diseases
[ PUBLICATION ]
BACKGROUND: The role of dietary factors in the development of allergies is a topic of debate, especially the potential associations between infant feeding practices and allergic diseases. Previously, we reported that increased food diversity introduced during the first year of life reduced the risk of atopic dermatitis.
OBJECTIVE: In this study we investigated the association between the introduction of food during the first year of life and the development of asthma, allergic rhinitis, ...
| で知られている Food Diversity | Allergic Diseases | Year Life | Development Asthma | Atopic Sensitization |
のための重要な人々 Atopic Dermatitis
世界のトップコル
Erika RM von Mutius:専門家の影響
その概念Erika RM von Mutius直接的な影響があります:Atopic dermatitis, Childhood asthma, Allergic diseases, Atopic sensitization, Allergic rhinitis, International study, Farm milk, East germany.
Erika RM von Mutius:KOLインパクト
他の著者の仕事に関連する概念for which Erika RM von Mutius 影響力があります:Atopic dermatitis, Allergic rhinitis, Childhood asthma, Food allergy, Lung function, Air pollution, Early life.
Tools
これはあなたのプロフィールですか？ あなたのプロフィールを主張します URLをコピーします プロフィールへのリンクを埋め込みます |